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ABSTRACT 
The transcription activator-like effectors (TALE) are the largest family of the type III 
effector proteins from Xanthomonas spp. Each TALE contains an N-terminal signal for its 
secretion and translocation into host cells, a central modular DNA-binding repeat domain, and 
three nuclear localization signals (NLS) and an acidic activation domain (AD) at the C-terminus. 
Once internalized, TALEs facilitate the bacterial parasitism by transcriptionally activating the 
host target genes. TALE repeats recognize and bind to the target DNA sequence in a simple and 
unique “one to one” fashion, i.e., one repeat corresponds to one nucleotide and one type of repeat 
preferentially binds one of four necleotides, a code that makes TALE an ideal material to achieve 
the recognition of any preselected DNA sequence.  
In my thesis I describe the development and functional characterization of TALENs, 
fusion proteins of native or artificial TALEs and the cleavage domain of the restriction enzyme 
FokI, in vitro and in yeast, and demonstrate the feasibility of customizing the novel TALEN to 
target and inactivate the yeast endogenous genes. I also investigated the efficiency of the gene 
editing through the repair of TALEN-caused double-stranded DNA breaks by non-homologous 
end-joining (NHEJ) and homologous recombination (HR). Furthermore, I utilized the designer 
TALENs to edit the TAL effector binding elements (EBEs) in the promoters of the disease 
susceptibility (S) genes targeted by the rice blight pathogen Xanthomonas oryzae pv. oryzae 
(Xoo). The gene editing disrupted the induction of the S genes by the naturally occurring TALEs 
(PthXo1 and AvrXa7) and thus generated the disease resistant rice lines. Finally, using Xoo-
delivered designer TALEs to induce the expression of rice SWEET genes that encode sugar 
transporters in rice, I identified two disease susceptibility genes potentially targeted by the as yet 
unidentified TALEs in Xanthomonas oryzae pv. oryzae. 
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CHAPTER I 
LITERATURE REVIEW 
TALEN-MEDIATED GENOME EDITING: PROSPECTS AND PERSPECTIVES 
 
David Wright*1, Ting Li*1, Bing Yang*2 and Martin H. Spalding*2 
* Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa 
50011, USA 
1 These authors contribute equally to this work. 
2 To whom correspondence should be addressed (email byang@iastate.edu, 
mspaldin@iastate.edu) 
 
Abstract 
Genome Editing is the practice of making predetermined and precise changes to a genome by 
controlling the location of DNA double strand breaks (DSBs) and manipulating the cell’s repair 
mechanisms.  This technology results from harnessing natural processes that have taken decades 
and multiple lines of inquiry to understand.  Through many false starts and iterative technology 
advances, the goal of Genome Editing is just now falling under the control of human hands as a 
routine and broadly applicable method.  This review attempts to define the technique and capture 
the discovery process while following its evolution from meganucleases and zinc finger 
nucleases to the current state of the art - TALEN technology.  We also discuss factors that 
influence success, technical challenges and future prospects of this quickly evolving area of 
study and application. 
Key words: TAL effector nuclease (TALEN), zinc finger nuclease, meganuclease, homologous 
recombination (HR), genetic engineering, gene editing, genome editing, non-homologous end-
joining (NHEJ) 
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Introduction 
Recombination is a mechanism by which cells repair damaged DNA and exchange 
information between identical or similar DNA molecules. This process is involved in many 
stages of the cell cycle and reproduction, and it aides in replication of some viruses, mobile 
elements and plasmids and plays a part in duplications, deletions and rearrangements of genetic 
material. In short, recombination appears to be essential for all known forms of life by acting 
both to ensure integrity of the genome and to contribute the genomic diversity needed for the 
action of evolutionary forces. 
The ability to manage and exploit this powerful process would bring direct benefit to 
scientific, environmental, medical, agricultural and industrial arenas. Understanding the basic 
mechanism of recombination has been the goal of decades of work, which has resulted in a 
stepwise advancement of techniques that allow it to be routinely managed in selected species, 
including some yeasts and bacteria and mouse and chicken cells. However, even with the 
insights gained so far, directing recombination as a general method for manipulation of genomes 
is limited, laborious and time consuming. 
The advent of high throughput DNA sequencing and the enormous amount of data that 
are available from many “omics” programs underscores the need for a precise method to target 
and modify specific DNA bases within the genome of a broad range of organisms – we refer to 
this practice as Genome Editing. This review will discuss the history, challenges, solutions and 
future of nuclease-mediated Genome Editing with an emphasis on TALEN (Transcription-
Activator-Like Effector Nuclease) technology. 
Genetic recombination is a broad topic with many important discoveries, mechanisms 
and contributors that have expanded our current understanding of the subject. A key element in 
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recombination is the DNA double strand break (DSB), which can halt the cell cycle and lead to 
death if not immediately and efficiently repaired. Here, we will examine nuclease-induced DSBs 
and the two aspects of recombination that seem to play a major role in Genome Editing: non-
homologous end-joining (NHEJ) and homologous recombination (HR). 
NHEJ is a DSB repair pathway that utilizes microhomology at the exposed ends of a 
DSB to guide repair without a template (Figure 1.1A) (Lieber 2010). This type of repair may 
include resection to generate additional single stranded DNA when damage beyond a simple 
DSB is detected. Repair by this pathway generally leads to restoration of the original gene 
sequence (a precise repair), or disruption by a small insertion or deletion (an error-prone repair) 
(Shrivastav, De Haro et al. 2008, Mladenov and Iliakis 2011). The ratio of restoration to 
modification is not known, however it is the mutation aspect that we are interested in exploiting. 
In principal, NHEJ has been a long standing laboratory practice for genetic manipulation.  
Techniques have been developed to randomly break DNA and induce arbitrary mutations 
typically using chemicals, radiation or exogenous DNA. Pools of mutagenized organisms can 
then be screened for interesting phenotypes or specific gene mutations. These techniques have 
led to many breakthroughs and have greatly enhanced scientific understanding of biological 
systems. 
HR is another DSB repair pathway, but it utilizes extended regions of homology between 
the exposed ends of a DSB and a donor DNA molecule, which is used as a template for repair 
(Figure 1.1B) (San Filippo, Sung et al. 2008). Donor DNA is typically endogenous to the cell, 
however, it has been demonstrated by a multitude of HR experiments that exogenous DNA can 
fulfill this role. Unlike NHEJ, HR can replace missing information at the DSB locus; however, if 
the donor DNA template contains alternative information then a gene conversion event can take 
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place. Exogenous template guided HR confers precise control over the DSB repair process, 
which is more valuable in a Genome Editing sense; however, NHEJ appears to be the preferred 
repair pathway in higher eukaryotic organisms (Mladenov and Iliakis 2011). 
Arguably, the most fruitful early eukaryotic recombination experiments were performed 
in the yeast Saccharomyces cerevisiae, which led to many fundamental discoveries and the 
development of new methods (Hinnen, Hicks et al. 1978, Orr-Weaver, Szostak et al. 1981, Orr-
Weaver, Szostak et al. 1983, Rothstein 1983, Szostak, Orr-Weaver et al. 1983). Among the 
findings, was that this organism naturally has a very high rate of HR relative to that of NHEJ. 
Initial recombination experiments in plant and animal cells found that NHEJ usually dominated 
and that HR events were relatively rare. Efforts have been made to improve HR results, typically 
by selecting for rare events through a marker scheme, but the rate of HR still proved to be too 
low for practical use in these species (Smithies, Gregg et al. 1985, Paszkowski, Baur et al. 1988, 
Sedivy and Sharp 1989, Lee, Lund et al. 1990, Offringa, de Groot et al. 1990, Halfter, Morris et 
al. 1992, Miao and Lam 1995, Risseeuw, Offringa et al. 1995). From these experiments, HR has 
been estimated to occur at a frequency of 1x10-3 to 1x10-6. The notable exceptions, outside of 
yeast, include murine embryonic stem cells and chicken DT40 cells. Murine embryonic stem 
cells have a 10 to 100 fold higher rate of HR than other mouse cells, which has led to their 
successful use in the development of gene knockout strategies in mouse (Doetschman, Gregg et 
al. 1987, Thomas and Capecchi 1987, Doetschman, Maeda et al. 1988, Capecchi 1989, Koller 
and Smithies 1992). DT40 cells displayed 50 to 90% HR, relative to the NHEJ rate.  However, 
later studies suggested that the HR rate is not unusually high, but that the NHEJ rate is 
suppressed in these cells (Buerstedde, Reynaud et al. 1990, Buerstedde and Takeda 1991, 
Iiizumi, Kurosawa et al. 2008). It should be noted that DT40 cells are immortalized pre-B-cells, 
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which limits their usefulness outside of studies involving cultured cell lines. While these 
experiments provided insight into recombination and other cellular processes and, in the case of 
mouse, lead to knockout mice, the techniques do not readily lend themselves to use in a broad 
range of organisms. 
Many approaches to controlling recombination have been undertaken, such as positive 
and negative selectable markers, recombinases, transposons, integrases, virus vectors, peptide 
nucleic acids (PNA) triplex-forming oligonucleotides (TFO) and derivative technologies, 
chimeric DNA/RNA molecules (chimeraplasty), small fragment homologous replacement 
(SFHR), and over-expression of recombination mechanism components to name a few. These 
methods have met with some success, but none have proven as broadly applicable as nuclease-
mediated DSB technology. DSB studies using standard restriction endonucleases (4 to 8 bp 
recognition sites) culminating in cell death and genome rearrangements as well as localized 
lesions resulting from the fact that these nucleases cleaved in millions of locations in a large 
genome, never the less, these studies generated a tremendous amount of information regarding 
the effects of DSBs on the cell (Thacker 1994, Stoilov, Mirkova et al. 1996). On the other hand, 
due to their relatively large recognition site requirements, mobile intron derived homing 
nucleases proved to be much more amenable to DSB studies and allowed progress in targeted 
recombination by limiting DSBs. 
 
Meganuclease Technology 
Mobile introns, typically found in phage, archaea, bacteria and lower eukaryotes, engage 
in a replicative process known as intron homing. This occurs when an intron from one allele is 
copied to an intron-less allele of a gene. The mechanism is initiated when an intron encoded 
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homing nuclease binds to an extended (typically 14 to 40 bp) recognition site in an intron-less 
allele, and then breaks the chromosome. The resulting DSB initiates repair, through HR, using 
the intron containing allele as a template. When the process is completed, both genes have the 
same homing-nuclease-gene-containing intron at the same position (Belfort and Perlman 1995, 
Belfort and Roberts 1997, Chevalier and Stoddard 2001). 
A well characterized example is the I-SceI system in Saccharomyces cerevisiae. The 
mitochondrial 21S ribosomal RNA gene of ω+ strains contains a mobile intron, encoding the 
homing nuclease I-SceI, that is transmitted to ω- strains during mating with greater than 95% 
efficiency (Dujon, Slonimski et al. 1974, Netter, Petrochilo et al. 1974, Bos, Heyting et al. 1978, 
Faye, Dennebouy et al. 1979, Dujon 1980, Jacquier and Dujon 1985, Zinn and Butow 1985, 
Dujon 1989). I-SceI recognizes a target of 18 consecutive bp, which would be predicted to cut 
once in 68.7 billion bases, assuming a random genome (Colleaux, d'Auriol et al. 1986, Colleaux, 
D'Auriol et al. 1988, Monteilhet, Perrin et al. 1990). For reference, the size of the yeast genome 
is about 12.1 million bp and that of the human genome is approximately 3.3 billion bp. 
The discovery, purification and characterization of I-SceI sparked an interest in studying 
DSBs in organisms other than yeast and enabled several key recombination studies in mammal, 
amphibian and plant cells during the 1990s (Puchta, Dujon et al. 1993, Rouet, Smih et al. 1994, 
Segal and Carroll 1995). Importantly, this and other work demonstrated an unprecedented 
increase in HR, with results as high as 10-2 to 10-3 for transfected mouse and transformed tobacco 
cells, making it clear that nuclease-mediated DSBs could induce high frequency recombination 
that might be applied universally (Choulika, Perrin et al. 1995, Jasin, Moynahan et al. 1996, 
Puchta, Dujon et al. 1996, Sargent, Brenneman et al. 1997). The remaining hurdle was how to 
introduce specific DSBs in targets for which an appropriate homing nuclease did not exist. 
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This work garnered substantial interest in engineering homing nucleases, also called 
meganucleases, for the task of Genome Editing. While academic researchers have contributed in 
this area, Cellectis and Precision Biosciences, Inc. have been the leaders in a large commercial 
effort. Engineering methods include dividing related nucleases into parts with random 
reassembly, mutation of areas that make DNA contact, changing amino acids in the DNA 
binding domain based on known interactions and computer modeling using algorithms (Gruen, 
Chang et al. 2002, Seligman, Chisholm et al. 2002, Chevalier, Turmel et al. 2003, Sussman, 
Chadsey et al. 2004, Chames, Epinat et al. 2005, Arnould, Chames et al. 2006, Ashworth, 
Havranek et al. 2006, Doyon, Pattanayak et al. 2006, Rosen, Morrison et al. 2006, Smith, Grizot 
et al. 2006, Chen, Wen et al. 2009, Ashworth, Taylor et al. 2010). Once assembled, libraries of 
new enzymes were screened for activity against a lengthy target of interest to find promising 
enzymes with altered specificity. 
These screens represent key technology developments that have been used as tools for the 
advancement of many types of engineered nucleases; not just meganucleases. Among them are 
bacterial two hybrid methods, several bacterial marker gene elimination assays, and, arguably the 
most direct screening strategy, the yeast-based nuclease mediated recombination assay (Joung, 
Ramm et al. 2000, Gruen, Chang et al. 2002, Seligman, Chisholm et al. 2002, Gimble, Moure et 
al. 2003, Sussman, Chadsey et al. 2004, Chames, Epinat et al. 2005, Doyon, Pattanayak et al. 
2006, Rosen, Morrison et al. 2006). Although there are variations to this method, this yeast-
based assay basically works as follows (Figure 1.2): a disrupted and non-functional yeast marker 
gene is constructed such that an engineered nuclease target site and a selectable gene are 
imbedded within a small internal duplication of the marker gene coding sequence. This plasmid 
and a plasmid encoding an engineered nuclease are transformed separately into yeast cells of 
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opposite mating type. After mating, the cells are assayed for marker gene repair, which is 
dependent on target site cleavage and is used as a reporter to determine the initial quality of the 
engineered nuclease (Chames, Epinat et al. 2005). This method is suitable for manual or 
automated production and has identified many thousands of engineered nucleases in both 
academic and commercial laboratories (Arnould, Chames et al. 2006, Smith, Grizot et al. 2006, 
Doyon, McCammon et al. 2008, Townsend, Wright et al. 2009). 
The success of meganuclease technology is just one facet of a continuously expanding 
and advancing field of academic study and commercial activity. While Genome Editing began 
with meganucleases, it certainly does not end there. Other highly successful tools for 
manipulating genomes combine two separate functional units: a DNA binding domain and an 
active element from a protein such as a transcription factor or a restriction endonuclease. 
 
Zinc Finger Nuclease Technology 
In the 1980s, transcription factor IIIA, an easily obtained and abundant egg protein from 
Xenopus laevis, was studied in great detail (Brown 1984). Analysis revealed that the protein 
contained zinc and nine tandem repeat units, each containing about 30 amino acids (Ginsberg, 
King et al. 1984, Miller, McLachlan et al. 1985). Initial structural models were built using a 
consensus from the repeats, then fitting this to the known structure of metalloproteins (Berg 
1988). Later, NMR was used to gain insight into the architecture and, finally, the crystal 
structure was deduced (Lee, Gippert et al. 1989, Pavletich and Pabo 1991, Nakaseko, Neuhaus et 
al. 1992, Neuhaus, Nakaseko et al. 1992). 
Through these studies, the zinc finger (ZF) DNA binding domain was defined. Today 
there are many recognized forms of this domain; however, the subject of this review is the ββα 
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structure that coordinates a zinc atom using a Cys2His2 motif to position the α helix into the 
major groove of a DNA strand for specific recognition of three consecutive bases (Pavletich and 
Pabo 1991). It should be noted that later analysis showed the α helix can have cross strand 
interactions with the base that precedes the ZF target, making it clear that each ZF can have a 
four base interaction with target site overlap between ZF modules (Fairall, Schwabe et al. 1993, 
Elrod-Erickson, Benson et al. 1998). 
Attempts to engineer this structure began almost immediately and a small collection of 
mutant ZFs with altered DNA binding profiles was amassed. ZF arrays were assembled, 
generally using the consensus linker sequence TGEKP, and tested for altered target affinity and 
specificity. One such ZF array was used to both down-regulate an oncogene through binding 
alone and to up-regulate a CAT gene when fused to the activation domain VP16 (Choo, Sanchez-
Garcia et al. 1994). Later, individual repressor domains fused to ZF arrays were used to 
demonstrate repressor activity (Papworth, Moore et al. 2003, Reynolds, Ullman et al. 2003). 
The success of ZF-based artificial transcription factors led to the formation of Sangamo 
BioSciences, Inc. and Gendaq Ltd to exploit the new science. ZF arrays with three, four and six 
finger architectures were created along with modular methods and more powerful library based 
selection schemes to make custom ZF arrays (Choo and Klug 1994, Choo, Sanchez-Garcia et al. 
1994, Rebar and Pabo 1994, Greisman and Pabo 1997, Isalan, Klug et al. 1998, Segal, Dreier et 
al. 1999, Choo and Isalan 2000, Joung, Ramm et al. 2000, Moore, Choo et al. 2001, Moore, Klug 
et al. 2001). Basically, individual ZFs with substitutions in the helix for residue positions -1, 2, 3 
and 6 were generated then assembled into ZF array libraries followed by screening using a 
variety of in vitro and in vivo methods. Eventually, engineered ZF transcription factors were used 
to demonstrate repression of human immunodeficiency virus (HIV) and herpes simplex virus and 
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activation of vascular endothelial growth factor (VEGF) (Liu, Rebar et al. 2001, Papworth, 
Moore et al. 2003, Reynolds, Ullman et al. 2003). In the meantime, ZF technology slowly 
matured as the efforts of academic and commercial researchers continued, and ZFs soon caught 
the attention of a research group that specialized in nucleases. 
Chandrasegaran’s group began a detailed mutagenesis analysis of FokI, a type IIs 
restriction endonuclease, which led to an engineered nuclease revolution (Li, Wu et al. 1992, Li 
and Chandrasegaran 1993, Li, Wu et al. 1993, Kim and Chandrasegaran 1994). This nuclease 
consists of a DNA binding domain similar to a helix-turn-helix motif and a functionally separate 
and nonspecific nuclease domain (Figure 1.3) (Wah, Hirsch et al. 1997). Restriction 
endonucleases commonly function as dimers, each half binding one side of a palindromic target 
prior to cleavage. The FokI target sequence (5’-GGATG-3’) is not palindromic and is typically 
singular in a given section of DNA. This arrangement should allow for a single FokI monomer to 
bind its target, impeding cleavage, since the nuclease domain contains a single catalytic center 
(Wah, Hirsch et al. 1997, Bitinaite, Wah et al. 1998, Wah, Bitinaite et al. 1998). Nonetheless, a 
DSB is made at the 3’ end of the recognition site, after the 9th base on the top strand and the 13th 
base on the bottom strand; leaving a four base 5’ overhang (Sugisaki and Kanazawa 1981). It is 
thought that either two separate DNA molecules, each with a FokI monomer bound, or a single 
DNA molecule with a FokI monomer bound and a free monomer must make momentary contact 
for a dimer interface to form and cleavage to occur (Bitinaite, Wah et al. 1998, Wah, Bitinaite et 
al. 1998, Vanamee, Santagata et al. 2001, Pernstich and Halford 2012). This is a trans cleavage 
model as opposed to the cis DNA binding site arrangement used by many classic palindromic 
restriction endonucleases to cleave within their recognition site. For example, a pair of EcoRI 
monomers must bind their target, one on either side of the palindromic recognition site 
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GAATTC, to form a dimmer interface then make a DSB (Pingoud, Fuxreiter et al. 2005). This 
seems a fine distinction, but the difference between these two types of interactions has 
implications for later technology development. 
After realizing that the FokI DNA recognition domain was dispensable, the catalytic 
portion was combined with several different types of DNA binding motifs (Kim and 
Chandrasegaran 1994, Huang, Schaeffer et al. 1996, Kim, Cha et al. 1996, Kim, Kim et al. 1997, 
Kim, Smith et al. 1998). Among those tested were three distinct Cys2His2 ZFs; these were the 
first zinc finger nucleases (ZFNs). Initial analysis of ZFNs was performed in vitro using purified 
proteins and either monomeric or multiple tandem target sites, which relied on trans-cleavage for 
digestion to occur (Huang, Schaeffer et al. 1996, Kim, Cha et al. 1996, Smith, Berg et al. 1999). 
Trans-cleavage is inefficient at low protein concentrations, but becomes more effective as the 
concentration of nuclease is increased (Bitinaite, Wah et al. 1998). It wasn’t until the 
Chandrasegaran and Carroll collaboration that the now-classic and more efficient pairing of two 
opposing ZFNs bound to DNA binding sites in a cis arrangement was utilized (Smith, Bibikova 
et al. 2000). This is now the most recognized visual model of engineered, FokI based nuclease 
binding for the creation of DSBs and control of the Genome Editing process (Figure 1.4A). 
The combination of engineered ZF arrays and the FokI nuclease domain could 
theoretically generate an enzyme capable of producing a single DSB anywhere in a complex 
genome. To illustrate the point, in a genome made of random DNA, a ZFN pair that employs 
three, four, or six ZFs per half site has a combined 18, 24 or 36 base recognition site, giving it a 
unique target in 6.87 x1010 bp, 2.81 x1014 bp or 4.72 x 1021 bp respectively. For reference, the 
largest genome found to date, Paris japonica, carries an estimated 1.5 x 1011 bp of DNA 
(Pellicer, Fay et al. 2010). 
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Once efficacy of the design was established, the potential benefits of ZFN technology 
were obvious and work soon began to demonstrate and define the limits of the technique. Initial 
engineered ZFN experiments demonstrated HR using an extrachromosomal target in Xenopus 
oocytes, NHEJ and later HR at an endogenous locus in Drosophila and marker gene restoration 
in human cells (Bibikova, Carroll et al. 2001, Bibikova, Golic et al. 2002, Bibikova, Beumer et 
al. 2003, Porteus and Baltimore 2003). Afterward, NHEJ at a small artificial target in 
Arabidopsis and HR at an integrated marker gene in tobacco were demonstrated using pre-
existing ZFNs (Lloyd, Plaisier et al. 2005, Wright, Townsend et al. 2005). This was followed by 
demonstrations of HR at three positions in an endogenous locus in tobacco and NHEJ and 
targeted gene insertion in maize using task specific engineered ZFNs, which confirmed the utility 
of ZFN technology in plants (Shukla, Doyon et al. 2009, Townsend, Wright et al. 2009). 
Following the initial success, many model and economically important organisms have been 
subjected to ZFN mediated Genome Editing with a notable record of success. Along with an ever 
broadening field of application came improved ZFN engineering methods that promised to put 
ZFN technology into the hands of more researchers (Carroll, Morton et al. 2006, Meng, 
Thibodeau-Beganny et al. 2007, Doyon, McCammon et al. 2008, Maeder, Thibodeau-Beganny et 
al. 2008, Kim, Lee et al. 2011, Sander, Dahlborg et al. 2011). 
Even though ZFN development and adoption have outpaced meganuclease technology, 
numerous challenges became apparent to those applying the technique. The principal 
complication appears to be toxicity. This could be general or species specific and seems to be 
associated with ZF binding in some cases and ZFN generated off target DSBs for many others 
(Bibikova, Golic et al. 2002, Porteus and Baltimore 2003, Alwin, Gere et al. 2005). In the later 
instances, off target DSBs appear to be caused by poorly designed ZF arrays. For example, it has 
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been shown that some ZFs can tolerate up to eight mismatches in a 24 bp target; drastically 
increasing the potential for off target binding (Mussolino and Cathomen 2011). Another matter is 
the trans cleavage nature that FokI brings to the system; allowing ZFN monomers to cleave sites 
that are unrelated to the intended target. Some of the observed toxicity was reduced by the 
advent of improved ZF engineering protocols that took into account cross strand interaction 
between the a helix and the opposing base that precedes the ZF module as discussed above. 
Additional reductions in toxicity were realized when obligate heterodimeric forms of the FokI 
catalytic domain were produced. As discussed below, the heterodimer design ensures that a left 
ZFN interacts with a right ZFN and that left/left or right/right combinations are minimized, 
which presumably reduces the off target DSB occurrence in a cell. Since the initial development 
of ZF technology, great strides have been made in generating optimized ZFNs that are less toxic 
and more specific; however, not every sequence can be targeted because highly specific ZFs do 
not exist for all triplet targets in all contexts. Until recently, it was estimated that only one target 
in 500 bp could be utilized by ZFN technology using context assembly methods, but with the 
development of extended modular assembly, this estimate has dropped to one in 52 bp (Maeder, 
Thibodeau-Beganny et al. 2008, Sander, Dahlborg et al. 2011, Bhakta, Henry et al. 2013). 
Today, Sangamo BioSciences is the dominant economic stake holder for ZF based 
technology with plant rights licensed to Dow AgroSciences LLC and ZFN manufacturing rights 
licensed to Sigma-Aldrich Corporation. ZFN technology will continue to play a significant role 
in the future of Genome Editing even as new technologies are developed. The preceding 
information was provided to explain the foundation for the creation of TALEN technology, 
which is the focus of the remainder of this review. 
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TALE Histroy, Function And Structure 
TALE Technology 
The transcription activator-like effectors (TALEs) represent the largest family of type III 
effector proteins from Xanthomonas spp., a group of Gram negative bacterial plant pathogens.  
TALE homologs can also be found in the bacterium Ralstonia solanacearum (Heuer, Yin et al. 
2007, Li, Atef et al. 2013). TALEs are secreted into plant cells and function as transcription 
activators during infection. They contain an N-terminal bacterial secretion and translocation 
signal, a single unique DNA binding domain, termed repeat 0, followed by a central repeating 
modular DNA-binding domain, three C-terminal eukaryotic nuclear localization signals (NLS), 
and a highly conserved acidic activation domain (AD) (Figure 1.5A.) (Boch and Bonas 2010). 
The central repeats are nearly-identical except for two amino acids at positions 12 and 13, called 
Repeat Variable Di-residues (RVDs) (Moscou and Bogdanove 2009). Different TALEs vary in 
repeat number and RVD composition (Boch and Bonas 2010). It is their role as plant 
pathogenesis factors that initially captured the attention of researchers, although, the deciphering 
of the DNA binding code and eventually of the crystal structure has led to their widespread use 
as artificial transcription factors and nucleases. Major license holders of TALE related 
technology include: Two Blades Foundation, Cellectis and Life Technologies (now part of 
Thermo Fisher Scientific). 
 
Natural TALE Function 
TALEs are pathogenic bacterial proteins that have evolved as eukaryotic transcription 
factors. They are secreted into plant host cells through the type III secretion system and 
translocated into the nucleus, where their specific binding to the promoter of host susceptibility 
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(S) genes facilitates colonization, proliferation, and dissemination of the bacteria. An example is 
the interaction between TALE AvrBs3 and the gene UPA20, a plant transcription factor of the 
bHLH family, which functions to enlarge mesophyll cells. TALE-mediated activation of this 
gene leads to hypertrophy, which facilitates infection in pepper plant (Kay, Hahn et al. 2007).  
Examples from rice include OsSWEET11 (also named Os8N3) and OsSWEET14 (also named 
Os11N3). These two genes reportedly serve as sucrose efflux transporters, facilitating sucrose 
movement through intracellular regions of the plant. Pathogenic bacteria use TALEs to 
specifically over-activate these genes, presumably to supply nutrients for continued bacterial 
growth (Chen, Hou et al. 2010, Chen, Qu et al. 2012). 
Occasionally, plants win the host-pathogen battle through evolution and natural selection.  
The TALE binding element (EBE) in the S gene can mutate so a TALE no longer binds, or an 
EBE can be created in the promoter of a resistance (R) gene to trap the otherwise pathogenic 
TALE, leading to plant resistance in either case. For example, in pepper, TALE AvrBs3 
normally induces UPA20, but an R gene called Bs3, has evolved an AvrBs3 EBE to provide 
resistance to the pathogenic strain Xanthomonas campestris pv. vesicatoria (Xcv) through the 
onset of a series of defense responses, including a hypersensitive response, a rapid, localized cell 
death that restricts bacterial spread (Kay, Hahn et al. 2007, Romer, Hahn et al. 2007). 
 
TALE DNA Recognition Code 
Decryption of the TALE DNA binding code occurred 20 years after characterization of 
the first TALE. Yang et al. provided the first clue in 2000, when they reported that TALE 
AvrXa7 is a DNA binding protein with a preference for dA/dT oligos (Yang, Zhu et al. 2000).  
The second clue came from an analysis of three related TALEs and their level of activity toward 
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a common gene. The amino acid (aa) sequence of AvrBs3 and AvrBs4 are 97% identical and 
both have 17.5 repeats, but only AvrBs3 activates the Bs3 gene in pepper. AvrBs3 and AvrHah1 
are only 87% identical and the latter has 13.5 repeats, yet both activate Bs3. Closer analysis 
showed that the RVDs of AvrBs3 and AvrHah1 are closely related, while those of AvrBs3 and 
AvrBs4 are not. This correlation between RVD similarity and Bs3 activation, but not overall aa 
identity and activation, suggested that RVD composition predominantly determines EBE binding 
specificity (Schornack, Minsavage et al. 2008). The third clue was the discovery that AvrBs3 
directly binds to its EBE, and that the number of repeats nearly equals the DNA target nucleotide 
length. Essentially, the authors noticed that AvrBs3 has 17.5 repeats and the Bs3 EBE length is 
18 bp (Romer, Hahn et al. 2007). 
Finally, in 2009, two independent groups using different methods reported the TALE 
DNA binding code in the same issue of Science. From published data, both groups speculated 
that TALEs recognize their target using one RVD per nucleotide. The Bogdonove group used a 
bioinformatics approach to search for minimal entropy regions in gene promoters then confirmed 
the technique using known TALE-EBE combinations. Next they used RVDs from numerous 
TALEs to predicted unknown EBEs and correlated this to public microarray infection data. The 
authors used this information to statistically surmise that each RVD displayed a preference for 
specific nucleotides (Moscou and Bogdanove 2009). The Bonas group manually aligned AvrBs3 
and its known EBE, then used these data to predict the EBEs of four TALEs with unknown DNA 
binding sites, which were then found in the promoters that each TALE is known to regulate. 
Following this, they used molecular biology methods to experimentally validate predictions 
(Boch, Scholze et al. 2009). The code, as it turns out, is relatively simple: the first base of the 
EBE is recognized by a region in the TALE N-terminus (repeat 0) and the remaining bases are 
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sequentially bound by one RVD per nucleotide with one type of RVD preferentially recognizing 
one specific nucleotide. 
Many RVDs have been described in the literature, the four major RVDs are HD, NI, NG, 
and NN, which predominantly bind to cytosine (C), adenine (A), thiamine (T), and guanine (G) 
or A, respectively. However, recognition is not absolute. Each RVD has the capacity to 
recognize other bases; though the interactions indicated above are the most common. TALE 
binding occurs in a stepwise manner beginning at the 5’ end of the EBE, which is normally 
occupied by a T, where repeat 0 initiates the process, then successive RVDs from the central 
repeat region bind to each consecutive base through the end of the EBE. It should be noted that 
TALEs are more sensitive to EBE mismatches at the 5’ end relative to the 3’ end. This is due in 
part to the polarity TALEs exhibit regarding target sites and the fact that repeat 0 is generally 
specific for T. Mutation of this initial T usually abolishes TALE binding activity, and other 5’ 
mutations make a TALE less likely to bind, while 3’ mutations are likely to have less of an effect 
since the more c-terminal repeat regions show less affinity for DNA (Meckler, Bhakta et al. 
2013). 
 
TALE Structure 
Shortly after discovery of the TALE DNA binding code, the structure of this domain was 
solved through protein crystallization by two groups (Deng, Yan et al. 2012, Mak, Bradley et al. 
2012). Crystal structure analysis sought to determine how TALE repeats are ordered and how 
they interact with specific DNA bases. Examination of TALE dHax3 and TALE PthXo1 
indicated that the central repeat region is a right handed super helix wrapping around the sense 
strand of the target DNA, and each repeat is a left handed helix-loop-helix structure. The 12th and 
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13th aa (RVD) of the repeats are located in the loop region where the 12th aa stabilizes the loop 
through hydrogen bonds with the protein backbone while the 13th aa determines base specificity 
when interacting with the major groove. Analysis of repeat 0, which precedes the central RVD 
repeats, revealed a degenerate helix-turn-helix motif. A tryptophan (W232) in the turn region 
specifically interacts with the conserved T in the EBE (Mak, Bradley et al. 2012). These crystal 
structures provided great insight into the TALE DNA binding domain architecture and will help 
guide future engineering efforts. Crystallization of the remaining TALE structures may give 
additional insights into TALE biology and engineering and may provide other future benefits 
that only the complete structure of this valuable protein can provide. 
 
TALEN Architecture, Assembly And Applications 
TALENs 
Efforts to engineer TALEs began immediately after the DNA binding code was 
discovered. Obvious parallels between established ZFN technology and the promising TALE 
DNA binding domain meant that experimentation with TALE nucleases (TALENs) was 
inevitable. Like ZFNs, TALENs are generated by fusing the FokI nuclease element to a TALE 
DNA binding domain. This configuration necessitates that two TALENs dimerize to generate 
efficient nuclease activity. To assist this, TALEN target half sites are chosen such that TALEN 
pairs are arranged in an opposing orientation on opposite sides of doubled-strand DNA with an 
optimal spacer sequence between them. If successful, left and right TALENs bind their half sites, 
allowing the FokI domains to dimerize and cleave the chromosome to generate a DSB (Figure 
1.5B). 
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Unlike ZFNs and meganucleases, TALEN technology has been broadly and rapidly 
adopted, which is due in large part to their binding affinity, specificity, ease of manufacture, high 
probability of generating functional nucleases and success rate in Genome Editing experiments. 
Additionally, the results of side-by-side comparisons of ZFNs and TALENs suggest that 
TALENs exhibit reduced nuclease associated cytotoxicity (Mussolino, Morbitzer et al. 2011). 
This may be due in part to longer DNA target sites and the T requirement at the 5’ end of a target 
site, together resulting in greater specificity, but much more comparative research is needed 
before a final conclusion can be drawn. It is for these features and more that TALEN mediated 
Genome Editing is listed as one of the ten breakthroughs of 2012 by the journal Science. 
 
FokI Homodimer and Heterodimer Forms 
The common usage of the FokI domain in artificial nuclease designs is largely due to its 
thorough characterization, acceptance of alternative DNA binding domains, indiscriminate 
nuclease activity, history of success in ZFN technology and convenience. Despite its nearly 
universal adoption, the FokI domain has some drawbacks; most notably its engagement in trans 
cleavage events and its normal function as a homodimer. The trans cleavage characteristic, as 
discussed above, is not completely understood and requires a concentrated effort to resolve, but it 
does appear to be associated with nuclease concentration, making promoter choice a 
consideration during experimental design of artificial nucleases (Bitinaite, Wah et al. 1998, 
Beumer, Bhattacharyya et al. 2006, Pruett-Miller, Connelly et al. 2008). On the other hand, the 
homodimer problem has been the subject of a number of independent studies. 
The difficulty of the homodimer becomes apparent when it is understood that artificial 
nuclease pairs designed with a homodimer nuclease can have three interactions: two left halves 
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or two right halves can make a functional nuclease just as easily as the intended interaction 
between the left and right sides. In essence, using the homodimer is like simultaneously 
introducing three different nucleases into a cell, then coupling this to the FokI trans cleavage 
complication and the probability of overwhelming the cell with DSBs becomes high. Both of 
these issues can decrease the overall effectiveness of Genome Editing by precipitating a high 
level of cell death and collateral damage in the genome of surviving cells. 
To reduce off-target toxicity, several obligate heterodimer versions of FokI have been 
developed. The engineered versions are based on structure-guided design, DNA shuffling and 
mutagenesis (Miller, Holmes et al. 2007, Szczepek, Brondani et al. 2007, Guo, Gaj et al. 2010, 
Doyon, Vo et al. 2011, Sizova, Greiner et al. 2013). These designs have greatly reduced the toxic 
effect of off-target DSBs observed when using the homodimer form of FokI. Which of the 
available heterodimer designs is actually most beneficial probably depends on the cell type and 
experimental plan; however, a thorough testing of multiple heterodimers pairs under the same 
conditions would be a welcomed and insightful study. Example heterodimer pairs are 
summarized in Table 1.1. 
 
TALEN Architectures 
The TALE family of engineered nucleases is diverse; the protein itself is relatively large, 
it has a host codon bias, and the FokI attachment sites are numerous. These variables lead to a 
wide range of engineered TALE architectures in the literature. For example, TALENs with an N-
terminal fusion are functional, but most reported architectures use a C-terminal fusion (Li, 
Huang et al. 2011). Additionally, FokI can be directly fused to the existing TALE structure, or 
the TALE can have a combination of N-terminal and/or C-terminal deletions. C-terminal 
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deletions affect the spacer length requirement (typically 12 to 33 bp) between half sites and may 
or may not remove the NLS and activation domains. N-terminal deletions generally remove the 
bacterial secretion and translocation signals and may include the addition of an NLS. Which 
specific TALE to use? What truncation, if any, and FokI fusion to use? What form of FokI to 
use? What promoter strength is right? To codon optimize or not? These and other questions are 
all relevant and are largely unanswered yet by comparative studies. Table 1.2 lists some of the 
more popular architectures. 
 
TALEN assembly methods 
Hitherto, many modular assembly methods have been developed to rapidly or robustly 
assemble TALEN fusion proteins: from PCR-based modules to plasmid-born assembly; from 
one step or two step “Golden Gate” cloning strategies to FLASH (Fast ligation-based 
automatable solid-phase high-throughput system); from LIC (ligation-independent cloning) to 
iterative capped assembly (Cermak, Doyle et al. 2011, Li, Huang et al. 2011, Briggs, Rios et al. 
2012, Reyon, Tsai et al. 2012, Kim, Kweon et al. 2013, Schmid-Burgk, Schmidt et al. 2013); 
from customized self-assembly to commercially available TALEN services (Table 1.3). A 
popular method for constructing TALENs is based on a Golden Gate cloning strategy that 
conveniently avoids mutations generated by PCR methods, and eliminates labor-intensive gel 
isolation of DNA fragments. One-step Golden-Gate cloning, compared with two-step Golden-
Gate cloning, not only eliminates the need to characterize intermediate constructs, it is also time 
saving, robotics-enabling and adaptable for automated high-throughput production. The one-step 
clone method is composed of ready-to-use trimer or tetramer plasmid libraries, which employs 
about 400 plasmids. Another strategy uses 16 dimers, 64 trimers or 256 tetramers was reported 
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as an alternative one step Golden-Gate strategy for TALEN construction (Kim, Kweon et al. 
2013, Liang, Chao et al. 2013, Yang, Yuan et al. 2013, Zhang, Li et al. 2013). In addition, the 
FLASH method is reported to be robust enough to permit genome-scale construction of TALENs 
(Reyon, Tsai et al. 2012). 
Resources 
There is a growing selection of web based TALEN resources, including target selection 
utilities, TALE technology tutorials, troubleshooting guides, mutation detection methods, 
specific species applications and current literature. In addition, there are TALE engineering kits 
available from specific laboratories or organizations such as Addgene. These kits greatly 
simplify acquisition and application of TALE technology and are a generous resource for 
scientists who are interested in TALEN research. At Addgene, a nonprofit plasmid repository 
(http://www.addgene.org/TALEN/), there are currently five TALEN assembly kits available to 
the public from the Voytas/Bogdanove collaboration, Joung lab, the Zhang laboratory, the 
Hornung laboratory and the Musunuru/Cowan collaboration, which harness different strategies 
to rapidly assemble TALENs. Several open-sources, web-server programs are listed in Table 1.4 
for selection of potential TALEN target sites.  
 
TALEN Application 
Quick and easy assembly, availability of powerful resources, cross species flexibility, 
plus a high rate of success make TALEN technology an easy choice for Genome Editing 
applications. In fact, more reports of TALEN usage have been published in the last few years 
than for all previous artificial-nuclease-based technology applications from the last few decades.  
TALEN technology has been used in a wide range of organisms, including yeast, plants, algae, 
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protozoann, nematodes, fish, insects, mammals, and human cells. The short time since the initial 
TALEN reports to the plethora of species applications demonstrates the simplicity and general 
applicability of TALEN technology. 
Animal Applications 
The application of artificial nuclease based technology in animal cells far outstrips all 
other research areas combined. Reports began with the modification of two endogenous genes in 
human cells (Miller, Tan et al. 2011). This research demonstrated that TALENs could mediate 
NHEJ events in up to 9% of cells at the NTF3 locus and generated NHEJ in 21% of cells and HR 
in 16% of cells at the CCR5 locus in human K562 cells. A report quickly followed that 
demonstrated successful TALEN targeting of the endogenous gene, ben-1 in Caenorhabditis 
elegans to produce NHEJ events in 3.5% of the progeny (Wood, Lo et al. 2011). Soon after, 
TALEN function was demonstrated in zebrafish (Huang, Xiao et al. 2011), where NHEJ reached 
12.25% for the tnikb locus and was also detected at the dip2a gene. Both mutations showed 
heritable Genome Editing events could occur in a vertebrate. 
More recent achievements demonstrated TALEN-mediated disruption of the mouse Y 
chromosome. Traditionally, it has been difficult to perform gene knockouts on the Y 
chromosome because Y is composed of highly repetitive DNA that proved difficult to target 
(Kato, Miyata et al. 2013, Wang, Hu et al. 2013). In a demonstration of the dual integrase 
cassette exchange (DICE) system, using human cells, it was shown that TALENs could mediate 
precise integration of a “landing pad” containing markers and phiC31 and Bxb1 integrase sites. 
The corresponding integrases were later used as a high fidelity system to replace the landing pad 
with genes of interest (Zhu, Gamboa et al. 2013). In a broader TALEN study, using Bos taurus 
(cow) and Sus scrofa (pig), it was demonstrated that 23 of 36 TALENs had high activity in 
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primary cells at 15 loci resulting in mono and biallelic knockouts. In addition, up to 75% of 
TALEN injected embryos resulted in knockout events (Carlson, Tan et al. 2012). 
Disease Models 
A critical application of TALEN technology is the production of disease models, both 
cell-based and whole-animal-based. These models can be used to follow protein expression, 
interactions and distribution in cells and to track the progression of disease through the life of an 
animal in response to specific therapeutics. Examples of reported TALEN generated models 
include human cells and the mouse. TALENs have reportedly been used to generate mutations in 
15 genes using cultured somatic cells or human pluripotent stem cells, with the resulting 
phenotypes associated with dyslipidemia, insulin resistance, hypoglycemia, lipodystrophy, 
motor-neuron death, and hepatitis C infection (Ding, Lee et al. 2013). In mouse, C9orf72, a gene 
that is known to be involved in amyotrophic lateral sclerosis (ALS) and fus, a gene involved in 
frontotemporal lobar degeneration (FTLD) were targeted using TALENs. C9orf72 and fus were 
disrupted by NHEJ in 31% and 7.5% of pups respectively and fus engaged in HR in 6.8% of 
pups (Panda, Wefers et al. 2013). 
Curing Disease 
Just as TALENs have the power to create disease models, they also have the potential to 
cure genetic disorders or diseases. For example, it has been speculated that some mitochondrial 
based diseases could be cured by reducing the expression of a disease causing protein. To this 
end, TALEN pairs were constructed to eliminate mutant mitochondrial DNA in patient-derived 
cells, resulting in a reduction of disease bearing genomes in this organelle (Bacman, Williams et 
al. 2013). TALENs have also been used to correct mutations in human sickle cell disease and 
Duchenne Muscular Dystrophy bearing cell lines (Sun, Liang et al. 2012, Ousterout, Perez-
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Pinera et al. 2013). Additionally, TALENs can have antiviral affects; for example, in a recent 
therapeutic strategy a TALEN pair was generated to target a conserved sequence in the DNA of 
several hepatitis B viral strains. When tested, it was confirmed that the TALEN pair reduced 
viral loads in human Huh7 cells and in a mouse model (Chen, Zhang et al. 2014). Genome 
Editing that leads to DNA elimination or gene correction may one day make locus specific gene 
therapy a safe and practical clinical application. 
Plants 
TALEN technology has been used in dicot species such as tobacco and Arabidopsis and 
in monocot species such as rice, Brachypodium, barley and maize (Christian, Qi et al. 2013, 
Liang, Zhang et al. 2013, Shan, Wang et al. 2013, Wendt, Holm et al. 2013, Zhang, Zhang et al. 
2013). The broad species range of these successes suggests that other plant species likely will be 
modified by TALENs in the near future and that TALEN-based Genome Editing will be 
generally applicable to most plants. TALEN mediated Genome Editing in plants was first 
reported in rice (Li, Liu et al. 2012). In this work the major virulence TALE AvrXa7 EBE site in 
the OsSWEET14 (Os11N3) promoter region was disrupted through NHEJ using an engineered 
TALEN pair in which the spacer region overlapped the AvrXa7 EBE. In plants that sustained an 
alteration, the wild type TALE AvrXa7 from Xanthomonas oryzae could no longer bind its target 
and activate this sucrose efflux transporter, which would have facilitated disease by increasing 
the availability of nutrients to the extracellular bacterial cells. 
In more recent examples TALENs were used to modify genes in barely and maize to 
combat the problem of phytic acid, a major storage form of phosphate in many grains that is not 
digestible by monogastric animals. Phytic acid is an anti-nutritional, and undigested phytic acid 
passes into the environment, where phosphate released from it by microbial phytases contributes 
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to water quality problems, such as phytoplankton blooms. TALEN-mediated NHEJ at four loci 
involved in the Phytic acid biosynthesis pathway produced independent maize transformants at 
all four loci with target-gene disruptions in about 39.1% of the transformants (Liang, Zhang et al. 
2013). In another approach, regulatory elements in a barley phytase gene promoter were targeted 
using TALENs. This approach produced NHEJ events in the targeted promoter of up to 31% of 
the transformants (Wendt, Holm et al. 2013). These studies indicate that TALEN-mediated 
Genome Editing technology can precisely modify predetermined loci in crop plants and that 
continued development of this critical tool could lead to improved yields, crops that are more 
environmentally friendly and that are disease or stress resistant. 
Understanding Gene Function 
The simplicity and speed of TALEN production coupled to its major use as a mediator of 
gene knockouts easily lends itself to the application of identifying the function of the thousands 
of genes whose functions remain unknown. For example, in cultured human cells, TALENs were 
harnessed to knockout the nuclear gene NDUFA9, a subunit of mitochondrial respiratory chain 
complex I, and enabled identification of its function as an assembly factor that stabilizes the 
junction between membrane and matrix arm (Stroud, Formosa et al. 2013). TALENS also can be 
used to expand knowledge by creating new model systems. For example, by using information 
from known C. elegans mutants, the species Caenorhabditis briggsae, was developed into a 
genetic model in a period of months instead of years. Hundreds of mutations were generated in 
dozens of genes, presenting the opportunity to make cross species comparisons and to identify 
new gene functions (Wei, Shen et al. 2014). Another area of interest for TALEN applications is 
determining the function of specific microRNAs, since their small target footprint makes them 
difficult to knockout by other means. In 2013, three independent groups successfully targeted 
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and disrupted microRNA with TALENs in a mouse model and in human cells, leading to the 
construction of a human cell microRNA deletion library containing 274 loci (Hu, Wallace et al. 
2013, Kim, Wee et al. 2013, Takada, Sato et al. 2013). 
The role of many genes varies in different developmental stages or in different tissues.  
The ability to generate inducible or tissue specific knockouts is essential to understanding gene 
function at a deeper level. This can be accomplished by placing TALEN pairs under the control 
of a heat shock promoter or tissue-specific promoter. This strategy has been applied in C. 
elegans and Ciona to generate mutations in certain developmental stages or specific somatic 
tissues (Cheng, Yi et al. 2013, Treen, Yoshida et al. 2014). On a finer scale, TALENs have been 
used to perturb chromosomal contacts through disruption of gene loops to gain a greater 
understanding of co-regulated genes (Fanucchi, Shibayama et al. 2013). 
Large-scale Editing 
When two pairs of TALENs are used to simultaneously target different loci in a cell, this 
action can result in a large deletion, inversion or translocation. This strategy has many benefits 
when studying gene clusters, microRNAs, long non-coding RNAs that do not respond to frame-
shift mutations or the effects of gross genome rearrangement (Carlson, Tan et al. 2012, Liu, Luo 
et al. 2013). Studies have demonstrated that deletion fragment size can range from 795 bp to 5.5 
Mb when a duel TALEN strategy is applied (Ma, Zhang et al. 2012, Gupta, Hall et al. 2013). In 
addition to deletions, inversion events also have been reported (Carlson, Tan et al. 2012, Gupta, 
Hall et al. 2013, Shan, Wang et al. 2013). For example, experiments in which two pairs of 
TALENs were simultaneously injected into pig fibroblast cells, resulted in large deletions and 
inversions in 10% and 4%, respectively, of injected cells. Fibroblast cells with desirable Genome 
Editing events were successfully used as nuclear donors for swine cloning, which clearly 
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demonstrated the efficacy of TALEN technology for use in these livestock (Carlson, Tan et al. 
2012). Another intense area of interest that may benefit from studies of chromosomal 
rearrangement is the study of cancer cell biology. For example, modeling gene rearrangement 
through TALEN technology contributed to the discovery of a drug resistance mechanism in 
prostate cancer (Nyquist, Li et al. 2013). Furthermore, translocations induced by TALENs in 
human cells have been used to study specific cancers. In one such report, cancer cells were 
generated de novo, and a preexisting translocation in a cancer cell line was reversed using 
TALENs to restore the native chromosome arrangement (Piganeau, Ghezraoui et al. 2013). 
 
Factors That Affect TALEN Efficiency 
TALENs have been successfully used in everything from invertebrates to vertebrates, 
unicellular to multicellular organisms, and both dicotyledonous and monocotyledonous plants, 
encompassing more than 25 species and resulting in hundreds of publications. This broad 
application complicates any general evaluation of TALEN efficiency, because of a variety of 
factors, such as the species involved, donor DNA for HR work, type and amount of molecule 
delivered, delivery methods, TALEN architecture, target choice, and detection methods. A good 
assessment of TALEN effectiveness will depend on a thorough evaluation of the literature that is 
most relevant to the species of interest. With that said, some general information gleaned from 
the literature can help with experimental design. 
 
Target Species 
Two of the most important factors affecting TALEN efficiency and efficacy are probably 
the species and the cell type. These two parameters will largely dictate the delivery method and 
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the type of molecule delivered (e.g. DNA, RNA or protein), as well as the outcome. Most species 
engage in NHEJ to a greater extent than HR in response to DSBs, but the efficiency rates for 
detectable edits will vary between species and may even differ between stages of the cell cycle 
and cell types from the same species. While it is clear that NHEJ events can be obtained in most 
species, not enough information is available to make general statements about the probability of 
success with HR. 
 
Donor DNA for HR 
Relatively few thorough HR experiments have been reported, but it is clear that some 
species engage HR more readily than others. Important considerations for HR experiments are 
the length of the donor DNA molecule, the position of the desired change relative to the DSB 
site, the level of heterology, inclusion of the nuclease target site in the donor, and the size of 
inserted DNA, if any, relative to the target. Reported Donor DNAs range from about four kb 
down to oligonucleotides and can be single or double stranded. The window of incorporation of 
genetic changes can be narrow, as demonstrated with I-Sce I in mouse cells with 80% of events 
having track lengths of 58 bp or less with HR occurring on either side of the DSB (Elliott et al 
1998). Although less stringently tested a similarly narrow HR window was observed in two 
independent HR experiments using human cells (Lee et al. 2012, Porteus 2006). In plants the 
story may be different, although the HR frequency was reduced from 4% at ~160 bp to 0.2% at 
~1500 bp distance from the DSB, the HR window in tobacco is relatively wide (Townsend et al. 
2009). Donor DNA divergence is another area that requires more study, however, it has been 
shown that as little as 1.2% heterology can reduce HR by about six fold in mammal cells (Elliott 
et al 1998). Additionally, removing the nuclease recognition site from the Donor DNA would 
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seem like an obvious improvement, however, reports suggest otherwise. For example, removal or 
inclusion of the nuclease recognition site in donor DNAs used in human or tobacco cells had 
little effect on HR efficiency (Urnov et al 2005, Porteus 2006, Townsend et al 2009). 
Furthermore several studies have shown relatively high incorporation rates for large DNA 
segments into DSB sites using plant and animal cells, which suggests that relatively large 
insertions may be treated differently than donor DNA containing many small changes (Porteus 
2006, Shukula 2009, Wright et al. 2005). Until more information is available, longer donor 
DNAs with a short relative distance between the DSB and the desired DNA change with low 
heterology may be good choices for donor DNA design. 
 
Delivery Molecule 
If DNA is the delivery vehicle for TALENs, there are a number of structural parameters 
to consider, along with the fact that DNA will leave behind a trace in the genome. Important 
considerations should include promoter strength and tissue specificity, independent expression or 
coupled expression using, e.g., a FMDV 2A type linker, TALEN architecture and codon bias, to 
name a few. If TALEN traces in the genome are undesirable, then the sexual nature of the cell is 
also a consideration. For species that can breed, traces of the transgenic TALEN DNA can be 
removed genetically, but, there is a cost both of time and money associated with breeding 
programs. For species that cannot breed, the use of RNA or protein may be a better choice to 
avoid retention of the transgenic TALEN DNA in the final product. 
RNA is a viable nuclease delivery form for some species, and it has the benefit of not 
leaving exogenous DNA in the cell (Carlson, Tan et al. 2012, Davies, Davies et al. 2013). 
However, use of RNA adds to the complexity of Genome Editing, because it is much more 
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susceptible to degradation than DNA. Additionally, the generation of RNA is more cumbersome 
than DNA. The RNA needs to be of high quality, produced in large quantity and have a 5’ cap 
and a poly A tail to be effective. RNA may also limit delivery options or may not be an option 
for some species. With that said, a growing body of evidence suggests that there may be less 
toxicity associated with nucleases when exposure time is limited; use of mRNA is one way of 
limiting that time (Porteus and Baltimore 2003, Pruett-Miller, Reading et al. 2009). 
A protein form of a nuclease can be taken up directly by some cell types, if a cell 
penetrating peptide is present or, as demonstrated ZFNs, the protein naturally passes through 
membranes (Gaj, Guo et al. 2012). Examples of cell penetrating peptides include the R9 (poly 
arginine) and TAT (from HIV) motifs. It was recently reported that TALENs bearing either cell 
penetrating peptide can be taken up by human cells and efficiently mediate NHEJ. A TALEN 
conjugated to the R9 motif reportedly led to gene disruption in 15% of HeLa cells while a 
TALEN fused to TAT led to a knockout in 5% of human induced pluripotent stem cells (Ru, Yao 
et al. 2013, Liu, Gaj et al. 2014). Coupling TALENs and cell penetrating peptides is a relatively 
new area of exploration and more research is needed before general conclusions can be drawn. 
 
Delivery Method 
TALEN delivery is largely dictated by the species and tissue type, but some general 
observations can be made. For animals there is a wider range of delivery methods available, and 
transfection efficiency is generally high, while plants have fewer delivery options, and the 
relative transformation efficiency is generally lower. 
Nuclease delivery for animal cells includes such methods as nucleofection with RNA or 
DNA, lipofection, microinjection of either RNA or DNA, particle based methods, and virus 
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mediated transfection. Differences in concentration and form of the delivery molecule, either 
mRNA or DNA, can contribute to Genome Editing efficiency. For example, it has been 
demonstrated that modification frequencies in single cell rat embryos microinjected with DNA is 
lower than with mRNA and that observed frequencies may be dose dependent (Tesson, Usal et 
al. 2011). For viral delivery, it has been demonstrated that adenovirus can deliver TALEN genes 
into various human cell types, but rearrangements of TALENs was a problem when performing 
lentiviral vector mediated transfection (Holkers, Maggio et al. 2013). 
For plants, the higher efficiency delivery methods reported fall into three basic areas: 
electroporation, physical methods such a biolistics, and Agrobacterium tumefaciens infection. 
Unlike many animal based studies, the goal of plant transformation generally is to regenerate 
whole plants that are capable of passing a modification along to their progeny. Electroporation 
most commonly involves DNA and is usually limited to the few species that can be regenerated 
from protoplasts. Biolistics and A. tumefaciens infection are more widely applicable and 
normally involve DNA, either as plasmids or T-DNA, respectively. However, compared to 
animal cells, both methods are relatively inefficient (Barampuram and Zhang 2011). A drawback 
of A. tumefaciens delivery is that transformation of a single cell by two different A. tumefaciens, 
each harboring one component of a TALEN pair, is difficult to achieve. Due to this constraint, 
both TALENs in a pair are normally encoded by one plasmid, either expressing the two TALENs 
separately or by using a single promoter and linking both TALENs by FMDV 2A translational 
skipping peptide (Li, Liu et al. 2012, Zhang, Zhang et al. 2013). A very recent paper 
demonstrated the delivery of nucleases to tobacco cells using a modified Geminivirus system 
that increased Genome Editing by one to two orders of magnitude over A. tumefaciens based 
delivery methods (Baltes, Gil-Humanes et al. 2014). 
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TALEN Architecture 
As discussed above, there are a growing number of TALE architectures, which, when 
combined with the numerous FokI dimer options, can make choosing the optimal TALEN design 
difficult. Various combinations may greatly affect TALEN performance, stability and toxicity, 
which directly influence outcomes. Also, architecture will determine half-site target length 
options and spacer length requirements. Flexibility, assembly method, success in the literature 
and target site characteristics are all parameters that should be carefully considered when 
choosing a TALEN architecture. 
 
Target Choice 
To a certain degree, DNA composition, half-site recognition lengths and spacer length 
can affect TALEN performance. Half-sites commonly range from 12 to 24 RVDs, and spacer 
length is determined by length and structure of the C-terminus and FokI fusion point, with a 
shorter C-terminus generally decreasing the optimal spacer length. Base composition of the 
target should also be carefully considered. Some rules have been suggested in the literature, but 
these have not been rigorously tested. Beginning the target-half site with a T, use of longer half 
sites with a good mix of bases and considering spacer length requirements are good starting 
points for target selection. The type of intended recombination is also a factor. If gene disruption 
by NHEJ is desired, the target should be closer to the 5’ end of the gene’s coding sequence and 
placed in an exon or on an intron-exon border. Intron disruption is usually not a good choice for 
gene knockout. Target placement in one of the first few exons ensures a higher probability of 
early protein truncation, which is more likely to lead to a nonfunctional gene and less likely to 
leave a lingering product that can interfere with later results. If HR is the preferred outcome, the 
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target should be as close to the point of change as possible. This placement increases the 
probability that changes provided by the donor DNA will be incorporated at the DSB site. 
 
Validation, Detection and Estimating Efficiency 
Even though TALEN-based Genome Editing is generally efficient and most TALEN 
pairs function effectively, it is advisable to validate the function of newly designed TALENs 
before using them in transformation/transfection experiments to avoid wasting time with 
ineffective pairs. The validation process for TALENs and other nucleases, methods for detection 
of editing events, and calculations for estimating efficiency of gene modification can vary greatly 
and often depend on the preferences of the researcher. For example, validation assays can be 
performed in vitro or in vivo, mutation detection can utilize a variety of effective methods and 
calculations of efficiency can use differing parameters that are inherent to each system or are 
dependent on the preferences of the researcher. All of these variables can result in a variety of 
estimates for nuclease activity. 
Many in vitro validation assays for nuclease function simply rely on plasmid cleavage, 
using purified or partially purified nuclease extracts, to confirm specific nuclease activity. On the 
other hand, in vivo assays often depend on transient expression of a disrupted reporter gene that 
is repaired through homologous recombination. Validating TALEN activity using a reporter 
disruption or recovery assay is relatively rapid compared to a full genome modification 
evaluation, which can be laborious and time consuming, especially when the gene of interest 
does not present a selectable or easily screenable phenotype. Different reporter genes can be used 
for this validation screen, such as LacZ, Luciferase, GFP or GUS. A good general assay is the 
yeast based recombination assay described above, but there are times when species specific 
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information is desirable. In these cases the reporter typically is disrupted by a small internal 
duplication that contains the TALEN target sequence, and cells from amenable species such as 
human, mouse, Arabidopsis, tobacco or rice protoplasts, or N. Benthamiana leaves are 
transiently co-transformed with the reporter construct and TALENs as singles or pairs. The cells 
are given time to activate the process by repairing the reporter gene, which is then assayed for 
restoration of function (Kim, Lee et al. 2011, Johnson, Gurevich et al. 2013, Zhang, Zhang et al. 
2013). 
For mutation detection, one of the most commonly used methods is a DNA mismatch 
cleavage assay. For this assay, wild type and putative mutant PCR products are annealed, then a 
mismatch sensitive endonuclease such as Cel1 (Surveyor) or T7 endonuclease I digestion is 
performed. Estimates of nuclease activity are made using gel densitometry to detect cleavage at 
the site of mismatches (Oleykowski, Bronson Mullins et al. 1998, Miller, Holmes et al. 2007, 
Kim, Lee et al. 2009). In other reported methods, cloned PCR products have been randomly 
sequenced or subjected to deep sequencing to evaluate mutation frequencies. Another reported 
detection method relies on restriction fragment length polymorphism (RFLP) analysis, but 
requires an appropriate restriction site in the spacer region to accurately estimate event frequency 
(Huang, Xiao et al. 2011). This method can be enhanced through pre-digestion of genomic DNA 
with the respective restriction enzyme before PCR amplification. 
More sophisticated mutation detection methods have also been reported that use PCR 
product mismatches as a basis for an assay. For example, high resolution melt analysis (HRMA) 
takes advantage of thermostability difference between perfectly matched and mismatched PCR 
fragments (Dahlem, Hoshijima et al. 2012, Hu, Wallace et al. 2013). Additionally, the 
heteroduplex mobility assay (HMA) uses poly-acrylamide gel electrophoresis (PAGE) or 
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microchip electrophoresis for easy high throughput mutation screening. This assay relies on the 
observation that heteroduplexes have reduced gel mobility proportional to their degree of 
divergence (Ansai, Inohaya et al. 2014). A similar strategy is described for screening 
transmission efficiency by observing PAGE migration of relatively small PCR fragments and 
searching for altered fragment sizes (Wei, Liu et al. 2013). 
A variety of methods also have been used for estimating efficiency using cells; some 
studies calculate a ratio based on the total number of cells, while others calculate the efficiency 
based on the total number of transfected or transformed cells. It is understandable why either 
total cell number or only the number of transfected or transformed cells might be used, but the 
latter calculation does result in a higher reported efficiency. Regardless of how estimates are 
made, it is important for the researchers to report exactly how the analysis was performed, so 
readers are not misled by reported results. 
 
NHEJ Endonuclease Enhancement 
As effective as TALENs are at inducing mutations through NHEJ, methods have been 
reported to improve their efficiency. The majority of DSBs do not produce mutations, because 
they are often efficiently and precisely repaired. Therefore, enhancing the Genome Editing 
potential of DSBs by decreasing the probability of precise repair is one way to improve overall 
TALEN efficiency. A recent example of this is the coupling of TALENs with an exonuclease.  
This strategy involves the use of an exonuclease to remove nucleotides from the DNA ends at the 
DSB before a precise repair can be made. Coupling TALENs with Exonuclease 1 (Exo1) 
increased mutagenesis efficiency up to 30% in rat cells (Mashimo, Kaneko et al. 2013), while 
coupling to Exonuclease 2 (Trex2) increased efficiency approximately 144% with no obvious 
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toxicity in human cells (Certo, Gwiazda et al. 2012). A paper describing a meganuclease TALE 
fusion also reports increased efficiency when Trex2 was included with this nuclease (Boissel, 
Jarjour et al. 2013). 
 
Engineered TALE Transcription Factors 
As discussed above, the native function of a TALE is to act as a eukaryotic transcription 
activator after being produced by a bacterial pathogen and secreted into a host cell. TALEs 
contain a nuclear localization signal and an acid activation domain, but their basic transcriptional 
mechanism has not been clearly demonstrated. In plants, a native TALE shifts the transcription 
start site of a target gene from its normal location to a position 44-61 bp downstream of the EBE, 
or in the case of some TALE activated plant defense genes, the transcription start site can be 
basically unchanged (Boch and Bonas 2010, Hummel, Doyle et al. 2012). Even with limited 
information, it is easy to imagine that engineered TALEs can be used as specific transcription 
factors for activation and repression of target genes. 
When designing engineered TALE transcription factors, the position of the target 
sequence appears to be relatively flexible. Positions as far as 500 bp upstream of the native target 
gene transcription start site have reportedly been successful, as have positions upstream, 
downstream or overlapping the TATA box (Maeder, Linder et al. 2013). Additionally, multiple 
TALEs targeted to different regions of the same promoter appear to act synergistically (Maeder, 
Linder et al. 2013, Perez-Pinera, Ousterout et al. 2013). This may be due to the creation of 
additional open chromatin as a result of TALE binding, but contradictory results cloud this issue, 
and additional evidence is needed to determine whether TALEs bind better to open or compact 
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chromatin and whether they can open silent chromatin (Maeder, Linder et al. 2013, Perez-Pinera, 
Ousterout et al. 2013, Scott, Kupinski et al. 2014). 
Additional modifications of engineered TALEs also have reportedly improved their 
functions as activators. For example, it has been demonstrated that the native acidic activation 
domain can be replaced with herpes virus VP16 activation domain (Zhu, Yang et al. 1999). In 
mammalian cells, TALEs usually display higher activity when using VP16 or VP64 fused with 
the most commonly used TALE truncation version, Δ152/+95 or when used with the FLASH 
system (Miller, Tan et al. 2011, Maeder, Linder et al. 2013). It has also been demonstrated that 
the TALE acidic activation domain can be replaced by a repressor, such as the mSin interaction 
domain (SID), and that this fusion can reduce expression of a target gene in plant and animal 
cells and that just physical binding can block transcription in bacteria (Table 1.5) (Cong, Zhou et 
al. 2012, Mahfouz, Li et al. 2012, Crocker and Stern 2013, Politz, Copeland et al. 2013). 
TALE proteins could be fused to a variety of functional units other than nuclease, 
activator or repressor modules. Such fusions might include, methylases, demethylases, 
recombinases, transposases, integrases, flouresent proteins, and protein interaction domains to 
name a few. Many of these fusions could be used to generate new tools, control gene expression 
at an epigenetic level or study the effects of new protein interactions in a chromosomal context. 
Examples in the literature include A TALE TET1 hydroxylase fusion that was successfully used 
to demethylate CpG sites in human gene promoters to stimulate gene expression and a TALE 
Gin recombinase fusion that lead to recombination in bacterial and mammal cells (Mercer, Gaj et 
al. 2012, Maeder, Angstman et al. 2013). 
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Opportunity For Improvement 
Progress in TALE-based technology development has occurred at an astounding pace, 
which speaks volumes about the positive change that a diverse group of research scientists can 
bring to a new technology when they have a common goal; in this case, creating a universally 
powerful tool for Genome Editing. On the other hand, there are still many areas that could be 
improved, including toxicity tests, alternatives for the T0 recognition domain, evaluation of 
alternative RVDs, and an improved nuclease domain. 
 
Toxicity Test 
Toxicity was identified as an issue early in the development of nuclease based Genome 
Editing, and it still is an apparent issue with TALENs although it may be to a lesser degree. 
While progress has been made in testing the relative functionality of nuclease designs using 
methods such as the yeast-based nuclease assay, a simple, general test for nuclease toxicity has 
yet to be developed. This is complicated by the fact that toxicity is not a universal issue, but may 
be more of a species-dependent or cell-specific problem. Often it is easier to simply test several 
engineered nucleases, then use the one that works best.  One way of screening for toxicity is to 
evaluate relative survival based on co-transformation with a marker gene. While this approach 
works, it is not always applicable or convenient, especially in plant cells that are not amenable to 
protoplast isolation or in animal cells in which nucleases are delivered to individual cells one at a 
time. Improvements in understanding toxicity and off target DNA binding will help, but some 
out-of-the box thinking will be required to solve this problem. 
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T0 Domain 
Another area for improvement is the repeat 0 region of the TALE DNA binding domain.  
Repeat 0 binds to the first base in an EBE, which is generally a T. Expanding the spectrum of 
this specificity would further increase TALEN flexibility by expanding the number of potential 
target sequences. Structural data show that repeat 0 has a helix-loop-helix motif and that T 
specificity is based on its interactions with W232 in the KQWSG sequence of the loop (Mak, 
Bradley et al. 2012). When mutations are generated in this region, the specificity for a T is 
relaxed; however, these gains appear to be context specific. That is to say, moving the mutation 
to a related TALE or using the mutation in a TALEN, TALE activator or a TALE recombinase 
changes the recognition pattern (Doyle, Hummel et al. 2013, Lamb, Mercer et al. 2013, Tsuji, 
Futaki et al. 2013). Additionally, it has been demonstrated that repeat 0 from R. solanacearum 
preferentially activates promoters containing EBEs with a 5’ G. However, when tested in a 
PthXo1 construct, although the R. solanacearum repeat 0 changed specificity to G, it did so at 
the expense of activity (de Lange, Schreiber et al. 2013, Doyle, Hummel et al. 2013). 
Interestingly, an optimized TALE scaffold using the N terminal 207 a.a. plus the C terminal 63 
a.a. from AvrXa10 reportedly exhibited similar activity whether a target DNA sequence 
contained a 5’ C, A, T or G (Sun, Liang et al. 2012). These reports suggest that the specificity of 
repeat 0 for a T is not immutable, but they also suggest that a larger scale effort will be needed to 
effectively accommodate A, C and G at position 0 in many contexts. 
 
Alternative RVDs 
The most commonly used RVDs are HD, NI, NG, and NN for the recognition of C, A, T 
and G respectively. While these RVDs work well, they each have strengths and weaknesses.  For 
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example, NN recognizes A about as well as G, HD interacts strongly with C, but is sensitive to 
5-methylcytosine (5mC), NI has a relatively weak interaction with A, and NG interacts strongly 
with T, but also recognizes 5mC (Deng, Yin et al. 2012, Streubel, Blucher et al. 2012, Meckler, 
Bhakta et al. 2013, Lin, Fine et al. 2014). 
Many other RVDs exist, but most have not been stringently tested.  Of the few examined, 
it has been found that NK has a higher specificity for G over NN, but also lower affinity, which 
results in less TALEN activity in yeast and human cell based recombination assays (Huang, Xiao 
et al. 2011, Mahfouz, Li et al. 2011, Cong, Zhou et al. 2012). In contrast, RVD NH has been 
shown to have higher specificity for G over NN without sacrificing affinity (Christian, Demorest 
et al. 2012, Cong, Zhou et al. 2012, Streubel, Blucher et al. 2012, Meckler, Bhakta et al. 2013). 
Also, N* (missing the 13th aa) was shown to bind 5mC as well as C, A, T and G; making it a 
generic RVD (Valton, Dupuy et al. 2012). 
In addition to differences in binding affinity and specificity among the various RVDs, 
there exits polarity in the TALE DNA binding domain, with binding being strongest in the N-
terminal region and weakest in the C-terminal end. This polarity makes a TALE much more 
sensitive to 5’ target site mismatches than 3’ mismatches, and at least one study has shown that 
RVD HD has a stronger affinity for C when located nearer to the N-terminus (Streubel, Blucher 
et al. 2012, Meckler, Bhakta et al. 2013, Lin, Fine et al. 2014). 
The ability to specifically recognize modified and unmodified DNA has important 
implications in epigenetic and cancer research, but also has consequences for general targeting 
efficiency. Until the alternative RVDs are systematically tested for binding affinity, specificity 
and position effect, it will remain an open question as to which RVDs are best for any specific 
application. 
 42  
Improved Nuclease Design 
TALENs and ZFNs could benefit from an improved nuclease design. Both commonly use 
FokI, but FokI functions as a homodimer and engages in trans cleavage. Each of these 
characteristics contributes to cell toxicity, which has been partially addressed by improved 
heterodimeric forms of FokI.  However, there is still much room for improvement. There are 
several reported examples of alternative nucleases being used, such a nickases, alternative 
dimeric nucleases and attempts to create monomeric TALENs that have the potential to improve 
application of TALENs under some conditions. 
Nickases 
A FokI nickase was produced by mutating the catalytic site (D450A) of one partner in a 
FokI heterodimer to induce a single strand break rather than a DSB (Kim, Kim et al. 2012, 
Ramirez, Certo et al. 2012, Wang, Friedman et al. 2012). The idea was to suppress the NHEJ rate 
in favor of HR, which worked; however, the HR rate was also greatly reduced (van Nierop, de 
Vries et al. 2009, Davis and Maizels 2011, Metzger, McConnell-Smith et al. 2011). A different 
approach to engineering a nickase reportedly fused the monomeric nickase MutH to a TALE 
DNA binding domain. MutH is a DNA mismatch repair endonuclease that recognizes the 
sequence GATC.  This fusion protein was tested in a plasmid cleavage assay in vitro and shown 
to function as a nickase (Gabsalilow, Schierling et al. 2013). Further exploration of these and 
other TALE-based nickases may eventually lead to higher HR efficiencies. 
 
Alternative Nucleases 
Because FokI trans activity appears to cause some toxicity, the development of 
alternative nuclease partners may improve the general application of TALENs in Genome 
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Editing. The Type IIP restriction endonuclease PvuII was fused with a TALE, a catalytically 
inactive I-SceI and a zinc finger array. These new homodimeric nucleases were shown to have 
high specificity, but retained the PvuII recognition sequence as part of the overall target site 
(Fonfara, Curth et al. 2012, Schierling, Dannemann et al. 2012, Yanik, Alzubi et al. 2013). This 
work demonstrates that other nucleases can be paired with various DNA binding domains to 
create greater specificity. One wonders if a restriction enzyme with a four base specificity may 
be more versatile or if base specificity could be eliminated by mutagenesis in an alternative 
nuclease. 
Monomeric nuclease 
Because FokI nuclease requires dimerization and thus the use of TALEN pairs, the 
development of monomeric forms may improve the general application of TALENs in Genome 
Editing. A real breakthrough may come from a fusion of a nonspecific monomeric nuclease and 
a TALEN. Such a nuclease would streamline TALEN production by halving the development 
work load and simultaneously produce a more compact enzyme. Some attempts have been made 
to design a FokI monomer and to make TALE fusions to known monomeric nucleases. 
A monomeric engineered nuclease has been reportedly isolated using a high throughput 
screen. The nuclease included a TALE DNA binding domain fused to tandem FokI cleavage 
domains separated by a 95 aa linker. Yeast and human assays indicated that, compared with a 
standard TALEN heterodimer, this nuclease only had 9% to 36% activity and exhibited 
significantly higher cytotoxicity. These characteristics may result from the shorter target leading 
to more off-target DSBs within the human genome, or they may be more related to the 
monomeric nature of this FokI design (Sun and Zhao 2014). 
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A “mega-TAL” fusion protein was described recently as another strategy for monomeric 
nuclease construction. This nuclease is composed of a TALE DNA binding domain and the site 
specific LAGLIDADG monomeric meganuclease I-Anil. In this fusion, I-Anil retains its native 
target site specificity, which is further enhanced by the TALE DNA binding domain. This 
architecture, when combined with the Trex2 exonuclease, demonstrated high specificity and 
increased rates of gene disruption, which exceeded 70% in human cells (Boissel, Jarjour et al. 
2013). 
In another monomeric example, a TALE DNA binding domain was fused to the site 
specific GIY-YIG monomeric meganuclease I-TevI catalytic domain. This domain was 
previously shown to be functionally separate from its native DNA binding domain, but it still 
retains partial site specific recognition, as the sequence CNNNG is required for nuclease action 
(Edgell, Stanger et al. 2004). Additionally, it was demonstrated that this I-TevI nuclease domain 
can be fused to other DNA binding domains to produce hybrid nucleases (Kleinstiver, Wolfs et 
al. 2012). The I-TevI::TALE fusion proved to be a functional monomeric nuclease, and, as 
expected, retained the CNNNG sequence requirement as part of its overall target sequence. This 
fusion was shown to have an activity of 8.9% compare to 6.9% for a standard TALE::FokI fusion 
in plants and 4.3% versus 9.2% respectively in hamster CHO-K1 cells (Beurdeley, Bietz et al. 
2013). 
Ultimately, development of a monomeric nuclease may need to be coupled to a trigger 
mechanism, such as a conformational shift that activates the nuclease only after tight TALE 
domain binding to the target site. Such a mechanism is suggested by the way the DNA binding 
domain of FokI may sequester its nuclease domain in the native structure (Wah, Hirsch et al. 
1997). 
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Conclusions 
The development of TALENs and related TALE technology is moving at a fast pace. The user 
friendly structure and availability of public resources have already changed the perception of 
DNA binding domain engineering from one of difficulty to one of ease, which has appealed to a 
broader audience of researches. In response, volumes of data have been published demonstrating 
TALEN mediated Genome Editing and the utility of other TALE based technologies in a wide 
variety of organisms. The technology still presents some challenges and there are many 
unknowns.  Over time, solutions will be presented and many more discoveries will be made. 
TALE technology appears to be positioned to move targeted manipulation of the genome well 
beyond previous platforms and will be useful into the foreseeable future even as newer genome 
modifying technologies such as CAS9/CRISPR are developed. 
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Figures And Tables  
 
Figure 1.1.  Simplified models of the NHEJ and HR processes are depicted in 1A and 1B.  
Double stranded chromosomal DNA is shown as two solid blue bars, the the green box is the 
DSB point, the red lighting symbol is an external DNA damaging agent, the checkered box is 
inserted DNA and the lighter black double bars are donor DNA carrying an orange box to 
represent change for HR.  In A step 1, DNA is damaged resulting in a DSB as in step 2.  In step 
3, DNA is either repaired precisely or DNA is removed by repair enzymes and re-ligated 
resulting in a deletion as shown by the loss of the green box or DNA is inserted as depicted by 
addition of the checkered box.  In B step 1, DNA is damaged resulting in a DSB as in step 2. In 
step 3, DNA is removed by repair enzymes then a free 3’ end of the damaged DNA invades the 
donor DNA at a point of homology and repair enzymes copy information from the donor using 
the free 3’ end of the damaged DNA as a primer.  After extension, homology is found between 
the free 3’ ends of the damaged DNA and the break is repaired by further polymerization and 
ligation as in step 4 resulting in gene conversion in the chromosome. 
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Figure 1.2.  A simplified Macro and molecular depiction of the yeast recombination assay.  For 
A, yeast are represented by large ovals with black outlines.  The nuclease expression and 
nuclease target constructs are shown as labeled boxes within each yeast cell. Step 1 of A, haploid 
a and a yeast strains are transformed with either a nuclease expression vector or an inactive target 
assay vector containing an internal duplication and a nuclease target site. Transformed yeast cells 
are selected then crossed to form diploids as in step 2.  Diploid yeast are then assayed by 
appropriate means to gauge the relative activity of the nuclease as indicated by step 3. For B, the 
target plasmid is shown as blue double bars representing the target with small internal 
duplications (black boxes with grid pattern) separated by the nuclease target (green box).  The 
nuclease expression plasmid is represented by black bars with a nuclease coding region (black 
box with wavy lines) while nuclease protein is depicted as red striped ovals. Step 1 of B depicts 
the nuclease and inactive target vector in diploid yeast. In step 2, the nuclease is expressed then 
binds the target sequence in pairs where they cleave the target sequence as in step 3. In step 4, 
repair enzymes remove 5’ DNA at the DSB site to generate free 3’ends that find homology with 
each other in the duplicated region as in step 5.  Repair enzymes eliminate unpaired ends, fill in 
missing DNA and ligate the plasmid together to form a functional marker gene to be assayed as 
in step 6. 
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Figure 1.3.  Simplified models of the FokI restriction endonuclease reaction process. Double 
blue bars represent double stranded DNA and FokI is represented by ovals with DNA binding 
subdomains labeled D1, D2, and D3 and a tethered nuclease domain labeled N.  FokI cleavage 
points are indicated by arrows and the numbers 9 and 13.  Crystal structure data indicates that 
FokI binds DNA as a monomer and further suggests that the nuclease domain is sequestered.  
Two cleavage models are shown in step 2, marked A. and B.  In 2A, FokI bound to DNA is 
joined by a free monomer while the nuclease domains are extended and form a dimer interface to 
cleave the DNA at positions 9 and 13 as shown in step 3.  In step 2B, FokI bound to DNA is 
joined another FokI monomer bound to DNA, the nuclease domains are extended and form a 
dimer interface to cleave at positions 9 and 13 as shown in step 3. 
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Figure 1.4. Depiction of a pair of zinc finger nucleases (ZFNs).  Individual ZFs are shown as 
colored ovals marked F1, F2, F3 and the FokI nuclease domain is indicated by the red striped 
oval marked N.  Small N and C indicate termini.  Black bars indicate binding of individual ZFs 
to DNA triplets and dotted lines indicate cross strand interactions.  In step 1, individual ZFNs 
bind their target DNA to form a pair with nucleases positioned over a six base spacer.  In step 2, 
the nuclease domains form a dimer interface and cleave the target DNA, leaving a four base 5’ 
overhang. This is followed by repair using a NHEJ or HR pathway as in step 3.  Note that ZFNs 
bind DNA backward with respect to its N-terminus and the 5’ DNA end. 
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Figure 1.5.  A TALE activator and a pair of Engineered TALENs are depicted.  The N terminus 
of a TALE effector,7A, contains bacterial secretion and translocation signals as shown by the 
white box, repeat 0 is shown as a green oval marked with R0, individual RVDs are depicted as 
small colored rectangles with their nucleotide binding code indicated, the large yellow box 
marked AD, represents a transcription activation domain and nuclear localization signals (NLS) 
are shown as black boxes. In 7B the large red striped ovals in 7B, marked N, represent tethered 
FokI nuclease domains.  Small N and C indicate termini. 7A represents a native 18 RVD TALE 
transcription effector that recognizes a target that is 19 bp long and activates transcription near 
the target site.  7B is an engineered 18 RVD TALEN pair that position FokI nuclease domains 
over a 12 base spacer where they will cleave the DNA to mediate NHEJ or HR.  Note that the 
TALE DNA recognition domain binds DNA in a forward orientation with respect to its N-
terminus and the 5’ DNA end. 
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Table 1.1 Summary of examples of FokI heterodimer pairs used for site specific nucleases in 
gene editing studies. 
Name Mutations Reference Notes 
RV-DA Left D483R, I538V 
Right R487D, I499A  
Szczepek et al. 
2007 
reduced activity in 
vitro and in vivo 
KK-EL Left Q486E:I499L 
Right E490K:I538K  
Miller et al. 
2007 
 
ELD-KKR Left Q486E,I499L,N496D  
Right E490K,I538K,H537R 
Doyon et al. 
2011 
higher nuclease 
activity and increased 
temperature tolerance 
Sharkey S418P and K441E  Guo et al. 2010 Improved nuclease 
activity and 
compatible with 
heterodimer forms 
RE S418R and K441E Sizova et al. 
2012 
Increased DNA 
binding and decreased 
nuclease activity 
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Table 1.2 Relevant TALEN architectures information. 
Name Truncation 
N-
terminal/C
-terminal 
Spacer 
Requirement 
(bp) 
FokI type Codon Bias Reference 
 -288/+295 16-31 homo no Li et al. 2011 
 ∆152/+63 12-21 homo no Miller et al. 2011 
 -287/+231 15-27 homo no Christian et al. 2010 
 -153/+17, -
153/+47 
12, 12-15 KV/EA no Mussolino et al. 2011 
 -111/+42 N/A N/A N/A Meckler et al. 2013 
 ∆152/+14 12-14 DAS/RR 
sharkey 
Human codon Kim et al. 2013 
 ∆152/+18 13-16 homo no Christian et al. 2012 
 -240/+63 14-16 NEL/CKK Silkworm 
codon 
Ma et al. 2012 
Goldy Modified 
∆152/+63 
15-16 homo no Bedell et al. 2012 
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Table 1.3 Commercial available TALEN production and services. 
Company Name Location 
Cellectis Bioresearch  Paris, France 
GeneCopoeia  Maryland, USA 
PolyGene Transgenetics  Zurich, Switzerland 
Stratech Scientific Ltd  Suffolk, UK 
Excellgen  Seoul, Korea 
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Table 1.4 Open-source, web-server programs for selection of potential TALEN target sites 
selection utilities, TALE technology tutorials, troubleshooting guides, mutation detection 
methods, specific species applications and current literature. 
 
Web Site Resources Notes Refer
ence 
http://eendb.zfgenetics.org/ind
ex.php 
 Including TALENs, ZFNs, and 
CRISPR/Cas systems. Collects targeted 
genes in different organisms, offers 
knowledge about TALEN construction, 
genome modification methods, 
mutation detection methods 
Xiao 
et al. 
2013 
http://egenome.org/    
http://www.genome-
engineering.org/taleffectors/ 
   
https://tale-nt.cac.cornell.edu/ TALEN-
NT 2.0 
TALEN design and off-target finder 
with support of restriction length 
fragment polymorphism (RLRP) 
mutation detection 
Doyle 
et al. 
2012 
 
http://idtale.kaust.edu.sa 
 
idTALE TALEN design and search for potential 
TALENs binding sites within five 
different organisms 
 
http://www.talendesign.org/m
ojohand_main.php 
Mojo hand TALEN design with support of 
automated download and extract exons 
for most genes and restriction length 
fragment polymorphism (RLFP) 
mutation detection 
 
http://galaxy.informatik.uni-
halle.de 
TALgetter predict TAL effector target site Grau 
et al. 
2013 
https://www.addgene.org/ Plasmids 
kits and 
information 
  
http://www.hornunglab.de/TA
LEN.html 
   
http://www.talenlibrary.net/    
http://www.e-talen.org/E-
TALEN/ 
   
http://talengineering.org/platf
orms-flash.htm 
   
http://zifit.partners.org/ZiFiT/    
http://baolab.bme.gatech.edu/
Research/BioinformaticTools/
TAL_targeter.html 
SAPTA 
 
TALEN design by scoring algorithm 
based on TALEN activities 
measurement 
Lin et 
al. 
2014 
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Table 1.5 Reported repressor domain utilized in TALE repressor fusion protein in different 
organisms.  
Organism Repression domain References 
Arabidopsis EAR-repression domain (SRDX) Mahfouz et al. 2012 
Mammalian cells  mSin interaction domain (SID) Cong et al. 2012 
E. coli 
No repression domain fused, 
simply by physically block Politz et al. 2013 
Drosophila 
Krüppel and Hairy repression 
domain, Hairy is stronger Crocker and Stern 2013 
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CHAPTER 2 
TAL NUCLEASES (TALNS): HYBRID PROTEINS COMPOSED OF TAL EFFECTORS 
AND FOKI DNA-CLEAVAGE DOMAIN 
A paper published in Nucleic Acids Research‡ 
Ting Li 1,*, Sheng Huang 1,*, Wen Zhi Jiang 2, David Wright 1, Martin H. Spalding 1,  
Donald P. Weeks 2, Bing Yang 1, † 
1 Department of Genetics, Development and Cell Biology, Iowa State University, Ames, IA 
50011 and 2 Department of Biochemistry, University of Nebraska, Lincoln, NE 68588, USA  
 
 
Abstract 
DNA double-strand breaks enhance homologous recombination in cells and have been 
exploited for targeted genome editing through use of engineered endonucleases. Here we report 
the creation and initial characterization of a group of rare-cutting, site-specific DNA nucleases 
produced by fusion of the restriction enzyme FokI endonuclease domain (FN) with the high-
specificity DNA binding domains of AvrXa7 and PthXo1. AvrXa7 and PthXo1 are members of 
the transcription activator-like (TAL) effector family whose central repeat units dictate target 
DNA recognition and can be modularly constructed to create novel DNA specificity. The hybrid 
FN-AvrXa7, AvrXa7-FN and PthXo1-FN proteins retain both recognition specificity for their 
target DNA (a 26 bp sequence for AvrXa7 and 24 bp for PthXo1) and the double-stranded DNA 
cleaving activity of FokI and, thus, are called TAL nucleases (TALNs). With all three TALNs, 
DNA is cleaved adjacent to the TAL-binding site under optimal conditions in vitro. When  
_______________________ 
‡ Reprinted with permission of Nucleic Acids Research, (2011) 39 (1): 359-372. 
* Both authors contributed equally to this work. 
† To whom correspondence should be addressed. Tel: 515 294 2968; Fax: 515 294 5256; Email: 
byang@iastate.edu 
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expressed in yeast, the TALNs promote DNA homologous recombination of a LacZ gene 
containing paired AvrXa7 or asymmetric AvrXa7/PthXo1 target sequences. Our results 
demonstrate the feasibility of creating a tool box of novel TALNs with potential for targeted 
genome modification in organisms lacking facile mechanisms for targeted gene knockout and 
homologous recombination.  
 
Introduction  
Perhaps the most significant application of endonucleases in the post-genome era is their 
coupling with custom-engineered proteins that recognize long stretches of DNA sequences and 
their application for targeting specific genes for knockout or gene replacement (1). The key 
component of these engineered nucleases is the DNA recognition domain that is capable of 
precisely directing the nuclease to the target site for the purpose of introducing a DNA double 
strand break (DSB). These breaks are principally repaired by one of two pathways, non-
homologous end-Joining (NHEJ) or homologous recombination (HR). Repair by NHEJ often 
results in mutagenic deletions/insertions in the targeted gene. Moreover, DSBs can stimulate HR 
between the endogenous target gene locus and an exogenously introduced homologous DNA 
fragment with desired genetic information, a process called gene replacement or genome editing 
(2, 3, 4). To date the most promising method involving genome editing is the use of custom-
designed zinc finger nucleases (ZFNs) (5). ZFN technology involves the use of hybrid proteins 
derived from the DNA binding domains of zinc finger (ZF) proteins fused with the nonspecific 
DNA cleavage domain of the endonuclease FokI (6, 7).  
FokI endonuclease, a type IIS nuclease, was first isolated from the bacterium 
Flavobacterium okeanokoites (8). The nuclease consists of two separate domains, an N-terminal 
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DNA binding domain and a C-terminal DNA cleavage domain. The DNA binding domain 
recognizes the non-palindromic sequence 5’-GGATG-3’ while the catalytic domain cleaves 
double-stranded DNA non-specifically at a fixed distance of 9 and 13 nucleotides downstream of 
the recognition site (9, 10). FokI exists as an inactive monomer in solution and becomes an 
active dimer upon binding to its target DNA and in the presence of specific divalent metals (11). 
It has been proposed that to form a functional complex, two molecules of FokI each bind to their 
recognition sequence in a double stranded DNA molecule and then dimerize in such a way that 
the two nuclease domains unite to form a functional endonuclease that cleaves both DNA strands 
at sites downstream of the FokI recognition sequence (12, 13, 14).  
ZFNs can be assembled as modules that are custom-designed to recognize selected DNA 
sequences, typically 18 to 24 bp with a 4-7 bp spacer between two half sites (15, 16, 17). 
Following binding at the preselected site, a DSB is produced by the action of the ZFN’s FokI 
cleavage domain (4). ZFN technology has been successfully applied to genetic modification in a 
variety of organisms, including yeast, plants, mammals, and even human cell lines [reviewed in 
(18, 19)]. Despite the promise of ZFN technology in basic and applied research, widespread 
adoption of this technology has been hampered by a bottleneck in custom-engineering zinc 
fingers that possess the requisite high specificity and affinity for preselected DNA target site. 
Such engineering is labor intensive, time consuming and associated with high rates of failure (20, 
21).  Since the effectiveness of these endonucleases depends almost solely on their DNA binding 
specificity, the required specificity theoretically can be supplanted by any high-fidelity DNA 
binding domain when fused with a functional endonuclease domain. The TAL effector proteins 
from a number of bacterial plant pathogens represent a potential source of modularly constructed 
DNA binding domains that could supply the needed DNA binding specificity.   
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TAL effectors belong to a large group of highly conserved bacterial proteins that exist in 
various strains of Xanthomonas spp. and are translocated into host cells by a type III secretion 
system and, thus, are called type III effectors [reviewed in (22)]. Once in host cells, some TAL 
effectors have been found to transcriptionally activate their corresponding host target genes 
either for strain virulence (ability to cause disease) or avirulence (capacity to trigger host 
resistance responses) dependent on the host genetic context (23, 24, 25, 26). Each of these 
bacterial effectors contains a functional nuclear localization motif and a potent transcription 
activation domain that are characteristic of eukaryotic transcription activators. Each TAL 
effector also contains a central repetitive region consisting of varying numbers of repeat units of 
34 amino acids. It is this repeat region that recognizes a specific DNA sequence and determines 
the biological specificity of each effector [Figure 2.1 A, and reviewed in (27)]. Each repeat is 
nearly identical except for two variable amino acids at positions 12 and 13, the so called repeat 
variable di-residues (RVD) (28). Recent studies have revealed that the recognition of DNA 
sequences within the promoter regions of specific host target genes is defined by the repeat 
regions of TAL effectors. The DNA sequence recognition is based on a fairly simple code where 
one nucleotide of the DNA target site is recognized by the RVD of one repeat (i.e., one 
repeat/one nucleotide recognition). The sequential tandem array of repeats thus specifies the 
DNA sequence that will be bound (28, 29). The majority of naturally occurring TAL effectors 
contains repeat units in a range of 13 to 29 that presumably recognize DNA elements consisting 
of the same number of nucleotides. Thus, in theory, the so called TAL recognition code can be 
used as a guide for custom-design of novel TAL effectors with the required specificity to target a 
single locus in a genome.  
AvrXa7 and PthXo1 are TAL type III effectors from Xanthomonas oryzae pv. oryzae 
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(Xoo), the causal pathogen of bacterial blight of rice. They each contain a unique combination of 
RVDs in 26 and 24 repeats, respectively (Figure 2.1B and 2.1C). For some Xoo strains, AvrXa7 
is a key virulence factor in susceptible rice. On the other hand, it is also an avirulence 
determinant in the otherwise resistant plants containing the cognate resistance gene Xa7 (30, 31). 
As the essential virulence factor, AvrXa7 activates the rice gene Os11N3 to induce a state of 
disease susceptibility (manuscript submitted). The gene induction by AvrXa7 is mediated 
through its recognition of a specific DNA element within the promoter region of Os11N3, an 
element we refer to here as the effector binding element (EBE) (sequence shown in Figure 2.1B).  
Similarly, PthXo1 is also an essential virulence factor for some strains of X. oryzae pv. oryzae 
and activates the rice gene Os8N3 to promote bacterial multiplication and disease development 
(24). PthXo1 recognizes an EBE of 24 nucleotides within the promoter of Os8N3 (32) (sequence 
shown in Figure 2.1C). 
As a proof-of-principle, we have tested the feasibility of generating a new type of DNA 
sequence-specific endonuclease by utilizing the sequence specificities of AvrXa7 and PthXo1 
and the catalytic activity of the endonuclease FokI. Here we report the creation of TAL effector 
nucleases (TALNs) by fusing the full-length AvrXa7 TAL effector or the full-length PthXo1 
TAL effector to the FokI nuclease domain and the characterization of their nuclease activities 
both in vitro and in vivo using a yeast cell assay. 
 
Results 
Construction of the chimeric genes for FN-AvrXa7, PthXo1-FN and PthXo1-FN 
            AvrXa7 and PthXo1 are two naturally occurring TAL effectors containing a central 
region of 26 and 24 repeat units, respectively, with, like their relatives, the last repeat containing 
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only the first 20 amino acid residues similar to other repeats. The specific arrays of 26 RVDs in 
AvrXa7 and 24 RVDs in PthXo1 make the target sequences of AvrXa7 and PthoXo1 unique in 
comparison with all other TAL effectors [Figure 2.1B and 2.1C; (26)]. AvrXa7 binds to a 
specific 26 bp promoter element, the effector binding element or EBE, in the rice Os11N3 gene 
through its DNA binding repeats [Figure 2.1 B; (32); and submitted manuscript], while PthXo1 
binds to a specific 24 bp sequence in the promoter region of Os8N3 (24).  The nucleotide “T” 
that precedes all known TAL effector target sites and is essential for the target gene activation 
(28, 29) is also present immediate upstream of the 1st nucleotide of EBEs of Os8N3 and Os11N3 
and, therefore, is treated as part of EBE throughout this paper. We reasoned that a chimeric 
protein composed of AvrXa7 or PthXo1 and a DNA cleavage domain of an endonuclease might 
function in recognizing the Os11N3 and Os8N3 target sequences, respectively, and cleaving 
DNA adjacent to the recognition site. The DNA cleavage domain of the endonuclease FokI was 
chosen due to its well-documented nonspecific catalytic activity when linked with other DNA 
binding domains, such as zinc finger proteins. Reflecting the configuration of the chimeric 
protein we designed, FN-AvrXa7 was constructed by fusing the DNA sequence encoding the 
full-length AvrXa7 TAL effector downstream of the DNA sequence encoding the cleavage 
domain of FokI.  AvrXa7 and PthXo1 constructs were also made that each express hybrid 
proteins with the FN domain at the C-terminus of each TAL effector. The resulting chimeric 
genes were predicted to encode proteins of 1645, 1648 and 1574 amino acid residues, 
respectively (Figure 2.1D, 2.1E and 2.1F). The 196 amino acid FokI domain is linked by 4 amino 
acid residues to the 1459 amino acids of AvrXa7 in FN-AvrXa7 and by 2 amino acids in both 
AvrXa7-FN and PthXo1-FN.   
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Transcription enhancement by FN-AvrXa7 in vivo 
In addition to a DNA binding domain, the TAL effectors contain a potent C-terminal 
transcription activation domain (27).  Thus, we reasoned that by placing the FokI nuclease 
domain at the N-terminus of TAL effectors, the activation domain would remain functional. We 
could then take advantage of transcription enhancement as an indirect measure of the DNA 
binding ability of the hybrid protein, FN-AvrXa7 in this case, or of any newly synthesized TAL 
fusion protein, in general.  
We adapted a modified Agrobacterium tumefaciens mediated transient expression assay 
that has been successfully used for studying the interaction of TAL effectors with their target 
host genes (26, 29). In our case, the “reporter” construct contained the gene encoding a green 
fluorescence protein (GFP) under the control of the Os11N3 promoter that contains the AvrXa7 
EBE. Two “effector” constructs were made to express either AvrXa7 or FN-AvrXa7 under 
control of the strong and constitutive CaMV 35S promoter. Both reporter and effector genes 
were delivered by injection of Nicotinana benthamiana leaves with Agrobacterium tumefaciens 
to allow co-expression of genes from the effector and reporter constructs. Both AvrXa7- and FN-
AvrXa7-containing constructs induced the expression of GFP while the construct lacking either 
AvrXa7 or FN-AvrXa7 did not (Figure 2.1G). These results indicated that the hybrid FN-
AvrXa7 retained the DNA binding ability of AvrXa7, and that the transient expression assay 
could provide a means to test the DNA binding ability or specificity of TAL-derived hybrid 
proteins in vivo.  
Overexpression and purification of FN-AvrXa7, AvrXa7-FN and PthXo1-FN 
            The FN-AvrXa7 and AvrXa7-FN were each cloned into an overexpression vector in 
frame with an N-terminal 6Xhistidine tag to allow for affinity chromatography purification on a 
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Ni-containing column after overproduction of the TAL hybrid protein in E. coli.  The proteins 
were successfully isolated in a relatively high purity. The identity of FN-AvrXa7 and AvrXa7-
FN were further confirmed with protein blot analysis using an antibody against the FLAG 
epitope that was integrated after the repeat regions of AvrXa7 and PthXo1. The FLAG-tagged 
proteins detected were approximately 175 KD, the calculated sizes of FN-AvrXa7 and AvrXa7-
FN, respectively.  IPTG-induced E. coli cells overexpressing FN-AvrXa7 or AvrXa7-FN did not 
exhibit any obvious growth defects (data not shown).  Overexpression and purification of 
PthXo1-FN were achieved in a similar fashion to that for FN-AvrXa7 and AvrXa7-FN. 
DNA binding activities of AvrXa7-FN and FN-AvrXa7 in vitro 
AvrXa7-FN and FN-AvrXa7 purified from E. coli were tested for their DNA binding 
specificities in vitro. The abilities of purified AvrXa7-FN and FN-AvrXa7 to bind DNA targets 
in vitro were investigated using double-stranded oligonucleotides containing the AvrXa7 EBE of 
Os11N3 or its mutated version, Os11N3M, containing five nucleotide substitutions near the 5’ 
end of its EBE sequence (Figure 2.2A). The binding reactions were carried out in the solution 
lacking divalent metal cations such as Mg2+ to prevent cleavage of the oligonucleotides (see 
Materials and Methods). The electromobility shift (EMS) assay demonstrated that AvrXa7-FN 
and FN-AvrXa7 preferentially bound to the labeled double stranded DNA containing the 
authentic AvrXa7 EBE target sequence but did not effectively bind to the probe containing the 
mutated target sequence containing five nucleotide changes near the 5’ end of the EBE (Figure 
2.2B, left panels). Furthermore, AvrXa7-FN and FN-AvrXa7 binding to the 32P-labeled AvrXa7 
EBE could be competed away using increasing amounts of unlabeled DNA nucleotides of the 
same sequence (Figure 2.2B, middle panels).  However, the binding to the labeled Os11N3 was 
not competed away with an excess of the variant oligonucleotide, Os11N3M (Figure 2.2B, right 
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panels).   
DNA cleavage activities of FN-AvrXa7, AvrXa7-FN and PthXo1-FN in vitro 
We also tested the abilities of FN-AvrXa7, AvrXa7-FN and PthXo1-FN to cleave 
substrate DNA individually or in combination in vitro. For experiments with individual FN-
AvrXa7 and AvrXa7-FN TALNs, we chose a plasmid containing a cloned DNA fragment of the 
Os11N3 promoter from rice. The plasmid pTOP/Os11N3 was first linearized at a unique 
restriction site (EcoNI) or digested with MluI (Figure 2.3A; 2.3B, lanes 2 and 3). The DNA was 
then incubated with FN-AvrXa7 or AvrXa7-FN at 37 ºC for 1 hr using the EMS assay buffer 
with the addition of 2.5 mM MgCl2. The FN-AvrXa7 and AvrXa7-FN each cleaved the EcoNI-
linearized pTOP/Os11N3 plasmid into two fragments of the expected size (0.8 kb and 2.1 kb) 
(Figure 2.3B, lanes 5 and 8). Incubation of the supercoiled pTOP/11N3 (Figure 2.3B, lane 1) 
with an appropriate amount of FN-AvrXa7 or AvrXa7-FN resulted in partial linearization of the 
plasmid (Figure 2.3B, lanes 4 and 7, respectively). Individual FN-AvrXa7 and AvrXa7-FN also 
cleaved the MluI predigested pTOP/11N3 into an expected pattern of DNA fragments (Figure 
2.3B, lanes 6 and 9, respectively). Taken together, the results indicate that both FN-AvrXa7 and 
AvrXa7-FN mediated-cleavages occur at the AvrXa7 EBE site. 
To investigate the specificity of cleaving action by FN-AvrXa7 in more detail, a plasmid 
containing a mutated binding site of AvrXa7 was generated from pTOP/Os11N3 using a linker 
scanning mutagenesis method to contain a six base pair insertion immediately downstream of the 
initial “T” residue of the Os11N3 EBE. This EBE mutation abolished the ability of AvrXa7 to 
elicit GFP gene expression when placed in the Os11N3 promoter in our Os11N3 promoter assay 
(data not shown), which is consistent with the finding that the “T” immediately upstream of the 
1st EBE nucleotide is essential for the TAL effector mediated activation of target genes (29). 
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Incubation of the same amount (1 ug) of EcoNI pretreated DNA of pTOP/Os11N3, the mutant 
pTOP/Os11N3m2 and pTOP/GFP (a plasmid containing a GFP gene sequence unrelated to the 
AvrXa7 EBE) with an appropriate amount of FN-AvrXa7 resulted in digestion of 
pTOP/Os11N3, but not the mutant- and GFP-containing plasmids. The specific and expected 
cleavage pattern observed with digestion of pTOP/Os11N3 DNA was not observed with the 
mutant pTOP/Os11N3m2 even with increasing amounts of FN-AvrXa7 protein. These 
experiments demonstrate that the FN-AvrXa7 is a highly selective endonuclease, having the 
ability to cleave double stranded DNA while discerning the preferred target site from a slight 
variant or unrelated DNA sequence.  
Additional evidence for specific cleavage by TALNs in close proximity to EBE sites has 
come from cleavage patterns of DNA sequences that are targets for PthXo1-FN as well as 
AvrXa7-FN and PthXo1-FN in combination.  Cleavages of the EBE site (Figure 2.3C) of 
plasmid pEBE-TD (Figure 2.3D) with either of the two TALNs (or EcoRI) cause linearization 
(or partial linearization) of the plasmid to produce a band of 3052 bp (Figure 2.3E, lanes 2, 4 and 
6). To define the site of TALN-mediated DNA cleavage, post treatment of TALN-digested 
plasmid DNA with BglI was employed.  BglI alone produces DNA fragments of 1786 bp and 
1266 bp (Figure 2.3E, lane 3). Incubation with AvrXa7-NF alone results in incomplete digestion 
of the supercoiled plasmid and produces a band of DNA migrating at approximately 3 kb along 
with another band migrating with an apparent molecular size of >10 kb (lane 4).  When BglI is 
added to the digestion mix 30 minutes after cutting with AvrXa7-FN has begun, four DNA 
fragments are observed that correspond to sizes interpreted to be 1786 bp, 1479 bp, 1266 bp and 
307 bp (Figure 2.3E, lane 5). This pattern is fully compatible with the interpretation that the 
initial cutting by AvrXa7-FN was at the EBE target site, but was only partially complete. Post 
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incubation with BglI resulted in two BglI-BglI DNA fragments of 1786 bp and 1266 bp and two 
AvrXa7-FN-BglI bands of 1479 bp and 307 bp. When pEBE-TD is incubated with PthXo1-FN 
three DNA fragments are observed (Figure 2.3E, lane 6), a weak band co-migrating with uncut 
supercoiled plasmid, a band co-migrating with linearized DNA and a band >10 kb.  When BglI is 
subsequently added to the reaction, again four bands of DNA are observed (Figure 2.3E, lane 7).  
Double digestion of pEBE-TD with AvrXa7-FN and PthXo1-FN using only one-fifth the amount 
of each TALN used in the reactions whose products are displayed in lanes 4 through 7, results 
once more in the appearance of four bands, but with somewhat greater representation of bands of 
molecular sizes of 1479 bp, 1266 bp and 307 bp – and significantly less non-specific DNA 
cleavage (compare lanes 5 and 7 with lane 8).  The possible nature of the DNA band migrating 
with an apparent molecular size >10 kb is considered in the Discussion section below.  
To further identify the major cleavage sites of the sense and antisense strand, the cleaved 
DNA fragments (expected sizes of ~840 bp and ~2120 bp) derived from pTOP/Os11N3 treated 
independently with AvrXa7-FN and FN-AvrXa7 were purified and subjected to sequencing. 
Each band was expected to contain part of the Os11N3 promoter fragment, but it was unclear 
which contained the actual target site. Primers that flank the original 0.4 kb Os11N3 promoter 
fragment were chosen to sequence each of the digested plasmid bands. These primers 
presumably were able to sequence through the entire EBE site if it was present. For AvrXa7-FN 
cleavage, the right side primer (M13R on pTOPO) was used to sequence the sense strand of the 
0.8 kb fragment, while M13F was used to sequence the antisense strand of the 2.1 kb fragment 
(Figure 2.4A). The reverse complementary DNA sequencing trace (Figure 2.4A, the upper 
chromatograph) from the sense strand of the 0.8 kb fragment ends two base pairs downstream of 
the last EBE nucleotide. On the other hand, the sequence from the antisense strand of 2.1 kb 
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fragment ends 17 base pairs downstream of last EBE nucleotide (Figure 2.4A, lower 
chromatograph), resulting in a 15 base pair cutting “zone” of each DNA fragment. These results 
indicate that the major cleavages of double stranded DNA by the action of AvrXa7-FN occur 
downstream of the EBE site, a finding that is consistent with the expected locations of the FokI 
nuclease domain and of the AvrXa7 binding domain given the configuration of the two 
components. For FN-AvrXa7 cleavage (Figure 2.4B), the sequence trace from the antisense 
strand of the 1.2 kb fragment ends 14 base pairs upstream of the first nucleotide of the EBE 
(Figure 2.4B, lower chromatograph), while the sequencing trace (reverse complementary to the 
original trace) generated from the sense strand of the 0.8 kb fragment terminated completely 
after the 6th nucleotide upstream of the last nucleotide of the EBE sequence (Figure 2.4B, upper 
chromatograph), but within the EBE site. These latter cutting sites were unexpected given the 
position of the FN domain relative to the FN-AvrXa7 DNA binding site and the presumable 
protection of the site by the AvrXa7 binding.  Repeated sequencing of DNA fragments from 
additional experiments yielded similar results and, thus, provide no explanation for the observed, 
but unexpected, DNA cleavage pattern with FN-AvrXa7.  
Stimulated homologous recombination in yeast by FN-AvrXa7, AvrXa7-FN, and AvrXa7-
FN/PthXo1-FN  
We sought to test the ability of the TALNs to bind and cleave target sequences in vivo by 
using a previously established yeast single strand annealing (SSA) assay (34, 36). In this assay, a 
“reporter” construct is coexpressed with an “effector” construct in yeast cells. The reporter 
construct contains a divided LacZ gene in which a duplicated 125 bp portion of the LacZ coding 
region has been created. The direct repeat within the LacZ gene is separated by a 1.2 kb sequence 
containing the URA3 gene (Figure 2.5A) or a shorter 0.2 kb sequence (Figure 2.5B) and a 
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multiple cloning site (MCS). It is expected that the direct DNA repeats will undergo homologous 
recombination at high efficiency when a DSB is created between the repeats, resulting in a 
reconstituted and functional LacZ gene. Measurement of β-galactosidase (LacZ product) 
enzymatic activity was used to quantify the recombination frequency that, in turn, reflects the 
activity of TALNs in the presence of various target sequences (37, 38, 39). 
 For TALN assays, the Saccharomyces cerevisiae YHP500 strain carrying the reporter 
plasmid with only a single EBE of AvrXa7 EBE (x7-S) was mated with YHP499 harboring 
pCP3M-FN-AvrXa7/pCP4M or pCP3M-AvrXa7-FN/pCP4M (Figure 2.5). Cells carrying the 
reporter and effector plasmids in either combination did not show increased β-galactosidase 
activity compared with control cells transformed with two effector plasmids lacking any TALN 
(data not shown). The results suggested that a single EBE site was insufficient for TALNs FN-
AvrXa7 or AvrXa7-FN to effectively cleave double stranded DNA at the target site or at any 
nearby site within the reporter plasmid in vivo. The results also suggested a possible requirement 
for binding of two TALNs in an orientation allowing efficient dimerization of their FokI 
nuclease domains – in a fashion similar to that needed for successful DNA cleavage by ZFNs. 
We, therefore, reasoned that two TAL EBE sites in a proper orientation and with an appropriate 
spacing could bring the FokI nuclease domains in sufficiently close vicinity to dimerize and 
consequentially execute a double strand cleavage. To test the hypothesis, we designed two 
constructs, one with two identical AvrXa7 EBE sites located in a head-to-head orientation (HD) 
for FN-AvrXa7 and the other in a tail-to-tail orientation (TD) for AvrXa7-FN. Another construct 
was made containing two EBE sites, one for AvrXa7 and one for PthXo1, appropriately situated 
to allow tail-to-tail (TD; FN to FN) interaction between EBE-bound AvrXa7-FN and PthXo1-
FN. We also sought to determine the optimal range of spacer lengths between the two EBE sites 
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in each configuration to allow for efficient TALN cleavage (Figures 5A and 5B).  For FN-
AvrXa7, the head-to-head oriented dual EBE sites (HD) were separated by a series of spacers of 
6, 14, 19, 24, 30, 35 and 40 bp in length (Figure 2.5A, DNA).  Each reporter plasmid was 
coexpressed with pCP3M-FN-AvrXa7. Yeast cells containing constructs with spacers of 30 
nucleotides or more exhibited -galactosidase activities that increased with the length of the 
spacer element employed (Figure 2.5C).  
To compare the cleavage efficiency of the TALNs containing a C-terminal FN (using a 
tail-to-tail orientation of dual target sites) with efficiency obtained with a known ZFN under the 
similar context, we performed an assay with a ZFN consisting of the “original” BCR-ABL three-
finger array and the FokI nuclease domain (35). For this experiment, YHP499 cells expressing 
BCR-ABL-FN were mated with YHP500 cells containing the reporter plasmid pzf-TD6 that 
contained a dual tail-to-tail target site for the BCR-ABL three-finger domain. As expected, the 
diploid cells exhibited high β-galactosidase enzymatic activity compared to cells lacking the 
effector plasmid (Figure 2.5D). For experiments with AvrXa7-FN, the tail-to-tail dual EBE sites 
were separated by spacers of 2, 5, 8 and 19 bp (Figure 2.5A). Among this collection of reporter 
plasmids, only the plasmid containing the 19 bp spacer produced increased -galactosidase in 
yeast cells when coexpressed with AvrXa7-FN. The magnitude of response was directly 
comparable to that obtained with the zinc finger nuclease (Figure 2.5D). Only background levels 
of -galactosidase expression were obtained when FN-AvrXa7 was substituted for AvrXa7-FN 
(data not shown). Furthermore, no stimulation of -galactosidase activity was observed in cells 
expressing AvrXa7-FN if either one or both AvrXa7 EBEs was mutated (Figure 2.5D). We 
further tested the ability of two different species of TALNs, AvrXa7-FN and PthXo1-FN, to act 
in concert to recognize and cleave an asymmetric target sequence separated by a serial spacer 
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(x7/o1-TDn3, n3=6, 11, 16, 21, 26, 31, 36 bp) (Figure 2.5B). The yeast cells containing reporter 
plasmids each with spacer in length of 16, 21, 26 or 31 exhibited significant increased -
galactosidase activity in the presence of AvrXa7-FN and PthXo1-FN together (Figure 2.5D). 
Taken together, these results suggest requirements for dual EBE target sites, optimized spacer 
lengths between the EBEs as well as dimerization of TALN FN domains for efficient cleavage of 
double stranded DNA target sites by TALNs in living yeast cells.   
 
Discussion 
Many years of effort spent in elucidating the interaction between TAL effectors and their 
modulated host genes has led to a recent breakthrough in deciphering the DNA recognition code 
of TAL effectors (28, 29). The predictability and potential manipulability of the TAL central 
repeat domain for DNA binding specificities make TAL an excellent system for exploiting 
potential biotechnological applications. In the present study, we created chimeric TALNs, FN-
AvrXa7, AvrXa7-FN and PthXo1-FN containing the entire AvrXa7 or PthXo1 TAL effectors 
and the nuclease domain of the FokI restriction enzyme either at the C-terminal end or the N-
terminal end of each TAL effector. All three constructs were tested for the ability to bind to the 
respective EBE recognition site and to cleave adjacent DNA. Binding of FN-AvrXa7 to the 
AvrXa7 EBE in vivo was demonstrated by its ability to activate transcription of a GFP coding 
sequence driven by the rice Os11N3 promoter that contains the AvrXa7 EBE binding site (Figure 
2.1G).  All three TALNs were successfully overproduced and purified from E. coli cells 
(AvrXa7 TALNs). FN-AvrXa7 and AvrXa7-FN each were shown to bind specifically to double-
stranded oligonucleotides containing the AvrXa7 EBE target site, but not to a slightly modified 
version of the binding site in an EMS assay (Figure 2.2).  Moreover, the purified AvrXa7-FN 
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and FN-AvrXa7 TALNs exhibited cleavage activity near the expected EBE binding site under 
optimized reaction conditions in an in vitro assay, the results of which were confirmed by DNA 
sequencing (Figures 2.3 and 2.4). Likewise, PthXo1-FN (alone and together with AvrXa7-FN) 
was shown to specifically cleave at its specific EBE DNA target site and produce the predicted 
sized DNA fragments (Figure 2.3). Finally, expression of the chimeric FN-AvrXa7, AvrXa7-FN 
and PthXo1-FN TALNs in yeast stimulated HR between internal repeats of a disrupted and non-
functional reporter gene (LacZ) that contained appropriately paired AvrXa7 or asymmetric 
AvrXa7/PthXo1 target sites (Figure 2.5). These observations demonstrate the successful creation 
of functional TALNs and lead the way to future experimentation directed toward development of 
a technology for high-specificity gene knockout and homologous recombination in organisms 
that currently lack the ability to support either process in a practical manner.  
FokI and its fusion proteins with zinc finger DNA binding domains have been 
extensively studied. The endonuclease domain (FokI nuclease, FN) by itself has no specificity 
for cleavage, but cuts DNA at a set distance from the binding site specified by the FokI DNA 
binding domain when the two domains are linked together (13, 14, 15). In this sense, several 
types of FN based fusion proteins have been successfully created that combine new DNA 
sequence binding specificities with the FN cleavage activities, with zinc finger nucleases (ZFNs) 
being the most familiar (6, 7, 41). Study has shown that fusion of FN to ZF motif does not 
change the DNA binding specificity of the ZF protein although it may cause slight decrease in 
binding affinity (41). We chose the FokI cleavage domain to fuse with members of the TAL 
effector family and, as a proof of principle, demonstrated the feasibility and generality of 
creating a new class of rare-cutting, site-specific DNA nucleases with sequence specificities 
attributable to the TAL effectors.  The DNA binding features of TAL effectors make this group 
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of proteins or their repetitive domains desirable as the key component of such chimeric 
endonucleases for a number of applications, including various sorts of genome editing. For 
example, the majority of naturally occurring TAL effector proteins contains a large number of 
repeat units and, correspondingly, recognizes lengthy DNA target sites (32, 43). These TAL EBE 
sites are comparable in length to, or longer than, target sites of rare-cutting meganucleases or 
homing nucleases (i.e., 14 to 40 bp) as well as binding sites for artificial zinc finger proteins 
assembled from multiple single fingers (i.e., 18 or 24 bp) (5, 42). All TAL effector proteins 
investigated thus far exhibit high sequence specificity to the EBEs of their target genes (32, 43). 
The known code of TAL effectors predicts an alignment of a single type of repeat unit to a single 
nucleotide species (A, G, C or T) based on the specific di-residues at positions 12 and 13 in the 
repeat unit. This modular nature of the TAL repeat domain for DNA binding specificity suggests 
that techniques can be developed to produce an array of repeat units that can precisely recognize 
a unique, lengthy sequence of nucleotides in any given gene.  If so, investigators will be able to 
create truly gene-specific TALNs for use in organisms with large genomes and lacking robust 
systems for homologous recombination. 
Thus far, several TAL effectors have been found to function as transcription activators.  
Like many other transcription factors, TAL effectors may function as dimers to bind target DNA. 
However, to date, AvrBs3 is the only TAL effector shown to dimerize in vitro and in the 
cytoplasm in vivo before entry into nuclei of host cells (44). The sequence specificity of known 
TAL effectors that bind DNA can be aligned to only one strand of the target site which is usually 
asymmetric (28, 29). Thus, it is not yet clear if most TAL effector proteins form dimers or 
multimers in the presence of target DNA (or in the absence of DNA). The results from the 
present yeast SSA assay imply that TALNs do not form homo- or hetero-dimer at a single TAL 
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EBE site, or at least the dimerization of TAL subdomain does not facilitate the dimerization of 
FokI nuclease domains for effective double stranded DNA cleavage in yeast cells. More detailed 
structural studies of TAL effectors or TALNs likely will be needed to resolve this uncertainty, 
which may or may not negatively influence the ability to easily and successfully design sequence 
specific TAL effector nucleases in the future. 
It has been established that for efficient double strand cleavage of target DNA 
dimerization of FokI monomer nuclease domains is required (11). Therefore, it is conceivable 
that TALNs need to dimerize for the efficient cleavage of DNA in solution where sufficient 
concentrations of purified proteins and substrates are present or in vivo where TALN and target 
substrate are otherwise limited. This could be achieved through various mechanisms, three of 
which are presented below.  In one model, one EBE-bound TALN might form a dimer with 
another bound or unbound TALN through an as yet uncharacterized dimerization motif of TAL 
effector. In such a case, the TAL subdomain-mediated dimerization could bring the two FokI 
nuclease domains in close proximity near the binding site and allow DNA cleavage.  
Alternatively, one TALN monomer could bind to one EBE target site and, similar to the model 
proposed for the native FokI or hybrid ZFNs in vitro (13, 14), dimerization of two DNA bound-
TALNs through the well characterized dimerization motif in the FokI nuclease subdomain could 
occur in close proximity and, thereby, support DNA cleavage in trans if sufficient concentrations 
of nucleases were present. Successful in vitro cleavage of DNA carrying a single AvrXa7 EBE 
by the FN-AvrXa7, AvrXa7-FN and PthXo1-FN TALNs (Figure 2.3) is consistent with this 
model.  In a third model in which two tandem, head-to-head or tail-to-tail EBE sites are present, 
TALNs could bind to each of the EBE sites.  This would bring the two FN domains of the two 
TALNs into sufficiently close proximity to allow dimerization and DNA cleavage. Our yeast 
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SSA data (Figure 2.5) is consistent with this latter model. 
The function of native FokI is allosterically regulated through DNA and divalent metal 
binding. Without DNA binding and in the absence of divalent metal, FN is sequestered through 
tight interaction with the DNA recognition motifs of FokI and, thus, the FokI monomer 
maintains an idle state. Following binding of two FokI holoenzymes to the FokI recognition site 
and in the presence of metals, the two FokI nuclease domains are freed and can dimerize. This 
dimerization then allows double stranded DNA cleavage (14, 16, 17). It is possible that the 
interaction between the FN subddomain and the TAL DNA binding subdomain in hybrid TALN 
lacks such tight regulatory mechanism and, hence nuclease domains form dimers with less 
difficulty. That may explain why the apparent stringency of cleavage by the presently studied 
chimeric TALNs (and also ZFNs) is lower and leads to the non-specific cleavage observed in the 
presence of excess of TALNs. The structure (length and composition) of linker segment between 
the DNA binding and cleaving domains of FokI and its derived nucleases (i.e., ZFNs and, likely, 
TALNs) also dictate the enzymes’ cleavage pattern, for example, the distance of cleavage sites 
from the DNA binding site (45, 46, 47). The linker segment of native FokI is 15 amino acids 
(residues 373-387) long and allows the FN to extend and cleave the sense strand 9 bp and 
antisense strand 13 bp downstream of the binding site (12). An 18 amino acid flexible linker of a 
ZFN accommodates effective cleavage of target spacer in a range of 6 to 18 bp with 8 bp as an 
optimum in Xenopus oocytes as determined in a single-strand annealing reporter assay (45). The 
latter study also reported that the dependence of efficient cleavage on spacer length in vitro 
differed from that under in vivo condition. Because the minimum-sized TAL effector fragment 
required for efficient DNA binding is unknown, the full-length AvrXa7 and PthXo1 were used to 
construct the TALNs in our study. Therefore, the N-terminal 288 amino acids in FN-AvrXa7 and 
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the C-terminal 295 amino acids in AvrXa7-FN and PthXo1-FN function as long inter-domain 
linkers between FN and the repeat DNA binding domain in TALNs. Such an extended inter-
domain linker may allow significant “reach” for the nuclease domain to cut at a moderate 
distance away from the ends of the EBE or allow greater flexibility for the nuclease domain to 
cut within a moderately wide zone as we observed in vitro with our TALN enzyme assays and in 
vivo with our yeast assays. Future investigations will be required to determine how various 
combinations of inter-domain sequence and length affects the cleavage efficiency of TALNs 
[e.g., tests of TALNs consisting of the FN connected directly to the TAL effector repeat domain 
or through linkers of various lengths and composition]. 
Other important questions are presently under active investigation.  One such question is 
the nature of the DNA fragment with an apparent molecular size >10 kb when supercoiled 
plasmid DNA is mixed with a TALN (lanes 4 and 7 in Figure 2.3B, lanes 4 and 6 in 3E).  Such a 
band of DNA is not observed if the supercoiled plasmid is cleaved before mixing with the TALN 
(Figure 2.3B and 2.3E). Our working hypothesis is that the uppermost, slow migrating DNA 
band may be a complex between plasmid DNA and the TALN protein that exists prior to DNA 
cleavage (by the TALN or a restriction enzyme), but not after cleavage.  Future analyses of the 
component(s) of this DNA band (i.e., ethidium bromide stained band) should resolve this present 
enigma.  Another issue is TALN stability. We have observed that all of the TALNs created for 
the present study have quite short half-lives (i.e., ~30 to 45 minutes).  This currently imposes 
serious practical constraints on the degree of purity of recombinant TALNs that can be obtained 
and on the duration and extensiveness of biochemical analyses, including accurate measurements 
of TALN binding affinities to DNA.  Further attempts to discover conditions that stabilize 
TALNs overproduced in E. coli will be important undertakings along with endeavors to 
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determine if such instability does or does not exist in vivo in various cell types. 
The work presented here unambiguously demonstrates several points: the ability to fuse 
TAL effectors with other proteins to create functional chimeric proteins; the specificity of DNA 
binding by TAL effectors when fused with a nonspecific nuclease domain; and the specific 
cleavage of DNA target sites by engineered TALNs both in vitro and in vivo. The newly 
emerging TALN-based approach could be an attractive alternative to the still improving ZFN-
based or meganuclease-based (48) genomic tools for a wide variety of possible applications 
including targeted genome editing. However, a few basic questions remain unanswered 
regarding the feasibility of using TALNs for genome modification. First, can novel TALN DNA 
binding domains with the requisite specificity and affinity be synthesized based on the actual 
DNA target sequences? Although arbitrarily assembled, TAL effectors were able to activate 
promoters containing sequence elements synthesized based on the “code” (29), this capability is 
not yet demonstrated for a TALN fusion protein. Second, can two different TALNs work 
coordinately at preselected adjacent target sites? The reaction involving cleavage of a dual 
asymmetric PthXo1 EBE/AvrXa7 EBE site with a mixture of PthXo1-FN and AvrXa7-FN (2.3E, 
lane 7) hints this may be possible.  That is, the two TALNs together produced somewhat better, 
albeit still incomplete, plasmid cleavage than when each TALN was used independently at 5 
times the concentration employed in the dual cutting reaction – and with less nonspecific plasmid 
DNA cleavage (compare Figure 2.3E, lanes 5 and 7 with lane 8). Third, will the DNA 
recognition and cleavage by the TALNs occur in a chromosomal context in living cells?  Data 
from the yeast experiment described in this paper (Figure 2.5) provide strong initial evidence that 
a TALN or sets of TALNs can successfully find, bind and cleave an EBE target site within yeast 
chromatin. Addressing these issues will assist in achieving the goal of generating a tool box of 
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TALNs for targeted genome editing based on the DNA binding specificity of custom-designed, 
synthetic TAL repeat domains and the DNA cleavage function of FokI or other nucleases. 
 
Materials And Methods 
Chimeric gene construction 
Chimeric genes encoding fusions of TAL effector AvrXa7 or PthXo1 with the FokI 
nuclease domain (FN) at either the N-terminus or the C-terminus (i.e., FN-AvrXa7, AvrXa7-FN 
or PthXo1-FN) were constructed using standard E. coli strains and DNA techniques (33). The 
full-length AvrXa7 was first modified with PCR primers Tal-F and Tal-R to integrate the 
restriction sites KpnI and BglII upstream of the start codon at the 5’ end and HindIII, XbaI and a 
stop codon containing SpeI at the 3’ end based on the plasmid pZWavrXa7 (30). AvrXa7 without 
its repetitive central region was PCR amplified using primers Tal-F and Tal-R and cloned into 
pBluescript KS using KpnI and SpeI. Then the central repeat coding region was cloned back into 
the plasmid lacking the central repeat element using SphI, resulting in the plasmid pSK/AvrXa7.  
The SphI fragment for central repeat domain of AvrXa7 in pSK/AvrXa7 was replaced with that 
of PthXo1 from pZWpthXo1 (24), resulting in the plasmid pSK/PthXo1.  The DNA fragment 
encoding the DNA cleavage domain (amino acids 388-583) of FokI (NCBI accession number 
J04623) was PCR amplified using the primers Fokn-F1 and Fokn-R1 and a plasmid containing 
the FokI gene as template. Fokn-F1 contained the restriction sites KpnI and BglII, while Fokn-
R1 contained a BamHI restriction site. The product was cloned into the A/T cloning vector 
pGEM-T (Promega, Madison, Wisconsin). The KpnI and BamHI digested DNA fragment 
encoding FN was cloned into KpnI and BglII treated pSK/avrXa7 resulting in pSK/FN-AvrXa7 
which contained the chimeric gene with the FN coding region at its 5’ and AvrXa7 at its 3’ end. 
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Similarly, FN coding sequence for C-terminal fusion of AvrXa7 and PthXo1 was PCR amplified 
with primers Fokn-F2 and Fokn-R2, which contain restriction sites for HindIII and SpeI, 
respectively. The HindIII and SpeI digested FN fragment was cloned into pSK/AvrXa7 and 
pSK/PthXo1 individually at their 3’ ends. The accuracy of all PCR products was confirmed by 
sequencing. Primer sequences are provided in the Supplementary Data Table S1.  
Transient expression assay for DNA binding activity of FN-AvrXa7 
A construct containing green fluorescence protein (GFP) reporter gene cloned 
downstream of Os11N3 promoter, which contains the AvrXa7 EBE sequence was made as 
follows. The coding region for the GFP gene in plasmid pEGFP (Clontech Laboratories, 
Mountain View, CA) was PCR amplified using primers GFP-F and GFP-R and cloned into 
pGEM-T for sequence confirmation. The GFP coding region with added restriction sites was 
cloned downstream of the promoter region containing the AvrXa7 EBE and upstream of the 
Os11N3 terminator, resulting in pEBE-GFP.  The GFP expression cassette was then cloned into 
pCAMBIA1300 (CAMBIA) at KpnI and HindIII restriction sites. The resulting construct was 
transformed into Agrobacterium tumefaciens strain EHA105 to create a “reporter” 
Agrobacterium strain.  DNA encoding FN-AvrXa7 was cloned downstream of the cauliflower 
mosaic virus (CaMV) 35S promoter in a modified pCAMBIA1300 vector and mobilized into 
EHA105 to create an “effector” Agrobacterium strain. The effector strain containing AvrXa7 
(lacking the FN domain) was similarly constructed to serve as a positive control. The reporter 
and the effector strains were co-infiltrated into Nicotiana benthamiana leaves. The inoculated 
leaves were checked for expression of GFP using a Leica M205 FA fluorescent 
stereomicroscope.  
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Expression and purification of FN-AvrXa7, AvrXa7-FN and PthXo1-FN 
 The chimeric gene FN-AvrXa7 was cloned into pPROEX HTb (Invitrogen, Carlsbad, 
CA) by ligating the BglII and SpeI digested FN-AvrXa7 fragment from pSK/FN-AvrXa7 into 
the BamHI and SpeI digested expression vector. Similarly, the BglII and SpeI digested AvrXa7-
FN DNA fragment was cloned into pPROEX HTb for AvrXa7-FN overexpression. For PthXo1-
FN, the expression vector pET28a (Novagen, Madison, WI) was used. The expression constructs 
were transformed into E. coli strain BL21 (DE3) for overexpression of the recombinant proteins 
with induction by isopropyl-1-thio-β-D-galactopyranoside (IPTG) following the manufacturer’s 
instructions (Invitrogen, Carlsbad, CA). The 6Xhistidine tagged FN-AvrXa7, AvrXa7-FN and 
PthXo1-FN were purified with Ni-NTA agarose (Qiagen, Valencia, CA) and the protein 
concentrations were determined using the BioRad Bradford protein quantification kit (BioRad, 
Hercules, CA).  
Electromobility shift (EMS) assay 
The complementary oligonucleotides of Os11N3-F & Os11N3-R containing AvrXa7 
EBE and Os11N3M-F & Os11N3M-R containing a mutated AvrXa7 EBE were annealed, 
respectively, and 5’-end labeled with [γ-32P]ATP catalyzed by T4 polynucleotide kinase. The 
labeled oligonucleotide duplex DNA was mixed individually with AvrXa7-FN and FN-AvrXa7 
in a 10 ul reaction volume containing Tris-HCl  (15 mM, pH 7.5), KCl (40 mM), DTT (1 mM), 
glycerol (2.0%), poly(dI.dC) (50 ng/ul), EDTA (0.2 mM), 32P-labeled DNA (final concentration, 
5 fmol), and hybrid protein (final concentration, about 15 fmol). Unlabeled oligonucleotides 
were used as competitor probes, and were added in increasing amounts (final concentration, 0-
250 fmol) to successive reaction. The binding reactions were kept at room temperature for 30 
minutes before loading onto a 6% TBE polyacrylamide gel. After electrophoresis, the gel was 
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exposed to X-ray film for radioactive image capture.  
In vitro DNA cleavage 
A 406 bp genomic region of the rice Os11N3 gene encompassing the AvrXa7 EBE was 
PCR amplified with the forward primer Os11N3P-F, and the reverse primer Os11N3P-R, then 
cloned into the cloning vector pTOPO (Invitrogen, Carlsbad, CA), resulting in pTOP/11N3. The 
plasmid was also used to generate pTOP/Os11N3m2 using linker scanning mutagenesis method 
with an insertion of 6 nucleotides (5’-cccggg-3’) within the AvrXa7 EBE site.  A DNA fragment 
containing the dual EBEs for PthXo1 and AvrXa7 in a tail-to-tail orientation was cloned into 
pPCR Script Amp (Stratagene, Santa Clara, CA), resulting in the plasmid pEBE-TD. For 
pTOP/Os11N3 and pTOP/Os11N3m2 digestions, the sequenced clone was digested to 
completion with EcoNI or MluI and purified, One microgram of uncut plasmid or the digested 
DNA was incubated individually with FN-AvrXa7 (225 ng or otherwise indicated in the text) 
and AvrXa7-FN (200 ng) in a volume of 15 uL.  The buffer condition was the same as used for 
the EMS assay described above, but in the presence of 2.5 mM MgCl2.   
In vitro digestions of pEBE-TD with TALNs AvrXa7-FN and PthXo1-FN were 
performed differently. Assays for TALN activities with or without post digestion with restriction 
enzyme BglI were conducted in vitro using 1 g of pEBE-TD supercoiled plasmid DNA in a 30 L 
reaction volume containing Tris-HCl (20 mM), pH 8.5, NaCl (150 mM), MgCl2 (2 mM), 
glycerol (5%), BSA (0.5 mg/ml), DTT (1 mM) and 5 g of Ni+-affinity column-purified PthXo1-
FN and/or AvrXa7-FN incubated for 30 min at 37.  For reactions in which BglI was used after 
TALN digestion, 10 units of BglI were added and digestion continued for an additional 20 min.  
For reactions in which both PthXo1-FN and AvrXa7-FN were used simultaneously, the reaction 
conditions were identical except that only 1 g of each TALN was employed.   
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Yeast homologous recombination assay 
The yeast strains YPH499 (MATa ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 
his3-Δ200 leu2-Δ1) and YPH500 (MATα ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 
his3-Δ200 leu2-Δ1) as well as expression vectors (pCP3, pCP4 and pCP5) were described and 
kindly provided by Dr. Dan Voytas (34). The pCP5 derived reporter construct containing a single 
AvrXa7 EBE was made by inserting the annealed oligonucleotides (EBES-F and EBES-R) into 
the BglII- and SpeI-digested pCP5. A set of duplexes of oligonucleotides (x7-HDn1-F and x7-
HDn1-R, n1=6, 10, 14, 19, 24, 30, 35, 40 bp) containing the dual AvrXa7 EBEs in a head-to-
head (corresponding to FN domain to FN domain of FN-AvrXa7) orientation separated by a 
serial of spacers (n1) were cloned into the BglII and SpeI digested pCP5 plasmid. Similar 
constructs with two AvrXa7 EBEs in a tail-to-tail orientation and separated by various lengths 
(2, 5, 8, 19 bp) of spacers were also made using duplexes of oligonucleotides (x7-TDn2-F and 
x7-TDn2-R, n2=2, 5, 8, 19 bp). For the 19 bp spacer configuration, an additional one reporter 
construct with a mutation in one AvrXa7 EBE and another with a mutation in each of the 
AvrXa7 EBEs were made. A third set of dual asymmetric EBEs with one corresponding to 
AvrXa7 and the other to PthXo1 in a tail-to-tail orientation were also cloned into pCP5 using 
PstI and SpeI. The duplexes of oligonucleotides are x7/o1-TDn3, n3=6, 11, 16, 21, 26, 31, and 
36 bp. The expression vectors pCP3 and pCP4 were first modified with a linker sequence 
containing multiple cloning sites downstream of the translation elongation factor 1α (TEF1) 
promoter, resulting in pCP3M and pCP4M, respectively. The linker was made by annealing two 
oligonucleotides (Linker-F and Linker-R) and cloned into the XbaI and XhoI digested pCP3 and 
pCP4 individually. The chimeric genes FN-AvrXa7 and AvrXa7-FN were digested with BglII 
and SpeI and cloned into the BamHI and SpeI digested pCP3M vector, while the chimeric gene 
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PthXo1-FN was cloned into pCP4M by BglII and SpeI. The reporter plasmids each were 
transformed into the yeast mating strain YPH500 (MATα) and effector plasmids in a 
combination of pCP3M-FN-AvrXa7/pCP4M, pCP3M-AvrXa7-FN/pCP4M, and pCP3M-
AvrXa7-FN/pCP4M-PthXo1-FN into YPH499 (MATa). Yeast cells from a single yeast colony 
carrying the reporter plasmid with little β-galactosidase background was mixed with cells from 
single colony with the effector plasmid (in a combination indicated in text) in triplicate on yeast 
nutrient medium (YPD) overnight, then cultured in synthetic complete medium lacking leucine, 
histidine and tryptophan to select for mated cells. The cells were then harvested for quantitative 
measurement of β-galactosidase activity by using the yeast β-galactosidase assay kit from 
Thermo Fisher Scientific (Rockford, IL) following the manufacture’s manual. Enzyme activity is 
calculated based on the equation: β-galactosidase activity = (1000xA420)/(txVxOD660), t=time of 
incubation in minutes, V=volume of cells used in the assay in ml.  
As a positive control to our yeast assay for TALN activity, we also constructed an 
effector plasmid containing a zinc finger nuclease and a reporter plasmid containing the 
corresponding ZF binding site. A DNA fragment encoding the “original” BCR-ABL three-finger 
array was obtained by the digestion of pGP-FB-orig BA (35) with XbaI and BamHI and cloned 
into pCP3, resulting in a translational fusion of BCR-ABL with a C-terminal FokI nuclease 
domain. The oligonucleotide duplex containing the dual ZFN target sites in a tail-to-tail 
orientation separated by a 6 bp spacer was cloned into pCP5 by BglII and SpeI, resulting in the 
reporter plasmid. The effector plasmid pCP4-ZFN and pCP3M were transformed into YPH499. 
The transformants were mated with YPH500 containing the reporter plasmid pzf-TD6 and 
measured for β-galactosidase activity as described  for TALNs.  
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Figure 2.1. Schematics of TAL effectors AvrXa7 and PthXo1 as well as their fusions with FN. 
(A) A typical TAL effector contains a central region of 34 amino acid (aa) direct repeats (open 
boxes) and three nuclear localization motifs (NLS, black bars) as well as a transcription 
activation domain (AD, red solid box) at the C-terminus. The representative 34 aa repeat is 
shown below with the variable amino acid residues at the positions 12 and 13 in red. (B) and (C) 
AvrXa7 and PthXo1 contain central 26 and 24 tandem repeats (shown as boxes) of 34 amino 
acid residues, respectively. The repeats are highly conserved, except for residues at positions 12 
and 13 (*, missing aa residue at position 13). The sequence recognition of AvrXa7 to Os11N3 
(and PthXo1 to Os8N3) is dictated by the order of the 34 aa repeat units that each contain at 
positions 12 and 13 a pair of amino acids that exactly recognize one nucleotide at one position in 
the DNA sequence of the effector binding element (EBE) of the Os11N3 gene. (D), (E) and (F) 
Schematics of TAL effector fusion proteins with FokI nuclease domain (FN) at the N-terminus 
of AvrXa7 (D) or at the C-termini of AvrXa7 (E) and PthXo1 (F). (G) Transient activation by 
AvrXa7 and FN-AvrXa7 of the Os11N3 promoter (containing the AvrXa7 EBE) driving a GFP 
reporter gene (GFP-EBE).  The plasmid containing the GFP reporter gene was co-injected along 
with a plasmid containing a gene encoding the AvrXa7 or AvrXa7-FN driven by the CaMV 35S 
promoter [or with a plasmid containing the 35S promoter but no AvrXa7 coding sequence 
(Control)]. The dotted line indicates the edge of the inoculation site. 
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Figure 2.2. Binding specificity of AvrXa7-FN and FN-AvrXa7 fusion proteins to their target 
DNA. (A) Sense-strand sequences of the wild type (Os11N3) and mutant (Os11N3M) 
oligonucleotide duplexes used in the electrophoresis mobility shift (EMS) assays. (B) EMS 
assays demonstrating specificities of AvrXa7-FN and FN-AvrXa7 binding to the AvrXa7 EBE 
sequence. The set of gel images to the left depict results with AvrXa7-FN, while set of gel 
images to the right depict results with FN-AvrXa7. The left panels of each set show binding of 
AvrXa7-FN and FN-AvrXa7 to the authentic, 32P-labeled, Os11N3 DNA target element but not 
to the mutated target. Competition assays (middle and right panels of each set) showing that the 
binding of 32P-labeled Os11N3 EBE target by AvrXa7-FN and FN-AvrXa7 is effectively 
competed by excess amounts of nonradioactive Os11N3 oligonucleotides (middle panels of each 
set), but not by the nonradioactive mutated version of Os11N3 DNA (right panels). Positions of 
the bound and free probes are indicated at the left of the autoradiograph.  
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Figure 2.3. Target DNA digestion by the FN-AvrXa7, AvrXa7-FN and PthXo1-FN TALNs. (A) 
Circular plasmid containing a 400 bp Os11N3 promoter region (thick bar in red) with one 
AvrXa7 EBE site (position 0). EcoNI cuts once at position 842 and MluI cuts twice at positions 
1405 and 2246 relative to EBE of the plasmid. The expected sizes of fragments after cleavages 
are shown below the plasmid map. (B) Gel image of plasmid DNA treated with different 
enzymes individually or in combinations. M, 1 kb markers with size labeled on the left side. 
Different treatments are indicated above lanes 1 to 9 and in combination with TALNs labeled 
below lanes 4 to 9. Arrows in red indicate DNA fragment sizes expected if the NF-AvrXa7 or 
AvrXa7-FN nuclease cleavage takes place correctly at the AvrXa7 EBE target site in 
pTOP/Os11N3. (C) Structure of adjacent PthXo1 and AvrXa7 EBE sites (underlined) in a tail-to-
tail orientation (to allow FN to FN proximity) and separated by 19 spacer nucleotides (lower case 
letters) which contains a unique EcoRI site (underlined). (D) Map of plasmid pEBE-DT with 
predicted cleavage sites for EcoRI (position 0), PthXo1-FN and/or AvrXa7-FN EBEs and BglI 
(positions 1479 and 2745).  (E) Gel image of intact pEBE-DT (lane 1), EcoRI–linearized 
plasmid (2), BglI-cleaved plasmid (3), AvrXa7-FN digested plasmid DNA (4), AvrXa7-FN 
digested plasmid followed by BglI digestion (5), PthXo1-FN digested plasmid (6), PthXo1-FN 
digested plasmid followed by BglI digestion (7), and double digestion with PthXo1-FN and 
AvrXa7-FN (at one-fifth the concentrations of each protein used individually in reactions for 
lanes 3 to 6) followed by BglI digestion (8). The label “M” indicates the DNA marker lane with 
marker sizes provided in kilo-base (kb). Arrows to the right indicate sizes of DNA fragments 
expected from complete DNA digestion with BglI and partial digestion with PthXo1-FN (lane 5), 
AvrXa7-FN (lane 7), or PthXo1-FN combined with AvrXa7-FN (lane 8). 
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Figure 2.4. DNA sequencing revealing the major cleavage sites created by the AvrXa7-FN (A) 
and FN-AvrXa7 (B). (A) DNA sequencing chromatogram above the original Os11N3 dsDNA 
sequence (sense strand colored for ease of viewing) is based on the sense strand of the 0.8 kb 
fragment purified from lane 8 in Figure 3B. The M13R primer was used for sequencing the sense 
strand. The chromatogram, which represents the sense strand sequence around the cleavage site, 
is in reverse-complement orientation for ease of viewing. The chromatogram below the dsDNA 
sequence is derived from the antisense strand of the 2.1 kb DNA fragment (also from lane 8 in 
Figure 3B) to the left of the predicted AvrXa7-FN cleavage site. The AvrXa7-FN binding site is 
boxed in shaded gray. The vertical arrows denote the obvious cleavage sites in both strands. The 
thick underline indicates the 15 bp region downstream of the EBE site in which the vast majority 
of AvrXa7-FN cleavage occurred. (B) DNA sequencing chromatograms of two DNA fragments 
derived from pTOP/11N3 treated with FN-AvrXa7 and purified from lane 5 in Figure 3B. 
Labeling is similar to that used for (A).   
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Figure 2.5. Yeast SSA assay for detection of FN-AvrXa7, AvrXa7-FN and PthXo1-FN TALN-
induced homologous recombination. (A) Schematics of the reporter constructs (not drawn to 
scale) with dual BCR-ABL target site, AvrXa7 EBE site in different configurations drawn 
below. Two nonfunctional LacZ gene fragments (LacZn and LacZc, blue solid bars) were 
separated by the yeast URA3 gene (gray line) and a multiple cloning site (MCS) (black line). The 
125 bp duplicated LacZ coding sequences are represented as hatched blue boxes. The target sites 
in the reporter constructs are designated as zf-TD6 (ZFN dual sites), x7-S (single EBE site), x7-
DHn1 (dual AvrXa7 EBEs in a head-to-head orientation separated by the red-lined spacers), x7-
TDn2 (dual tail-to-tail AvrXa7 EBEs) followed by the number of spacer nucleotides. The 
constructs x7-TD19m1 and x7-TD19m2 contain a 19 bp spacer and carry a mutation in their 
EBE site caused by a 4 bp substitution (depicted as a red cross). (B) Schematics similar to (A) 
with a 125 bp fragment (gray line) instead of the URA3 gene between the MCS and LacZn. (C) 
Activity of FN-AvrXa7 on reporters with different lengths of spacer between the AvrXa7 EBE 
sites (respective spacer lengths are given below each column). Fold change represents the β-
galactosidase activity of yeast cells co-expressing the respective reporter and FN-AvrXa7 
compared to cells containing the same reporter but lacking the FN-AvrXa7 expression vector. 
(D) Stimulation by the ZFN, AvrXa7-FN and AvrXa7-FN/pthXo1-FN constructs of their 
respective reporter genes containing various spacers (lengths in base pairs given below each 
column). Fold change represents the β-galactosidase activity of yeast cells co-expressing each 
reporter and its respective effector nuclease(s) (indicated below the columns) compared to those 
containing the same reporter but lacking the presence of genes encoding the respective 
nuclease(s). Error bars represent the standard deviation of three samples.  
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Abstract 
Recent studies indicate that the DNA recognition domain of TAL (transcription activator-
like) effectors can be combined with the nuclease domain of FokI restriction enzyme to 
produce TAL effector nucleases (TALENs) that, in pairs, bind adjacent DNA target sites and 
produce double strand breaks between the target sequences, stimulating non-homologous 
end-joining and homologous recombination. Here, we exploit the four prevalent TAL repeats 
and their DNA recognition cipher to develop a “modular assembly” method for rapid 
production of designer TAL effector nucleases (dTALENs) that recognize unique DNA 
sequence up to 23 bases in any gene. We have used this approach to engineer ten dTALENs  
________________________________ 
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to target specific loci in native yeast chromosomal genes. All dTALENs produced high rates 
of site-specific gene disruptions and created phenotypic mutant strains. Moreover, dTALENs 
stimulated high rates (up to 34%) of gene replacement by homologous recombination. 
Finally, dTALENs caused no detectable cytotoxicity and minimal levels of undesired genetic 
mutations in the treated yeast strains. These studies expand the realm of verified TALEN 
activity from cultured human cells to an intact eukaryotic organism and suggest that low-
cost, highly dependable dTALENs can assume a significant role for gene modifications of 
value in human and animal health, agriculture and industry. 
 
Introduction 
Technologies for precise and efficient gene editing in living cells hold great promise 
in both basic and applied research, including therapeutic interventions for genetic diseases. 
These technologies exploit the ability of endonucleases to cause chromosomal double 
stranded DNA breaks (DSBs) and stimulate the subsequent breakage repair mechanisms in 
living cells (1, 2, 3). The two widely conserved, major repair pathways in eukaryotes are 
non-homologous end-joining (NHEJ) and homologous recombination (HR). NHEJ repair 
often results in mutagenic deletions/insertions and substitutions in the targeted gene; DSBs 
stimulate HR between the endogenous target gene locus and an exogenously introduced 
homologous donor DNA carrying the desired genetic alterations (4, 5, 6). At the forefront of 
these methods are custom-designed zinc-finger nucleases (ZFNs), which are hybrid proteins 
derived from the DNA binding domains of zinc finger (ZF) proteins and the nonspecific 
cleavage domain of the endonuclease FokI. However, despite their promise, widespread 
adoption of ZFNs is hampered by a bottleneck in custom-engineering zinc fingers with high 
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specificity and affinity for the DNA target sites (7, 8). Further, ZFN utility is somewhat 
limited by the number and location of potential target sites within a genome. Alternative 
strategies that overcome limitations in current technologies for targeted genome editing could 
greatly accelerate adoption of artificial nucleases for efficient gene disruption and gene 
replacement in a variety of heretofore recalcitrant eukaryotic organisms. 
 ZFN efficacy depends almost solely on the DNA binding specificity of their ZF 
domains (9), which theoretically can be supplanted by any high-fidelity DNA binding 
domain (10, 11, 12). TAL effector (TALE) proteins, a large group of bacterial plant pathogen 
proteins, have emerged as alternatives to ZF proteins. TALE proteins contain a varying 
number of centrally-located tandem 34-amino-acid repeats that mediate binding to a specific 
DNA target sequence, referred to as the effector binding elements (EBE). Each repeat is 
nearly identical except for two variable amino acids at positions 12 and 13, known as repeat 
variable di-residues (RVD). Polymorphism in the number of repeats (a range of 13 to 33) and 
in the RVD composition collectively determines the DNA binding specificity of individual 
TALE proteins. Remarkably, recognition of a specific DNA sequence is based on a fairly 
simple code wherein one base of the DNA target site is recognized by the RVD of one repeat 
(i.e., one repeat/one nucleotide). The sequential repeat arrangement in a single TALE protein 
thus specifies the contiguous DNA sequence that will be bound by that TALE protein (13, 
14). TALE recognition studies also reveal a preference for certain RVDs over others in 
recognizing a particular nucleotide.  In most cases, the RVDs asparagine and isoleucine (NI), 
histidine and aspartic acid (HD), asparagine and glycine (NG), and two asparagines (NN) 
each pair to recognize the nucleotides “A”, “C”, “T” and G”, respectively (13, 14). The 
prevalence of these four RVDs in the native TALEs made it possible to use them exclusively 
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to de novo synthesize or assemble TALE repeat arrays of up to 13 repeat units to target DNA 
sequences in plant and human cells (15, 16, 17). The addition of FokI nuclease domains to 
the C-termini of two paired synthetic TAL effectors (as in ZFNs) should allow for highly 
gene-specific gene targeting. Because of the modular nature of TALEs and the potential to 
use long DNA recognition sites, custom-made designer TALE nucleases (dTALENs) may 
overcome limitations of current ZFN technologies and may significantly advance the use of 
targeted genome editing for challenging long-term opportunities such as therapeutic repair of 
genetic diseases.  Toward this end, we and others have recently shown that TALEs can be 
linked with FokI nuclease domain to direct targeted cleavage of DNA containing a specific 
EBE (17, 18, 19).  More recently, Miller et al (20) demonstrated TALEN-mediated editing of 
endogenous genes in cultured human cells.  
Here we report development of a modular assembly technology for custom-
engineering dTALENs and characterization of ten such dTALENs for targeted gene 
modification. The method uses four basic repeats with RVDs of NI, NG, NN, and HD to 
generate 48 ready-to-use modules of single TAL repeat units that can be assembled up to 23 
repeat units in any contiguous order. The modular assembly method is simple, fast and 
inexpensive and can be performed in most academic or industrial molecular biology 
laboratories. Remarkably, all ten dTALENs demonstrated efficient gene knockout and/or 
gene replacement in tests with three different chromosomal genes in yeast (Saccharomyces 
cerevisiae). The high success rate and facile synthesis of potent dTALENs against a variety 
of chromosomal targets further establishes dTALENs as an emerging and viable technology 
for precise gene modification in living cells.  As previously practiced, all materials described 
in the present manuscript will be provided to other laboratories upon request. 
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Results 
Tractability of yeast for testing gene modification by TALENs 
We chose yeast, a classic eukaryotic model for studies of homologous recombination 
(30), as a platform to develop and test TALEN-based technologies for targeted gene 
modification based on the recent breakthroughs in the area of TALE research (13, 14). First, 
we determined if the yeast chromosome, which has not been subjected to genome 
modification using any artificial nucleases, is tractable for TALE nuclease-based 
modification. For this experiment, the EBEs for AvrXa7 and PthXo1 were precisely 
integrated in-frame between the first and second codons of the yeast URA3 gene on 
chromosome 5.  In parallel, DNA target sequences for the known ZFNs Zif268 and BCR-
ABL were inserted into the identical URA3 gene site for comparison of activities conferred 
by these two types of nucleases (Figure 3.1). The resulting yeast strains were prototrophic in 
uracil-free medium and sensitive to 5-fluoroorotic acid (5-FOA), indicating that the chimeric 
URA3 genes were functional and intact. Yeast strains bearing the chimeric URA3 genes were 
transformed with plasmids expressing the paired TALENs or ZFNs, grown for 5 days, plated 
on medium containing 5-FOA to select cells with an inactivated URA3 gene. Approximately 
0.9% of cells (out of ~106 cells) expressing paired TALENs produced 5-FOA resistant 
colonies while approximately 0.3% of cells expressing paired ZFNs yielded 5-FOA resistant 
colonies.  In contrast, no 5-FOA resistant colonies were observed among ~106 cells (a ratio 
of <0.0001%) containing plasmids lacking a functional nuclease gene.  Sequenced PCR 
products from the relevant alleles revealed all of the selected 5-FOA resistant clones harbor 
mutations (insertions and/or deletions that caused frame shift in the URA3 genes) at the 
nuclease target sites (Figure 3.1). These results established similar gene disruptions and 
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comparable mutation rates elicited by ZFNs and TALENs targeted against genes in a native 
yeast chromosomal environment. 
Modular dTALEN assembly 
To fully realize the potential of TALENs, they must be custom-engineered to target 
any chromosomal DNA sequence of interest. By exploiting the repeat homology and the 
unique recognition sequence of the type IIS restriction enzyme BsmBI within each repeat of 
AvrXa7 or any TALE, we developed a method to assemble repeat domains in an exact 
predetermined order to recognize a specific DNA sequence in any gene of choice from any 
organism. Briefly, four AvrXa7 “core” repeats whose coding RVDs each recognize one of 
four nucleotides (i.e., NI, NG, NN and HD, respectively, for A, T, G, and C) were used to 
construct independent modules (single repeats) whose 5’- and 3’- ends were designed to form 
a unique 4-bp overhang with single-base polymorphism after digestion with BsmBI. The 
BsmBI site is immediately downstream of codons 18 and 19 of each repeat and BsmBI 
cleaves these two triplets into a 5’overhang of 4-bp at each end. The 18th and 19th codons are 
GCG CTG and can be modified into 8 variant triplets GC(A, T, G or C) (T, or C)TG (Figure 
3.2A). Therefore, combinations of eight or fewer such overhangs, one at each end of a single 
repeat, were created without altering the encoded amino acids. This allowed the ordered 
ligation of 8 or fewer repeat modules in any predetermined sequence for construction of sub-
arrays of repeats (Figure 3.2B). Each sub-array was cloned into the cloning vector pGEM-T 
and sequenced to confirm the correct number and order of the repeats. Similarly, multiple 
sub-arrays (2-3 in this study) were further assembled to match the order of nucleotides at the 
preselected genomic site. The AvrXa7-FN nuclease (18) lacking its repeat domain was used 
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as the scaffold for the assembled repeat domains, resulting in a finished dTALENs (Figure 
3.2C).  
To test the feasibility of our approach, we selected five distinct dual target sites (two 
in URA3, two in LYS2, and one in ADE2) based on the criteria: 1) “T” preceding each target 
sequence, 2) avoiding G rich blocks, and 3) 17-20 bp spacer between the inverted two EBE 
target sites. Accordingly, ten dTALENs were synthesized for gene targeting based on the 
preselected DNA coding sequences of the three yeast genes (Figure 3.3A). All ten dTALENs 
were expressed in yeast to levels comparable to those of hybrid nucleases made from PthXo1 
or AvrXa7, except U3b-L which had somewhat lower expression.  
To test the function of newly synthesized dTALENs and to reveal their relative DNA 
cleavage activity, we modified a transient and plasmid-borne single strand annealing (SSA) 
assay (31, 32) as a facile analytical tool.  This method uses a yeast plasmid carrying a lacZ 
gene divided into upstream and downstream portions by insertion of two opposing EBEs, one 
recognized by a proven AvrXa7 TALEN (18) and the other EBE recognized by a candidate 
dTALEN.  The separated lacZ fragments share at the 3’ end of the upstream fragment and the 
5’ end of the downstream fragment a 125 bp segment of identical lacZ sequence.  If a 
functional dTALEN is co-expressed in yeast cells with the AvrXa7 TALEN along with the 
target lacZ gene, it will bind to its target EBE sequence adjacent to the AvrXa7 TALEN and, 
thereby, create a double strand DNA break (DSB) (Figure 3.3B). The duplicated lacZ 
sequences are thus available for homologous recombination and restoration of an intact lacZ 
gene.  The amount of β-galactosidase activity produced by the transformed yeast cells thus 
provides a measure of the amount of DNA cleavage supported by the candidate dTALEN.   
We initially tested this assay by first pairing the proven AvrXa7 TALEN with another proven 
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TALEN PthXo1 (18).  The activity of this TALEN pair provides a standard against which the 
activity of any candidate dTALENs can be judged (Figure 3.3C).   The ten newly produced 
dTALENs, each designed to recognize a specific 17 to 23 base DNA sequence in different 
yeast genes, were all found in yeast SSA tests to function nearly as well or better than the 
standard AvrXa7/PthXo1 TALEN pair (Figure 3.3C). 
Efficient gene modification by dTALEN-induced NHEJ and HR 
As a final evaluation of the function of the five pairs of dTALENs, we tested their 
ability to elicit site-specific DNA alterations at the preselected target sites in the URA3, LYS2 
and ADE2 genes, which all have easily scored knockout phenotypes. Yeast cells were 
transformed with individual pairs of dTALEN-expressing plasmids and grown for five days 
on synthetic complete medium to allow accumulation and activity of the heteromeric 
dTALEN pair. Two yeast cultures were transformed separately with one or the other pair of 
dTALENs targeting the URA3 gene and plated for 5-FOA selection of cells lacking a 
functional URA3 gene. Likewise, two yeast cultures were transformed separately with one or 
the other pair of dTALENs targeting the LYS2 gene and plated for α-aminoadipate (α-AA) 
selection of cells with LYS2 gene mutations. URA3 and LYS2 mutants were obtained at a rate 
of approximately 10-4 to 10-2 (Figure 3.4A). Yeast cells transformed with the dTALENs pair 
targeting the ADE2 gene were plated on medium containing limiting adenine concentrations 
that result in the formation of pink colonies if a functional ADE2 gene is not present. Pink 
colonies appeared with a frequency of 0.15 % (Figure 3.4A). In contrast, ~106 yeast cells 
carrying plasmids lacking a functional dTALEN gene pair yielded no colonies resistant to 5-
FOA or α-AA or with a pink color. Sequence analysis of PCR-amplified genomic DNA from 
the relevant target sites in several putative URA3, LYS2, and ADE2 gene knockout mutants 
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revealed that all alleles harbored mutations at the dTALEN target sites as expected. A high 
proportion of the mutated loci contained deletions in a range from 1 to 75 bp (Figure 3.4B).   
One experimentally and practically important virtue of DSBs caused by agents such 
as ZFNs (3) is that they increase rates of recombination between the DNA sequences within a 
broken gene and homologous endogenous or exogenously-supplied DNA sequences, which 
enables powerful gene replacement research opportunities. To determine if dTALEN-
mediated DSBs stimulate homologous recombination (HR), we targeted the URA3 gene for 
breakage with artificial dTALEN pairs in the presence of two different exogenously supplied 
DNA fragments, one containing a URA3 gene interrupted by a neomycin phosphotransferase 
II (NPTII) expression cassette and the other a DNA fragment with the URA3 ORF deleted. 
Both fragments contained at their 5’ ends a 0.5 kb segment homologous to the 5’ end of the 
URA3 gene and, at their 3’ ends, a 0.2 kb segment from the 3’ end of the URA3 gene. Yeast 
cells of YPH500c, a strain containing the functional URA3 with the integrated EBEs for 
AvrXa7 and PthXo1, were transformed with one set of three different paired TALENs (i.e., 
U3a-L & U3a-R, U3b-L & U3b-R, and AvrXa7-FN & PthXo1-FN) and one of the two 
modified URA3 gene constructs. The transformants were plated after five days of incubation 
on either selective medium containing 5-FOA (deleted URA3 construct) or medium 
containing the neomycin-like antibiotic, G418 (NPTII interrupted URA3). Cells transformed 
with TALENs and the URA3 ORF deletion construct (DURA3) showed frequencies of 5-
FOA resistant colonies in the range of 4.5% to 27%. The negative control [transformed with 
donor DNA and plasmids lacking a nuclease gene (Empty Plasmid)] yielded 5-FOA resistant 
colonies at a rate of 0.01% (Figure 3.4C). The frequency of gene replacement for cells 
transformed with the NPTII-interrupted URA3 gene construct (NPTII) was in the range of 9% 
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to 34% with the negative control (Empty Plasmid) displaying only ~0.1% gene replacement 
activity (Figure 3.4C). Overall, the enhancement of TALEN-induced gene replacement was 
between100 to 2700 fold higher than the control. The scale and consistency in the stimulation 
of HR by dTALENs suggests they have the potential to promote HR when used in eukaryotic 
cells that lack other sufficiently robust mechanisms to facilitate HR. 
Genome-wide undesired mutations caused by TALENs 
Some ZFNs have been found to be associated with toxicity in living cells (33, 34, 35, 
36, 37, 38, 39). Whether such effect also exists for TALENs is unknown. To test the 
possibility, yeast cells were transformed with plasmids encoding six pairs of TALENs (one 
pair of native TALE-derived nucleases and five pairs of synthetic dTALENs targeting 
sequences in a size range between 17 bp to 27 bp) and one pair of known ZFNs [Zif268 and 
BCR-ABL with target sequences of 9 bp (33, 40)]. The transformed cells were grown in SC 
medium lacking leucine and histidine. TALEN-expressing yeast cells displayed no distinct 
phenotype in terms of cell viability and proliferation compared to the control, as did yeast 
strains with ectopic expression of paired ZFNs during five days of growth (Figure 3.5). Yeast 
cells expressing individually each of the eight introduced nuclease genes showed similar 
results. The results indicate the lack of any apparently deleterious effects on the viability of 
yeast cells expressing the tested TALENs and ZFNs under our experimental conditions.  
Undesired genetic mutations (genotoxicity) due to promiscuous cleavage also have 
been reported for ZFNs (33, 40, 41), but it is unknown whether TALENs also induce such 
genotoxicity. It is possible that such mutations occurred in our cell survival experiment but 
did not visibly affect the viability of the yeast cells. The haploid nature and relatively small 
size (~12 mega bases) of the yeast genome in combination with the next-generation 
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sequencing technology enabled us to investigate any potential genome-wide undesired effects 
of TALENs. Five strains, including the parental strain YPH500 and four mutants, were 
chosen to investigate the occurrence of unintended mutations in addition to the site-specific 
mutations at the URA3 locus mediated by the respective nucleases. The four mutant strains 
included one that contained a deletion in the chimeric URA3 gene at the integrated EBE site 
targeted by the paired nucleases of natural TAL effectors AvrXa7 and PthXo1, one that 
contained an insertion in the chimeric URA3 gene with integrated target sequences for the 
ZFNs Zif268 and BCR-ABL, and the other two that each contained a deletion mutation in the 
wild type URA3 genes induced by the paired dTALENs U3a-L&-R and U3b-L&-R, 
respectively. The five strains were sequenced using Illumina/Solexa Genome Analyzer II, 
and their genomes were assembled with the coverage depth [(number of reads x Average 
read length)/(size of genome)] in a range of 135 to 170X (sequences available upon request). 
The assembled genomic sequence of each mutant strain was first screened for possible 
mutations at the sites that matched or loosely matched (defined as at least two-thirds of 
match as the cut-off) either intended sub-dual target sequence for the respective nucleases. 
No mutations were found at those locations other than the specific-site mutations mediated 
by the respective pairs of TALENs and ZFNs in each genome (Data not shown). However, 
alignment of the genomes of the individual nuclease treated strains with that of parental 
strain revealed a number of mutations in each strain (in a range of 3 to 5 mutations). These 
mutations were almost all nucleotide substitutions instead of predominant 
deletions/insertions at the nuclease target sites and they, therefore, were highly likely to be 
simultaneous mutations which might or might not be associated with the nuclease treatment. 
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Discussion 
We have developed a simple, cost effective method to assemble functional TALE 
DNA binding domains, combine them with a nuclease module and confirm their activity 
against specific gene targets in vivo. Using this method, dTALENs were readily produced 
and rapidly validated using a facile yeast SSA assay.  Importantly, these dTALENs were then 
demonstrated to function as pairs to mediate efficient gene disruption by NHEJ and gene 
replacement by HR at specific yeast chromosomal loci. 
The DNA binding domain encoded by a TALE gene is modular by nature, having 13 
to 33 RDV units that bear a simple code for target site recognition (13, 14). However, the 
high repeat homology imposes technical difficulty when using PCR-based de novo gene 
synthesis methods (42) for construction of the lengthy repeat arrays required for high-level 
DNA specificity. To simplify gene synthesis and reduce dTALEN production costs, a 
modular assembly technique was developed. TALE repeat domains have been assembled 
from the single RVD coding repeats to bind DNA targets predicted by the cipher; but they 
were assembled in a random way, not in a predetermined order and not based on the target 
DNA sequence (13). Our method involves creation of 48 ready-to-use modules and their 
assembly into repeat arrays in a controlled order based on any user chosen target DNA 
sequences (Figure 3.2). The ready-to-use modules can also be adapted for high-throughput 
dTALEN synthesis. By manipulating the combination of 5’ and 3’ unique overhangs of the 
modular sets, dTALENs with varying number of repeat units (up to 23 bp in this study) can 
be designed to better meet the criteria in choosing the dual target sites. Our facile modular 
TALEN assembly method contrasts with another recently reported method that involves 
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several rounds of PCR amplifications and ligations to assemble individual repeats into 12 
repeat TAL effectors for gene activation in human cells was reported (16).   
A modified plasmid-based yeast SSA lacZ assay was employed to determine activity 
of the candidate dTALENs before use for final gene targeting.  This test system is based on 
assays developed to initially validate engineered meganucleases and ZFNs (31, 32) and was 
used previously in a preliminary form for TALEN testing (17, 18).  The original yeast SSA 
assay relied on inverted repeat DNA targets and engineered homodimeric nucleases (32).  
For our modified assay, one candidate dTALEN was paired with the proven TALEN 
AvrXa7-FN (18) to target two adjacent EBEs, one for recognition by the candidate dTALEN 
and the other for binding of AvrXa7-FN.  The paired TALENs derived from the natural 
TALEs AvrXa7 and PthXo1 were used as a standard. Another advantage of the modified 
SSA assay is that one EBE and the spacer remain constant so only the second EBE has to be 
replaced to test a different dTALEN.  When testing many dTALENs, this represents a 
significant (~5X) cost saving due to using much shorter oligonucleotides to create a single 
(vs. double) TALEN site while allowing rapid evaluation of the activity of each individual 
candidate dTALEN.  Moreover, construction of 3’ to 3’ EBE sites containing nonidentical 
DNA sequences avoids the technical challenges associated with cloning and stably 
maintaining inverted EBE sites containing identical TALEN recognition sequences.   From a 
broader perspective, this plasmid-based transient assay should be readily adapted as a facile 
screening tool in animal and plant cell culture systems. 
The ten dTALENs engineered for this study were designed in pairs to target the 
native sequences of the yeast genes, URA3, LYS2 and ADE2. Each gene has a selectable or 
easily scored phenotype, so any dTALEN activity should be readily apparent.  Expression of 
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dTALEN pairs under appropriate selections indicated that all five dTALEN pairs were 
functional in creating phenotypic mutant strains whose site-specific DNA alterations were all 
confirmed by genotyping (Figure 3.4).  The activity of the five dTALEN pairs was 
comparable to the standard TALEN pair, AvrXa7 and PthXo1. Two pairs of dTALENs also 
were tested to compare their ability to mediate HR by targeting URA3 for gene replacements 
against HR stimulated by the standard TALEN pair. The results indicated that dTALENs and 
standard TALENs increase HR at a comparable rate (Figure 3.4). The low rates of gene 
disruption via NHEJ in present study are probably attributable to the cryptic NHEJ repair 
pathway in yeast. The NHEJ repair of DSBs in yeast is mostly accurate. For example, repair 
to DSBs with 4-base overhangs led to an error frequency of only about 1% (43, 44) Only 
cells with mutagenic alterations in the intentionally targeted genes might be recovered (for 
URA3 and LYS2) or detected (for ADE2) by using our procedures. Thus, while the number of 
dTALENs examined was somewhat limited, these experiments establish that dTALENs are 
active in vivo in promoting NHEJ- and HR-mediated gene modifications at endogenous loci 
in an intact, free-living, eukaryotic organism and, thus, verify the power of TALENs for 
targeted genome editing in eukaryotes beyond the TALEN-mediated gene disruption 
previously demonstrated in cultured human cells (20). 
Taken together, the results of this study indicate that the modular assembly technique 
is valid, that the yeast SSA assay is a reliable and facile indicator of TALEN activity and that 
functional dTALENs can target a diverse range of genomic loci. Our study also establishes 
that yeast, as an intact eukaryotic organism, is a reliable platform to develop and potentially 
refine engineered nuclease based technology for targeted genome editing. The designer 
TALEN technology described here may overcome a number of critical hurdles (e.g. high 
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cost, limited plasticity and high rates of failure) faced in designing and producing other types 
of nucleases with DNA targeting capabilities (7, 8). The opportunity to build dTALENs with 
quite long DNA recognition domains bodes well for developing TALENs with exceptionally 
high accuracy in targeting any gene in any organism, including eukaryotes with highly 
complex genomes.  Such technology has significant potential in experimental biology and 
medicine and in the development of products with value for human and animal health, 
agriculture and in a wide range of life sciences industries. 
 
Materials And Methods 
Yeast strains and growth conditions.  
Yeast strains YPH499, YPH500 and RFY231 as previously described (18, 21) were 
grown in nutrient medium YPD or synthetic complete medium (SC) lacking the appropriate 
nutrients. 5-FOA was used at 0.1% in SC medium as described (22). α-AA was used at 0.2% 
in SC medium lacking the normal nitrogen source, but containing a small amount of lysine 
(30 mg/L) (23). The adenine limited medium is SC medium containing a limited amount of 
adenine (10 mg/L) and lacking leucine and histidine (24).  
dTALEN constructs.  
Four repeats, each encoding the RVD of NI, NG, HD or NN from AvrXa7, were used 
as the “core” repeats. [More recently, NK has been substituted for NN in the recognition of G 
nucleotides based on the observations of Miller et al. (20)]. Using a combination of 12 
forward and 11 reverse primers (Supporting Information Table S1), twelve repeat sets 
were constructed from the 4 “core” repeats. For construction of the 1st 8-mer repeat array, 
combinations of the PCR primers were: TAL-Sph-F&TALcgct-R, TALcgct-F&TALcctt-R, 
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TALcctt-F&TALctct-R, TALctct-F&TALcgtt-R, TALcgtt-F&TALcttt-R, TALcttt-
F&TALcatt-R, TALcatt-F&TALccct-R, and TALccct-F&TAL/Pst-R for repeat Set 1 to 8, 
respectively. For ligation of the 2nd and the 3rd 8-mer repeat arrays, two additional repeat sets 
each corresponding to Set 1 were constructed by using primers TAL/Pst-F&TALcctt-R and 
TAL/Bsr-F&TALcctt-R, respectively; another two repeat sets corresponding to Set 8 were 
also constructed by using primers TALccct-R&TAL/Bsr-R and Tailcact-F&TAL-Sph-R, 
respectively. In total 12 repeat sets were generated and then individually digested with 
BsmBI. Based on the base entity and order of the preselected target DNA sequence (e.g. any 
sequence combination of 22 bp long), one repeat from each of 8 repeat sets was sequentially 
selected for one ligation reaction to construct the 8-mer repeat array. Each set of ligated DNA 
was directly cloned into pGEM-T for sequencing. Once all confirmed, the 1st 8-mer array 
was digested with SphI and PstI, the 2nd 8-mers with PstI and BsrGI, and the 3rd array with 
BsrGI and SalI. The three purified DNA fragments were ligated into pSK/AvrXa7 (18) that 
was digested with SphI and SalI, resulting in pSK/dTALE plasmids. The repeat regions of 
individual dTALEs were swapped with the TALE repeat domain of AvrXa7 in pCP3M-
AvrXa7-FN or pCP4M-AvrXa7-FN (18), resulting in the chimeric genes encoding the fusion 
of the full-length dTALE and the C-terminal FokI homodimeric cleavage domain. The 
expression level of these nuclease genes should be moderate due to the low copy number 
(about 1 copy per cell) of the centromeric plasmids pCP3M and pCP4M and the strong 
translation elongation factor 1α promoter (25).    
Yeast SSA assay for dTALEN activity.  
The individual target sites were constructed into pCP5 (18) in a tail-to-tail (3’ to 3’) 
orientation with AvrXa7 EBE. The oligonucleotide sequences for all TALEN EBEs were 
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provided in Table S2. AvrXa7 EBE (x7-EBE-F&R) was cloned into the PstI and SpeI sites of 
pCP5. The EcoRI site immediately upstream of SpeI site enabled all other TALEN EBEs to 
be cloned individually between EcoRI and SpeI sites, resulting in the reporter plasmids for 
individual TALENs in pair with AvrXa7-FN. The assay for individual TALENs each in pair 
with AvrXa7-FN was performed in a manner similar to that described (18). The assay was 
performed in triplicate. 
Targeted gene disruption of URA3, LYS2 and ADE2 in yeast.  
The Ty1 inserted URA3 gene (ura3-52) in YPH500 was restored to a functional 
URA3, resulting in strain YPH500a. Similarly, the target sequences for ZFNs (Zif268 and 
BCR-ABL) and for TALENs of AvrXa7 and PthXo1 were individually integrated into the 
URA3 gene immediately downstream of the start codon and used to restore the ura3-52 
mutant, resulting in strain YPH500b and YPH500c, respectively. YPH500b was transformed 
with plasmids pCP3M/Zif268-FN and pCP4M/BCR-ABL-FN. DNA fragment for the zinc 
finger protein Zif268 was PCR amplified from pMal-Zif268 (kindly provided by David J. 
Segal) using primers Zif268-F and Zif268-R and cloned in frame with FokI cleavage domain 
in pCP3M. Construct pCP4M/BCR-ABL-FN was described previously (18). YPH500c was 
transformed with pCP3M/AvrXa7-FN and pCP4M/PthXo1-FN, two plasmids previously 
described (18). YPH500a was transformed with plasmids expressing the paired dTALENs 
U3a_L & U3a_R and U3b_L & U3b_R. The respective yeast strains were transformed with 
plasmids pCP3M and pCP4M as negative control for each paired nucleases. The 
transformants were grown on the SC medium lacking histidine and leucine for 5 days before 
plating on the SC medium containing 0.1% 5-FOA for selection of resistant colonies and in 
parallel on SC medium without 5-FOA to test for plating efficiency. Genomic DNA extracted 
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from a number of 5-FOA resistant colonies for each pair of nucleases was used for PCR 
amplification of the relevant regions. The PCR products were sequenced using the respective 
primers. Similarly, gene disruption of LYS2 and ADE2 was performed in yeast strain 
RFY231. See Supporting Information for detailed information about the creation of these 
strains and gene disruption. 
HR-based URA3 gene replacement stimulated by dTALENs.  
Donor DNA constructs were made each with the ORF of URA3 deleted (pΔura3) and 
replaced by the NPTII expression cassette (pΔura3::Kan). YPH500c was transformed with 
donor construct and individual pair of plasmids expressing AvrXa7-FN & PthXo1-FN, 
dTALENs U3a-L & -R, U3b-L & -R, and the plasmids lacking a nuclease gene as control.  
The transformed cells were grown in SC media lacking histidine and leucine for five days, 
then plated on SC medium supplemented with either 5-FOA (for pΔura3) or YPD medium 
supplemented with 200 mg/L of G418 (for pΔura3::Kan), the duplicated cells were in parallel 
plated on the SC medium or YPD medium for plating efficiency. See Supporting 
Information for additional details. 
Cell growth assay.  
YPH500 cells were transformed with individual plasmids as indicated in the text. 
Three single colonies for each plasmid were picked and grown to a concentration of 
OD600=1.0. The cells were serially diluted and applied to appropriate solid medium for 
growth, which was observed daily for five days.  
Solexa sequencing and data analysis.    
The Genomic DNA from each of five yeast strains derived from YPH500, which is 
congenic with S288C (26), was extracted as described by Philippsen et al. (27). The DNA 
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processing and sequencing were performed according to manufacturer’s instruction for the 
Illumina/Solexa Genome Analyzer II at the Iowa State University DNA facility. The Illumina 
short reads for each strain were aligned to the yeast reference genome S288C to assemble 
each genome using the BWA software (28). The consensus sequences and polymorphisms 
among the five sequenced strains and S288C were delineated using SAMtools (29).  
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Figures And Tables 
 
Figure 3.1. DNA alterations by natural TAL effector-derived TALENs at chromosomally-
integrated paired EBE target sites in the URA3 gene. (A) Schematic of TALENs used in the 
study. Full-length TALEs were fused with the homodimeric cleavage domain of FokI (FN) 
with number of amino acids (aa) shown above each region (NLS, nuclear localization motifs; 
AD, transcription activation domain).  (B) Target sequences between the first and second 
codons of the yeast URA3 gene for cleavage by hybrid TALENs derived from AvrXa7 and 
PthXo1. (C) Alignment of genomic sequences of mutants and their parental strain at the 
TALEN target site. The number of nucleotides inserted (lowercase letters in red) or deleted 
(dashes) compared to parental sequences (PT) from each mutant colony is indicated on the 
right of each sequence. 
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Figure 3.2. Design and modular construction of dTALENs.  (A) TALEN repeat gene sets for 
modular construction of multi-repeat TALEN genes. Each set contains four single-repeat 
genes each encoding one of the four “core” TALEN repeat modules containing NI, NG, NN, 
and HD RVDs with binding specificity for A, T, G and C nucleotides, respectively. The core 
repeats in each set (boxed) contains a 5' and 3' termini unique to that particular set – as listed 
in the inset table.   For construction of a TALEN repeat recognizing a specific 8 nucleotide 
DNA recognition sequence (e.g., AGGTACTC), an NI repeat gene is selected from set 1, an 
NN repeat gene from set 2, an NN repeat gene from set 3, an NG repeat gene from set 4, etc.  
The 5’ and 3’ terminal regions are designed such that BsmBI digestion results in generation 
of 5’ and 3’ 4-base overhangs.  Because of the unique complementarity of 3’ overhangs from 
set 1 genes with the 5’ overhang of genes from set 2, the complementarity of the 3’ 
overhangs of set 2 with 5’ overhangs from set 3, etc., the annealing and ligation of overhangs 
results in one, and only one, ordered alignment of the 8 repeat genes that, when translated, 
will specifically recognize and bind (in the present example) the AGGTACTC DNA 
recognition sequence. (B) Once two (or three) such blocks of repeats are constructed, they 
are combined in a similar ordered fashion to create a TALE repeat region that is capable of 
binding a specific 16 (or 24) base pair target site. (C) The assembled TALE repeat domains 
are cloned into the TALEN repeat-deficient pAvrXa7-FN scaffold to create a candidate 
dTALEN. 
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Figure 3.3. Yeast SSA assay of modularly assembled dTALENs targeting three endogenous 
yeast genes. (A) RVD sequences within repeat modules of ten custom-synthesized 
dTALENs. N* represents dTALEN repeat modules with the 13th amino acid missing. (B) 
Schematic of the yeast SSA assay for measuring dTALEN activity based on plasmid-borne 
HR. Individual candidate dTALENs are assayed in combination with AvrXa7-FN for their 
ability to stimulate the recombination between the duplicated regions of LacZ gene (hatched 
boxes), leading to formation of a functional lacZ gene. (C) Activities of individual dTALENs 
in creating DSBs as detected in a β-galactosidase assay. Control denotes the β-galactosidase 
activity (<5 units) of yeast cells lacking a functional TALEN gene. Error bars denote s.d.; 
n=3. 
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Figure 3.4. dTALEN induced gene modifications by NHEJ and HR. (A) The frequency of 
gene disruption induced by five sets of paired dTALENs at five specific gene target site as 
measured by the numbers of colonies with the indicated mutant phenotypes. “⎯” denotes not 
applicable. (B) TALEN-induced insertion/deletion mutations at the three of five gene loci 
tested. Genomic sequences from each mutant clone at the relevant loci are aligned with the 
respective wild type sequences. dTALEN target sites are underlined. The number of 
nucleotides inserted (bold uppercase letters) or deleted (dashes) is indicated to the right of 
each sequence. (C) TALEN-induced HR as measured by the percentage of yeast colonies 
displaying the indicated phenotypes.   
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Figure 3.5. Growth of yeast cells expressing the paired TALEN and paired ZFN genes. 
Strains containing plasmids encoding the indicated nuclease genes (on the left side of each 
row) or lack thereof (pCP3M & pCP4M) were serially diluted (from 104 to 10 cells), applied 
as spots to SC medium plates lacking histidine (for pCP3M and its derived plasmids) and 
leucine (for pCP4M and its derived plasmids) and allowed to grow for four days. 
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Abstract 
We report the use of TALEN technology to thwart the ability of Xanthomonas oryzae pv. 
oryzae to cause bacterial blight, a major disease with significant impact on rice production 
worldwide.  Strong disease resistance was engineered using two independent designer 
TALEN pairs to destroy the DNA target sites for binding of the bacterial TAL effectors, 
AvrXa7 and PthXo3, within the promoter region of the rice Os11N3 gene. Genetic crosses 
were used to remove the TALEN genes and produce rice plants lacking transgenes or other 
foreign DNA elements.  These studies provide a demonstration of the potential power of 
TALEN technology for improvement of agricultural crops. 
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Introduction 
Transcription activator-like effectors (TALEs) of Xanthomonas oryzae pv. oryzae (Xoo) 
contribute to pathogen virulence by transcriptionally activating specific rice disease 
susceptibility (S) genes 1,2. TALE nucleases (TALENs), fusion proteins derived from the 
DNA recognition repeats of native or customized TALEs and the DNA cleavage domains of 
FokI 3-5, have been used to create site-specific gene modifications in plant cells 6,7, yeast 8, 
animals 9-12 and even human pluripotent cells 13. Here we exploit TALEN technology to edit 
a specific S gene in rice to thwart the virulence strategy of Xanthomonas oryzae and, thereby, 
engineer heritable genome modifications for resistance to bacterial blight, a devastating 
disease in a crop that feeds half of the world’s population. 
 
Results 
We targeted the rice bacterial blight susceptibility gene Os11N3 (also called 
OsSWEET14) for TALEN-based disruption.  This rice gene encodes a member of the 
SWEET sucrose efflux transporter family and is hijacked by Xanthomonas oryzae pv. oryzae 
using its TAL effectors AvrXa7 or PthXo3 to activate the gene and thus divert sugars from 
the plant cell to satisfy its nutritional needs and enhance its persistence 2,14. The Os11N3 
promoter contains an effector binding element (EBE) for AvrXa7, overlapping with another 
EBE for PthXo3 and the TATA box (Fig. 4.1a and Supplementary Fig. 4.1). Two pairs of 
designer TALENs (Pair 1 and Pair 2) were independently deployed to induce mutations in 
these overlapping EBEs of the Os11N3 promoter and thus to interfere with the virulence 
function of AvrXa7 and PthXo3 but not the developmental function of Os11N3 
(Supplementary Fig. 4.1). The TALE repetitive regions used for nuclease fusions included 
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the native AvrXa7 and three designer TALE repetitive regions custom-synthesized using a 
modular assembly method 8. Each designer TALEN contained 24 repeat units for recognition 
of a specific set of 24 contiguous nucleotides at the target sites (Supplementary Fig. 4.1). 
For each pair of TALEN genes, one TALEN gene (half of the pair) was under the 
control of the 35S promoter of cauliflower mosaic virus and the other gene was driven by the 
maize ubiquitin 1 promoter, comprising a specific TALEN pair in a single plasmid 
(Supplementary Fig. 4.2). Each plasmid also contained a marker gene for hygromycin 
resistance. These constructs were introduced into rice embryonic cells using Agrobacterium 
tumefaciens, and individual transformant cells were selected, propagated and regenerated into 
whole plants (T0). The Os11N3 promoter regions from a number of independent hygromycin 
resistant callus lines and the segregating progeny (T1) of self-pollinated T0 plants were PCR-
amplified and sequenced to detect potential sequence alterations. For TALEN Pair 1 genes, 
two of five examined callus lines contained biallelic mutations (Supplementary Fig. 4.3). Of 
twenty three randomly selected T1 progeny produced from self-pollination of seven 
independent T0 plants transformed with TALEN Pair 1 genes, about half (48%) carried 
mono- or bi-allelic mutations (including the four mutations detected in the two previously 
examined callus lines) (Fig. 4.1b). Approximately two-thirds (63%) of the randomly selected 
T1 plants (n=30) generated from self-pollination of sixty-six independent T0 plants from the 
two independent transformation experiments carried mutations that were induced by the 
TALEN Pair 2 genes (Fig. 4.1c and Fig. 4.1d). In total, sixteen distinct mutations, including 
6 homozygous lines, were detected in fifty-three T1 plants from TALEN Pair 1 and Pair 2. 
The majority of these mutations were small deletions that left the TATA box intact, with the 
exception of two deletions in heterozygous lines containing a wild type allele (Fig. 4.1e and 
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Supplementary Fig. 4.4). Bacterial infection assays using leaf tip clipping method on other 
T1 plants (n=627) generated from TALEN Pair 2 (Experiment 1) and not previously 
genotyped demonstrated that approximately 48% of the treated plants exhibited resistance to 
infection by pathogenic Xoo in terms of length of leaf lesions (1~4 cm for resistance vs. 10 
~14 cm for susceptibility) (Supplementary Fig. 4.5). DNA sequence analyses of 27 such 
Xoo-resistant T1 plants confirmed the presence of homozygous monoallelic or heterozygous 
biallelic EBE mutations and revealed 17 additional, distinct mutant haplotypes 
(Supplementary Fig. 4.6). All mutant plants were morphologically normal compared to wild 
type plants, indicating that the developmental function of Os11N3 was not disrupted. 
Forty plants from the second generation (T2) of three self-pollinated T1 plants were 
also genotyped by sequencing to determine the heritability of 3 TALEN generated mutations, 
all of which, whether homozygous or heterozygous, were passed on to T2 plants 
(Supplementary Fig. 4.7). 
To determine the effects of TALEN-directed mutations, we investigated whether the 
pathogenic strain of Xoo that is dependent on AvrXa7 or PthXo3 for virulence is able to 
either induce the modified Os11N3 gene in T2 homozygous plants or cause disease. The 
modified Os11N3 gene was no longer inducible by AvrXa7 or PthXo3 delivered by the 
pathogenic strain of the bacterium [ME2(avrXa7) or ME2(pthXo3)] in T2 plants homozygous 
for either the 9, 6, 15, or 4 bp deletion (Fig. 4.1f for AvrXa7, Supplementary Fig. 4.8a for 
PthXo3). The loss of induction was specific to Os11N3, as the induction of Os04g19960, a 
transposon coding gene collaterally targeted by AvrXa7, was not prevented (Fig. 4.1g). 
Similarly, the induction of another S gene (Os8N3/OsSWEET11) by PthXo1 in the T2 mutant 
plants remained unaffected (Supplementary Fig. 4.8b). These TALEN modified T2 plants 
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also showed strong resistance to infection of AvrXa7- or PthXo3-dependent Xoo strain but 
not PthXo1-dependent pathogenic Xoo strain as determined by symptoms (Fig. 4.1h for 
AvrXa7) and by quantitative measurement of the lengths of leaf lesions in a standard 
pathogenesis assay described in Supplemental Methods and Materials (Supplementary Fig. 
4.9). 
We also investigated the possibility of using genetic segregation to obtain genetically 
modified rice lacking any selection marker and TALEN gene. The polymerase chain reaction 
(PCR) assay using primers for amplification of the hygromycin resistance gene and for 
amplification of the TALEN genes failed to detect the presence of either gene in 5 out of 37 
T1 plants that contained the desired genetic modifications in the Os11N3 promoter and that 
were disease resistant (Supplementary Fig. 4.10). Although these data clearly demonstrate 
the absence of intact TALEN and hygromycin resistance genes, further sequencing the 
genomes of several mutants and the Kitake parental line will be needed to conclusively 
demonstrate that all of the transgene fragments have been removed. 
 
Discussion 
The rice Os11N3 gene is induced by 32 of 40 Xoo strains collected worldwide 
(manuscript in preparation).  However, polymorphisms in the Os11N3 gene that prevent 
induction by AvrXa7- and/or PthXo3-dependent Xoo strains and also confer disease 
resistance have not been identified in rice germplasm. The approaches described here for 
precisely and efficiently editing the disease susceptibility elements in Os11N3 and for the 
subsequent removal of transfer DNA (T-DNA) sequences by classical genetics likely can be 
applied directly to elite rice varieties to simultaneously or sequentially edit multiple 
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susceptibility genes (e.g. Os11N3 and Os8N3), leading to resistance to the major forms of 
bacterial blight. Present methods using TALEN-based technology in rice should be easily 
modified for application to other plant species and, thus, holds significant promise in 
facilitating gene modification-based research and crop improvement. 
 
Materials and Methods 
TALEN design and construction.  
Two pairs of designer TALENs (Pair 1: dTALEN L1 and dTALEN R1 and Pair 2: 
TALEN AvrXa7 and dTALEN R2) were used in the present studies.  TALEN AvrXa7 was 
based on a native AvrXa7 TAL effector and contained a truncated transcription activation 
domain fused at its C-terminus with a wild type FokI DNA cleavage domain 3,8. The other 
three TALENs employed in these studies were made using previously described “modular 
assembly” methods8.  Such assembly used four different genes encoding TAL effector DNA 
binding domains that, due to specific codons in position 12 and 13 of the coding sequence, 
are capable, respectively, of recognizing either an A, G, C or T residue in the DNA sequence 
of a particular target effector binding element (EBE). Each designer TALEN contained a 
wild type FokI DNA cleavage domain 3,8. All TALENs used a complete TAL effector N-
terminus.  Diagrams showing the structure of each TALEN and the EBE DNA sequence to 
which it matches are shown in Supplementary Figure 4.1.  
 
Construction of TALEN expression plasmids and rice transformation.  
The two promoters used to express the paired TALEN genes were the maize ubiquitin 
1 promoter (ubi1) and the 35S promoter of cauliflower mosaic virus (35S) 15,16. One of the 
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paired TALEN genes was cloned downstream of the 35S promoter at BamHI and SpeI sites 
in a binary vector and the other under the control of the ubi1 promoter was cloned into the 
BamHI and SacI sites of an intermediate vector. The ubi1-TALEN gene expression cassette 
was excised with HindIII and moved into the HindIII site of the binary plasmid containing 
the 35S-TALEN gene expression cassette. The resultant plasmids were mobilized into 
Agrobacterium tumefaciens strain EHA105 by electroporation. Agrobacterium-mediated 
transformation of the rice cultivar Kitake was conducted according to a previously described 
protocol 17. 
 
DNA sequencing analysis of regions in the Os11N3 gene targeted by TALENs.  
Genomic DNA from individual plants was extracted using the CTAB method as 
described 18. Forward primer, 5’- TCCCTTAACTAGGACAACTTGGA-3’, and reverse 
primer, 5’- CCGGATCCAGCCATTGCAGCAAGATCTTG-3’, were used to amplify a 
region of ~ 550 bp with the preselected target sites located in the middle. The PCR products 
from individual plants were sequenced using an internal primer, 5’-
CATGGCTGTGATTGATCAGG-3’.  Each sequencing chromatogram was manually 
analyzed for polymorphisms within a trace.     
 
Quantitative RT-PCR analysis of rice gene inducibility.  
Bacterial inoculums with optical density of 1.0 at 600 nm (OD600) were infiltrated 
into rice leaves by using needle-less syringe as described 18. The bacterial strains used were 
Xoo strain PXO99ME2 (hereafter designated as ME2, a PXO99 derivative strain lacking 
TAL effector PthXo1 with concomitant loss of strain virulence), ME2(avrXa7), 
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ME2(pthXo3) and ME2(pthXo1), three ME2 transformants containing the respective TAL 
effector genes avrXa7, pthXo3 and pthXo1. Both ME2(avrXa7) and ME2(pthXo3) induce 
Os11N3 and retain virulence, while ME2(pthXo1) retains virulence by inducing another S 
gene (Os8N3) 1. Total RNA of the inoculated portion of leaves was extracted using TRI 
reagent from Ambion 24 hours after bacterial inoculation.  RNA concentration and quality 
were determined using an ND-1000 Nanodrop spectrophotometer (Nanodrop Technologies). 
One microgram of RNA from each sample was treated with DNase 1 (Invitrogen) followed 
by cDNA synthesis using the iScript cDNA synthesis kit (Bio-Rad). cDNA derived from 25 
ng of total RNA was used for detection of gene induction by AvrXa7, PthXo3 and PthXo1 
using real-time quantitative PCR analyses. PCR was performed on Stratagene’s Mx4000 
multiplex quantitative PCR system using the iQ SYBR Green Supermix kit (Bio-Rad). In 
addition to inducing Os11N3, AvrXa7 also “collaterally” induces another rice gene 
Os04g19960, which encodes a putative retrotransposon protein, but is not associated with 
disease susceptibility in rice.  Gene-specific primers for Os11N3 are 5’-
GAGAAGAAGGTAGCTGCATGAGTG-3’ and 5’- 
TCATGGAAGGAACCCTTACAGGTTG-3’, primers for Os04g19960 are 5’- 
AGAAGGCGTAGGCATTCACAT-3’ and 5’- ACATTAACACAGCACACGTCAAC-3’, 
and primers for Os8N3 are 5’-GACTCCATGTCCCCGATCTCC-3’ and 5’-
CACCACCTCGACCTTGTGCA-3’. The rice general transcription factor TFIIAγ5 
expression was used as an internal control with primers 5’-
CTACTCAGCCAATAAATTGATAACTGC-3’and 5’-
CAATTTCTACTACTCATCGTTTAG-3’. The average threshold cycle (Ct) was used to 
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determine the fold change of gene expression. The 2ΔΔCt method was used for relative 
quantification 19.  
 
PCR determination of the presence or absence of T-DNA in genetically modified rice plants.   
 Genomic DNA was extracted as described 18 and used for PCR amplification of 
fragments from the Os11N3 gene promoter, hygromycin phosphotransferase (hpt) gene and 
TALEN genes. Primers for the Os11N3 gene were: forward, 5’-
CATGGCTGTGATTGATCAGG-3’ and reverse, 5’- 
CCGGATCCAGCCATTGCAGCAAGATCTTG-3’; primers for the hpt gene were: Hyg-F, 
5’- CCGCTCGTCTGGCTAAGATC-3’ and 35S-R, 5’- CGCTGAAATCACCAGTCTCTC-
3’; and primers for the TALEN genes were: FokI-F, 5’-
CAGCTAGTGAAATCTGAATTGG-3’ and Nos-R, 5’-CATCGCAAGACCGGCAACAGG-
3’.    
 
Surveyor nuclease cleavage assay for detection of nucleotide insertions and deletions.  
Genomic DNA was extracted using the CTAB method as described18 from individual 
callus lines and subjected to PCR amplification of the Os11N3 promoter region (~ 550 bp) 
using the gene-specific primers (5’- TCCCTTAACTAGGACAACTTGGA-3’ and 5’- 
CCGGATCCAGCCATTGCAGCAAGATCTTG-3’). The Surveyor nuclease (Surveyor 
mutation detection kit, Transgenomic) was used to treat the PCR products following the 
manufacturer’s instruction. The treated DNA was subjected to electrophoresis in a 1.5% 
agarose gel and visualized by staining with ethidium bromide.  
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Disease resistance assay.   
Fully expanded leaves of rice plants were inoculated using leaf tip clipping method.  
In this previously described procedure 20, scissors blades are immersed in bacterial 
suspension (OD600=0.5) of avrXa7-containing strain PXO86, pthXo3-containing strain 
ME2(pthXo3) and pthXo1-containing strain PXO99 immediately prior to clipping each target 
leaf.  Symptoms were scored 12-14 days after inoculation by measuring lesion length.  Plants 
were categorized as resistant (R) if lesion lengths were shorter than 4 cm or susceptible if 
lesions were longer than 8 cm. 
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Fig. 4.1. High efficiency targeted gene editing using TALENs. (a) Overlapping elements 
targeted by two pairs (Pair 1 and 2) of designer TALENs in the Os11N3 promoter. (b) - (d) 
Genotypes of progeny (T1) of primary transgenic plants (T0) derived from TALEN-
expressing embryonic cells from three independent transformation experiments (Exp.). Each 
of the two alleles of an individual plant are designated as being wild type (wt), having a 
nucleotide insertion (+) or a deletion (-) and are separated top and bottom by a dividing line. 
The designation [-55/(-7/+3)] indicates that one allele contains a deletion of 55 bp and that 
the other allele has both a deletion of 7 bp and an insertion of 3 bp. (e) Sequences of Os11N3 
mutations induced by the Pair 2 TALENs with deletions (dashes) and insertions (red letters). 
TALEN-binding sequences are underlined in WT and the overlapping EBEs shaded in grey. 
(f), (g) Expression of Os11N3 and Os04g19960 induced by AvrXa7 in plants of different 
genotypes. Quantitative RT-PCR was performed with RNA derived from treatments of 
nonpathogenic Xoo strain ME2 and pathogenic ME2(avrXa7). 2ΔΔCt is a measure of transcript 
abundance for a selected gene [Os11N3 (f) or Os04g19960 (g)] relative to transcript 
abundance produced from a constitutively expressed gene (OsTFIIAγ5) as determined by 
relative PCR cycle thresholds (Ct). (h) Resistance phenotype displayed by two T2 mutant 
plants compared with the disease susceptibility phenotype of a nontransgenic wild type rice 
plant. 
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Supplementary Figure 4.1.  TALENs and their DNA targets in the promoter of 
chromosomal Os11N3 gene. Four basic modular repeats whose repeat variable di-residue 
(RVD) (colored blocks) recognizing one nucleotide (NT) in the target site are used to 
assemble the DNA binding domain of each designer TALEN. The two pairs of nucleases 
(Pair 1 and 2) are fusions between the DNA cleavage domain of FokI (FokI) and the native 
(AvrXa7) or customized TAL effector (dTALE). The last 40 amino acids at C-terminus of 
dTALE-L1 and AvrXa7 are truncated to avoid the inappropriate induction of Os11N3 by the 
activation domain. The other two TAL effectors (dTALE-R1 and dTALE-R2) contain the 
complete C-terminus. All four TAL effectors contain the complete N-terminus. Os11N3 
promoter contains an effector binding element (EBE) for AvrXa7 (underlined in black), an 
EBE for PthXo3 (underlined in red) and the TATA box (boxed). Lower letters represent 
regions wherein two FokI domains dimerize and cause a double stranded DNA break. 
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Supplementary Figure 4.2. Schematic diagram of a two-gene expression cassette in a 
single binary vector designed for Agrobacterium-mediated rice transformation. The 
expression cassette includes a promoter [maize ubiquitin 1 promoter (Ubi1) (red arrow) to 
drive expression of the TALEN-L gene (open box), the cauliflower mosaic virus 35S gene 
promoter (35S) (red arrow) to allow transcription of the TALEN-R gene (open box)] and a 
gene terminator (Nos-T) (black box).   
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Supplementary Figure 4.3. Analysis of site-specific mutations within the Os11N3 gene 
promoter in T0 callus lines expressing the Pair 1 TALENs. (a) Schematics of the Os11N3 
gene promoter target site with primers (FP & RP) for PCR amplification of promoter 
sequence (550 bp) and primer (Seq-P) for sequencing the PCR products. (b) Analysis of PCR 
products derived from five individual callus lines using the Surveyor nuclease cleavage assay 
(see Methods and Materials) and showing two out of five calli (#1 and #2) with biallelic 
mutations.  This assay is designed to detect and cleave “loop-out” regions between hybrids of 
wild type promoter DNA sequences and DNA sequences in promoters containing TALEN-
generated nucleotide deletions or insertions.  If loop-out sequences are present, cleavage by 
the single-strand DNA-specific Surveyor nuclease should generate two DNA fragments, one 
in the range of 230 bp and the other in the range of 330 bp.  Molecular sizes are indicated in 
base pairs at the left side of the ethidium bromide stained gel image. (c) DNA sequencing 
chromatograms of three DNA fragments derived from wild type (WT) tissue and two callus 
lines (#1, #2) each containing biallelic mutations (i.e., a deletion of 49 bp in one OS11N3 
allele and a 8 bp deletion in the other alleles of the OS11N23 gene in callus #1; a deletion of 
6 bp in one allele in the promoter of OS11N3 in callus #2 and a 5 bp deletion in the other 
allele). 
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Supplementary Figure 4.4. Sequence of Os11N3 gene mutations in T1 plants induced by 
the Pair 1 TALENs. Deletions and insertions are indicated by dashes and red letters, 
respectively. TALEN-binding sequences are underlined in the wild type (WT) gene 
sequence. Numbers and letters designating each individual mutant (with numbers reflecting 
the length of nucleotide deletions or insertions) are indicated to the right side of the DNA 
sequence.  
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Supplementary Figure 4.5. Disease resistance in transgenic rice T1 plants. Lesion lengths 
caused by infection with a pathogenic AvrXa7-dependent Xoo strain were measured 14 days 
after inoculation of 20 T1 mutant plants (1 – 20) generated from TALEN pair 2 and 2 wild 
type Kitake plants (21 – 22). The T1 plants contained either homozygous monoallelic or 
heterozygous biallelic EBE mutations as confirmed by genotyping through sequencing. Leaf 
lesion lengths of 1~4 cm indicate disease resistance and lesion lengths of 10 ~14 cm indicate 
disease susceptibility.  Error bars indicate 1 SD.   
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Supplementary Figure 4.6.  Additional haplotypes detected in T2 plants carrying Os11N3 
gene mutations produced with Pair 2 TALENs. Deletions and insertions are indicated by 
dashes and red letters, respectively. Numbers and letters designating each individual mutant 
(with numbers reflecting the length of nucleotide deletions or insertions) are indicated to the 
right side of the DNA sequence. TALEN-binding sequences are underlined in wild type (wt). 
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Supplementary Figure 4.7. Genetic Segregation of forty T2 plants derived from self-
pollination of three T1 plants associated with the Pair 2 TALENs. Each of the two alleles of 
an individual plant are designated as being wild type (wt) or having a nucleotide deletion (-) 
and are separated top and bottom by a dividing line.  
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Supplementary Figure 4.8.  Expression of Os11N3 (a) and Os8N3 (b), respectively, 
induced by PthXo3- and PthXo1-dependent Xoo strains in T2 plants of different genotypes 
(indicated below each column). Quantitative RT-PCR was performed with RNA derived 
from treatments of nonpathogenic Xoo strain ME2 and pathogenic Xoo strains ME2(pthXo3) 
and ME2(pthXo1). Transcript levels of the rice gene OsTFIIAγ5 were used as a reference for 
measurements of Os11N3 and Os8N3 transcript levels. 
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Supplementary Figure 4.9.  Severity of disease damage to wild type and transgenic rice 
plants caused by AvrXa7-, PthXo3-, and PthXo1-dependent Xoo strains.  Lengths of lesions 
in wild type plants (CK1), segregating T2 transgenic plants with intact Os11N3 (CK2) and 
T2 transgenic plants homozygous for Os11N3 promoter mutations of 6 bp (-6b), 9 bp (-9a), 
15 bp (-15) and 4 bp (-4d) deletions, respectively, were measured 14 days post inoculation 
with different TAL effector Xoo strains as indicated.  
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Supplementary Figure 4.10.  Removal of T-DNA sequences containing TALEN genes 
from TALEN-modified rice plants using genetic crossing. (a) Schematic diagrams of the 
transfer DNA (T-DNA) region containing a paired set of TALENs and the Os11N3 gene 
aligned with the paired primer sets P1, P2 and P3 used for specific gene segment detection by 
PCR amplification. LB and RB represent the left and right border sequences for 
Agrobacterium-mediated gene transfer; hpt represents the hygromycin resistance gene. (b) 
Gel images of PCR products obtained with the primer sets of P1, P2 and P3 for hygromycin 
phosphotransferase gene (hpt), TALEN genes and Os11N3 promoter, respectively. Labels 
below gel images represent: v, binary vector DNA; ck+, a positive control of DNA from a 
transgenic plant containing the T-DNA region depicted in (a) and the Os11N3 gene; wt, 
DNA from a nontransgenic, wild type rice plant; number, individual T1 plants selected from 
genetic crosses to lack the T-DNA region, but retain a functional Os11N3 promoter region 
containing inactivated or deleted AvrXa7 and PthXo3 EBE sites.  
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Abstract  
TAL (transcription activator-like) effectors from Xanthomonas bacteria activate the 
cognate host genes, leading to disease susceptibility or resistance dependent on the genetic 
context of host target genes. The modular nature and DNA recognition code of TAL effectors 
enable custom-engineering of designer TAL effectors (dTALE) for gene activation. 
However, the feasibility of dTALEs as transcription activators for gene functional 
analysis has not been demonstrated. Here we report the use of dTALEs, as expressed and 
delivered by the pathogenic Xanthomonas oryzae pv. oryzae (Xoo), in revealing the new 
function of two previously identified disease-related genes and the potential of one  
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developmental gene for disease susceptibility in rice/Xoo interactions. The dTALE gene 
dTALE-xa27, designed to target the susceptible allele of the resistance gene Xa27, elicited a 
resistant reaction in the otherwise susceptible rice cultivar IR24. Four dTALE genes were 
made to induce the four annotated Xa27 homologous genes in rice cultivar Nipponbare, but 
none of the four induced Xa27-like genes conferred resistance to the dTALE-containing Xoo 
strains.  A dTALE gene was also generated to activate the recessive resistance gene xa13, an 
allele of the disease susceptibility gene Os8N3 (also named Xa13 or OsSWEET11, a member 
of sucrose efflux transporter SWEET gene family). The induction of xa13 by the dTALE 
rendered the resistant rice IRBB13 (xa13/xa13) susceptible to Xoo. Finally, OsSWEET12, an 
as yet uncharacterized SWEET gene with no corresponding naturally occurring TAL effector 
identified, conferred susceptibility to the Xoo strains expressing the corresponding dTALE 
genes. Our results demonstrate that dTALEs can be delivered through the bacterial secretion 
system to activate genes of interest for functional analysis in plant. 
 
Key Words: TAL effector; rice; Xanthomonas; Xa27; disease susceptibility; disease 
resistance; designer TAL effector. 
 
Introduction 
Plant pathogens of Xanthomonas bacteria essentially depend on a type III secretion 
system for pathogenesis in their host plants (Bonas et al. 1991; Zhu et al. 2000; Cho et al. 
2008). The type III secretion system in Xanthomonas secretes a suite of effector proteins, 
including TALEs (transcription activator-like effectors), into host cells (White et al. 2009). 
Once internalized, TALEs function as transcription activators to mediate host gene 
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expression by binding to the promoters of host resistance (R) genes or susceptibility (S) 
genes, triggering resistance responses or inducing  disease susceptibility, respectively (Gu et 
al. 2005; Yang et al. 2006; Kay et al. 2007; Antony et al. 2010). In addition to the nuclear 
localization motif and trans-activating domain, each TALE contains a central region of 
multiple 34- to 35-amino acid direct repeats that are nearly identical except the 12th and 13th 
amino acid residues (so called repeat variable di-amino-acids, or RVD) (Boch and Bonas 
2010). The combination of repeat number and composition of RVDs of individual TALEs 
determine the specificity of the targeted genes (Bogdanove et al. 2010; Boch and Bonas 
2010). Each repeat of TALE recognizes contiguously one nucleotide of target DNA, 
hereinafter referred to as EBE for effector binding element, in a simple cipher (Boch et al. 
2009; Moscou and Bogdanove 2009). Among many native TALE repeats, four predominant 
types of repeats each recognize preferentially one of four nucleotides of target DNA. 
Therefore, the TALE recognition “code” can be used to guide custom-engineering of DNA 
binding domains with novel specificity to the user-chosen DNA sequences (Morbitzer et al. 
2010; Zhang et al. 2011; Li et al. 2011). A variety of methods have been developed and used 
to synthesize TALE repeats that can be subsequently used for different fusions, in most cases 
for TAL effector nucleases (TALENs) [see review by Bogdanove and Voytas (Bogdanove 
and Voytas 2011)].  
Bacterial blight of rice, caused by Xanthomonas oryzae pv. oryzae (Xoo), is a major 
rice disease in Asia and western Africa, often resulting in yield losses of up to 50% and 
sometimes loss of the entire crop (Mew 1987). The TALEs are important pathogenicity 
determinants in Xoo/rice interaction. Several TALEs have been found to be essential 
virulence factors of Xoo in susceptible rice, inducing host S genes and subsequently 
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promoting pathogen infection and disease development (Yang and White 2004; Yang et al. 
2006; Yu et al. 2011; Antony et al. 2010). For example, some Xoo strains use TALE PthXo1 
to induce the S gene Os8N3 (Xa13 or OsSWEET11) for disease in susceptible rice. 
Intriguingly, some genetic variations in the promoter of Os8N3 are non-responsive to PthXo1 
and confer disease resistance to PthXo1-dependent Xoo strains, and those S gene alleles are 
collective named as the recessive resistance gene xa13 (Yang et al. 2006; Chu et al. 2006; 
Chen et al. 2010). The “resistance” is not due to the active defense but a lack of S gene 
induction and loss of disease susceptibility (Yang et al. 2006). To encounter TALEs, plants 
have evolved R genes, such as Xa27, that recognize TALEs through the promoter sequence 
and activate defense process once induced.  Xa27, recognizing the cognate TALE AvrXa27, 
is the representative of an unusual class of dominant R genes in plant (Gu et al. 2004; Gu et 
al. 2005). Both resistant (Xa27) and susceptible (xa27) alleles contain identical coding 
sequences but only resistant cultivars express Xa27 upon infection by Xoo strains expressing 
AvrXa27 (Gu et al. 2005). Expression of Xa27 depends on the direct interaction between its 
promoter and AvrXa27 (Romer et al. 2009). When fused to the nonspecific pathogen 
inducible OsPR1 promoter, the induced Xa27 conferred resistance to Xoo strains regardless 
of the presence of AvrXa27 (Gu et al. 2005). Two additional, as yet uncharacterized, rice R 
genes (Xa10 for AvrXa10 and Xa7 for AvrXa7) have similar requirements for the 
transcription activation domain and nuclear localization motifs of their cognate TALEs as 
required for AvrXa27-mediated induction of Xa27 (Zhu et al. 1998; Yang et al. 2000). 
However, it remains unclear how many, if any, other TALE-recognizing R genes exist in rice 
genome.   
 153  
In this work, we describe the feasibility of using custom-engineered TALEs to 
investigate the functionality of host target genes involved in Xoo/rice interaction. 
Specifically, by using artificial TALEs, we show that xa13 can be induced by Xanthomonas 
oryzae pv. oryzae and confer disease susceptibility, lending further evidence for Os8N3 
(OsSWEET11 or Xa13) as an S gene. This approach allowed us to identify another SWEET 
gene (OsSWEET12) that can act as an S gene, provided that the Xoo pathogen contains a 
corresponding TALE. We also show that the xa27 allele can be activated and triggers 
resistance to the bacterium expressing a corresponding dTALE. However, four other Xa27 
family members do not appear to have the potential to act as R genes since their activation by 
dTALEs did not trigger resistance.   
  
Results  
Design of TAL effectors for targeted gene activation 
We used an improved modular assembly method to synthesize TAL effector DNA 
binding domains. Four types of modular repeats with RVDs of NI, NG, NN and HD were 
used to recognize the respective target nucleotides of A, T, G and C. Instead of ligating eight 
pre-digested PCR-derived single-repeat units in one reaction as developed in our previous 
study (Li et al. 2011), the improvement involved digesting and ligating eight or fewer 
plasmid borne single-repeat units into one receptor plasmid in one tube by adapting the 
“Golden-Gate” cloning strategy described by Eagler et al. (Engler et al. 2008). Three arrays 
of 8-mers were ligated into scaffold of repeat-less avrXa10, resulting in a full-length dTALE 
presumably retaining specificity for the user-chosen DNA sequence (Figure 5.1). The target 
DNA sequences in the promoter of genes of interest were selected and included based on the 
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criteria: 1) Potential or obvious TATA box upstream of the transcription initiation site or 
predicted translation start site (if no cDNA sequence existed); 2) “T” preceding each EBE 
sequence (or at zero position of target site); 3) EBE about 23 bp long.  
Designer TAL effector targeting susceptible allele of dominant R gene Xa27 elicited 
resistance responses 
  To test whether a dTALE could activate a host gene and produce a phenotype once 
translocated into host cells by pathogenic Xanthomonas bacterium, we carried out a proof-of-
concept experiment with a susceptible allele (xa27) of Xa27. The alleles of Xa27 between 
IR24 (referred to as xa27/xa27) and its near isogenic line IRBB27 (Xa27/Xa27) contain 
identical coding sequences but differ in the EBEs for AvrXa27 (Gu et al. 2005; Romer et al. 
2009). The IR24 allele was irresponsive to AvrXa27 in gene induction due to incompatibility 
between the repeat domain of AvrXa27 and the promoter sequence and thus did not confer 
resistance to the pathogenic Xoo strains containing AvrXa27 (Gu et al. 2005) (Figure 5.2A). 
No naturally occurring TAL effector has been identified that is able to induce xa27 and elicit 
resistance response in IR24. dTALE-xa27 was designed to recognize a sequence in the 
promoter of xa27 (Figure 5.2A) and introduced into PXO99, an avrXa27-containing Xoo 
strain that caused disease in IR24 but resistance response in IRBB27 (Gu et al. 2005). 
PXO99 caused susceptible reaction in IR24 (yellow coloration at the inoculation sites), 
consistent with the previous studies (Hopkins et al. 1992; Gu et al. 2005), but elicited a 
typical hypersensitive response (brown coloration at the inoculation site) in the presence of 
dTALE-xa27 in IR24 (Figure 5.2B). The presence of dTALE-xa27 in PXO99 also restricted 
the bacterial growth in IR24 leaves by about 40 folds of population per inoculation site 
compared to PXO99 alone (Figure 5.2C). Furthermore, xa27 is only induced by bacteria 
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containing dTALE-xa27 but not by PXO99 alone and mock inoculation (water) in a 
quantitative RT-PCR assay (Figure 5.2D). The results indicate that dTALE-xa27 is active 
and an avirulence factor corresponding to xa27 that is, in turn, a disease resistance gene and 
is functionally equivalent to Xa27 corresponding AvrXa27 in a gene-for-gene manner. The 
results also demonstrate, as proof-of-principle, the validity of expression, secretion and 
functionality of designer TAL effectors in rice/Xoo interaction.   
Four annotated Xa27-like genes in Nipponbare did not confer resistance responses even 
induced by the corresponding dTALEs 
The annotated Nipponbare genome encodes a family of four homologs with varying 
identities to XA27, referred to as Xa27-like genes (XALs), the most closely related one 
(XAL1, Os06g39810) shares 91%  identity with XA27 of IRBB27 (Gu et al. 2005). 
Sequences for other three XAL genes could not be identified from the sequenced indica rice 
variety 93-11, and their entities in the un-sequenced IR24 genome are unknown (data not 
shown). We asked whether other members of Xa27 family could also function as R genes 
upon induction in a gene-for-gene manner. Four dTALEs were designed to target the 
promoters of four Xa27-like genes in Nipponbare (Figure 5.3A). Each dTALE was 
introduced into PXO99, also a virulent strain in Nipponbare. PXO99 transformants with 
individual dTALEs caused strong water-soaking, a diagnostic feature of susceptible reaction 
(Figure 5.3B). The gene inductions of individual Xa27-like genes by individual dTALEs 
were validated in a quantitative RT-PCR (Figure 5.3C-F).  
dTALE acted as a virulence factor and overcame xa13 recessive resistance 
TAL effector PthXo1 induced the S gene Os8N3 and subsequently a state of disease 
susceptibility, while the allelic xa13 conferred resistance to PthXo1-dependent Xoo due to its 
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non-inducibility by PthXo1 and could be overcome by Xoo strains that induced an alternative 
S gene (e.g. Os11N3 by AvrXa7 and/or PthXo3) (Chu et al. 2006; Yang et al. 2006; Antony 
et al. 2010). We hypothesized that xa13-mediated resistance could also be overcome by Xoo 
strain that directly induced xa13 gene. To test this idea, we designed a TAL effector 
(dTALE11) based on the conserved promoter sequences of the allelic xa13 and Os8N3 
(Figure 5.4A and B). dTALE11 gene was introduced to ME2, a non-pathogenic mutant of 
PXO99 with pthXo1 gene knocked out and lack of any other major TAL effector (Yang and 
White 2004). As expected, dTALE11-containing ME2 induced both Os8N3 and xa13 in IR24 
and IRBB13, respectively (Figure 5.4C and D), and the inductions conferred disease 
susceptibility to ME2 in both varieties (Figure 5.4E), indicating a function of xa13 as disease 
susceptibility gene upon induction. In agreement with prior studies (Yang and White 2004; 
Yang et al. 2006; Antony et al. 2010), the ability of ME2 to cause disease was severely 
attenuated due to the lack of any major virulent TAL effector to induce the corresponding S 
gene in both IR24 and IRBB13; reintroduction of pthXo1 restored ME2 the ability to cause 
disease in IR24 but not in IRBB13 due to the difference in gene induction of Os8N3 and the 
allelic xa13, respectively (Figure 5.4C and D).  
 
dTALE targeted gene activation revealed the potential of OsSWEET12 as a disease 
susceptibility gene 
Finally, we sought to further validate the feasibility of dTALEs for targeted gene 
activation and to expand their application to gene function analysis of uncharacterized genes. 
Rice genome contains at least twenty-one SWEET (or N3) genes with a phylogenetic clade 
that harbors two known S genes (OsSWEET11 and OsSWEET14) and three additional 
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uncharacterized SWEETs (Chen et al. 2010). We designed two dTALEs to target one of 
them, Os03g22590 (also named OsSWEET12) in Nipponbare, by binding to its two putative 
TATA boxes (Figure 5.5A and B). The dTALE genes were transformed into ME2. Again as 
expected, ME2 transformant of each dTALE gene induced OsSWEET12 expression in 
Nipponbare 24 hours post inoculation (Figure 5.5C), and also induced a state of disease 
susceptibility in term of disease development (Figure 5.5D), indicating that both dTALEs 
were virulence factors and OsSWEET12 was a potential disease susceptibility gene for 
bacterial blight upon transcriptional activation. Similarly, test on other two SWEETs is in 
progress and the preliminary data indicates they also appear to contribute disease 
susceptibility upon induction (data not shown).  
 
Discussion  
The bacterial blight of rice represents an excellent plant/pathogen system for studying 
the biology of TAL effectors due to the large reservoir of TALEs in each strain of 
Xanthomonas oryzae pv. oryzae and the diverse roles of TALEs in pathogenesis of the 
disease (Nino-Liu et al. 2006; White and Yang 2009).  Indeed, many years of effort spent in 
understanding the interaction between TALEs and their host target genes has led to the 
discovery of the DNA recognition cipher of TALEs (Boch et al. 2009; Moscou and 
Bogdanove 2009). The programmability of the TALE central repeat domains enables 
custom-engineering DNA-binding proteins with predictable specificities feasible to 
manipulate gene function in eukaryotes (Bogdanove and Voytas 2011).  In the present study, 
we expanded the utilization of TALE-based technologies from targeted gene editing to gene 
activation and function analyses involved in Xoo/rice interaction (Li et al. 2012). We 
 158  
generated seven artificial or designer TAL effectors based on the promoter sequences of six 
loci in rice (Figures 5.2A, 5.3A, 5.4A and B, and 5.5A and B) and transformed them into 
Xanthomonas oryzae pv. oryzae. Gene expression analyses indicated all dTALEs were active 
in trans-activating target genes in rice (Figures 5.2D, 5.3C-5.3F, 5.4C and D, and 5.5C), 
achieving a 100% success rate in engineering active dTALEs. Gene activation of three alleles 
(xa27, xa13 and OsSWEET12) led to phenotypic changes in disease resistance or 
susceptibility in response to Xoo infection (Figures 5.2B and C, 5.4E, and 5.5D), suggesting 
the feasibility of this approach to the gene functional analysis. 
Prior studies demonstrated the gene activation by artificial TALEs, but the associated 
phenotypic changes were lacking. For example, dTALEs designed for activation of tomato 
Bs4, Arabidopsis EGL3 and KNAT1 could activate the respective genes upon Agrobacterium-
mediated ectopic expression of dTALEs, but the expected phenotypic alterations were not 
observed (Morbitzer et al. 2010).  Also in mammalian and human cells, dTALEs with an 
architecture of a viral nuclear localization motif combined with the VP16 or its derived 
transcription activation domain were only demonstrated in up-regulating the target genes 
upon ectopic expression (Zhang et al. 2011; Geissler et al. 2011; Bultmann et al. 2012). 
Therefore, realization of the potential of dTALEs for targeted gene activation in basic and 
applied researches needs more studies. 
  Bacterial blight of rice involves molecular interactions of genes or gene products 
from both pathogen and rice, and gene regulation in host through pathogen effectors appears 
to play an important role in the pathogenesis of disease (White and Yang 2009). dTALEs 
provide an useful tool box to transiently activate host genes of interest and to quickly assess 
the associated host phenotypic and physiological changes in response to pathogen infection. 
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As a case in point, we quickly assessed the four homologous genes of the R gene Xa27 for 
their functionality in conferring resistance responses and one sucrose efflux transporter gene 
for its vulnerability to bacterial disease. Likewise, dTALEs may be used for genome-enabled 
functional analysis of genes and networks involved not only in rice/Xoo interaction but also 
probably in other plant disease systems. 
 
Materials And Methods 
Plant Material and Growth Conditions 
Rice (Oryza sativa) varieties IR24, IRBB13, Nipponbare were used in the study. 
Seeds of Nipponbare (accession number PI 514663) were obtained from the USDA-
Agricultural Research Service National Small Grains Collection. IR24 and IRBB13 seeds 
were kindly provided by the International Rice Research Institute (courtesy of Casiana Vera 
Cruz). All rice plants were grown in growth chamber with temperature of 28°C, relative 
humidity of 75%, and photoperiod of 12 hours.   
Plasmids, Bacterial Strains and Growth Conditions 
Plasmids used in this study included those in the modular assembly kit we developed 
to synthesize designer TAL effectors (detailed information available upon request), 
pZWavrXa10 [avrXa10 in pBlueScript II KS, unique HindIII site after avrXa10 coding 
region (Zhu et al. 1999)], pHM1 [broad host range plasmid (Hopkins et al. 1992)], and the 
plasmids containing dTALEs as specified in the text.  E. coli strains included XL1-Blue 
MRF´ [F´proAB lacIqZ∆M15 Tn10 (Tetr), Stratagene, La Jolla, CA, U.S.A.], DB3.1 [F– 
gyrA462 endA1 Δ(sr1-recA) mcrB mrr hsdS20(rB–, mB–) supE44 ara-14 galK2 lacY1 
proA2 rpsL20(SmR) xyl-5 λ– leu mtl1, Life Technologies], JM109 [endA1, recA1, gyrA96, 
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thi, hsdR17 (rk–, mk+), relA1, supE44, Δ(lac-proAB), F′, traD36, proAB, laqIqZΔM15, 
Promega], C2110 [Nalr Rifr (polA1, rha, his) (Leong et al. 1982)]. Xanthomonas oryzae pv. 
oryzae strains included PXO99 (Hopkins et al. 1992) , its derivative ME2 (Yang and White 
2004), and their transformants with plasmids as specified in the text. E. coli cells were grown 
in Luria Broth with a standard culture technique (Ausubel et al. 1993). X. oryzae pv. oryzae 
was grown in either nutrient broth (Difco Laboratories) or typtone sucrose medium (tryptone, 
10 g/liter; sucrose, 10 g/liter; glutamic acid, 1 g/liter) at 28°C. Antibiotics used in this study 
were carbenicillin (100 ug/ml), cephalexin (10 ug/ml), kanamycin (50 ug/ml), tetracycline 
(12.5 ug/ml) and spectinomycin (100 ug/ml). 
dTALE Construction  
Four “core” repeats from avrXa7 encoding RVDs of NI, NG, NN and HD were PCR-
amplified with specially designed primers and the PCR products were individually cloned 
into the A/T cloning vector pGEM-T (Promega) to generate fifty-one plasmids, each 
containing a single modular repeat. Sequence information for the primers and modular 
repeats is available upon request. A receptor vector (pTL-n) was made to clone 8 or fewer 
single repeats together in a predetermined order by using the “Golden Gate” cloning strategy 
(Engler et al. 2008). Then three repeat arrays were cloned into the repeat-deleted 
pZWavrXa10, resulting in individual TAL effector genes consisting of 5’- and 3’-coding 
sequences of avrXa10 and the newly synthesized repeat domains. The kit with the fifty-three 
plasmids is available from the Yang laboratory under a Material Transfer Agreement (MTA) 
and the detailed protocol is also available upon request.  
Disease Assay 
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Fully expanded leaves of rice plants at the stages indicated in the text were inoculated 
using leaf tip clipping method for lesion measurement (Kauffman et al. 1973) and syringe 
infiltration for observation of water-soaking/hypersensitive reaction and for bacterial 
population counting as described (Yang and White 2004). Bacterial suspensions of optical 
density of 1.0 at 600 nm (OD600=1.0) were used for syringe infiltration and OD600=0.5 for 
clipping inoculation. One-way analysis of variance (ANOVA) statistical analyses were 
performed on all measurements. The Tukey honest significant difference test was used for 
post-ANOVA pair-wise tests for significance, set at 5% (P < 0.05).   
Gene Expression Analyses 
The rice leaves were inoculated with indicated bacterial strains and used for total 
RNA extraction 24 hours post inoculation. RNA was extracted using the TRI reagent from 
Ambion, and RNA concentration and quality were measured using an ND-1000 Nanodrop 
spectrophotometer (Nanodrop Technologies). One microgram of RNA from each inoculation 
with bacteria as indicated in the text was treated individually with amplification grade 
DNase1 (Invitrogen) followed by cDNA synthesis using the iScript Select cDNA synthesis 
kit (Bio-Rad). cDNA derived from 25 ng of total RNA was used for each real-time PCR with 
gene-specific primers. TFIIAγ5 expression was used as an internal control. The RT-PCR was 
performed on Strategene’s Mx4000 multiplex quantitative PCR system using the iQ SYBR 
Green Supermix kit (Bio0Rad). The average threshold cycle (Ct) was used to determine the 
fold change of gene expression. The 2∆∆Ct method was used for relative quantification (Livak 
and Schmidttgen, 2001). The primer sequences are provided in Supplemental Table 1 online.   
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Figures and Tables 
 
Figure 5.1. Structure of a typical design TAL effector (dTALE). The dTALEs consist of a 
scaffold of the repeat-less AvrXa10 and the custom-engineered TAL effector repeat domains. 
Each dTALE contains an N-terminal type III secretion signal (T3S signal), three functional 
nuclear localization motifs (NLS) and an acidic trans-activating domain (AD), and a varying 
number of repeats as each represented by the 12th and 13th amino acids (Variable repeats). 
Four types of 34-amino-acid repeats, each recognizing one of four nucleotides, are used to 
assemble the repeat domain of each dTALE.    
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Figure 5.2. dTALE-xa27 induced the susceptible allele of Xa27 and triggered resistance 
responses in rice IR24. (A). Promoter sequence for dTALE-xa27 (xa27 EBE, shaded in tan) 
in IR24 and the TAL effector AvrXa27 binding element of Xa27 (Xa27 EBE, shaded in grey) 
in IRBB27. (B). Disease reactions of IR24 leaves to PXO99 strains containing or lacking 
dTALE-xa27. Hypersensitive reaction (HR) is indicated by tissue browning within 48 hours 
compared to susceptible reaction (yellow coloration) at the inoculation sites. (C). Populations 
of PXO99 and derivative in leaves of IR24. Populations are expressed as colony forming unit 
(cfu) per inoculation spot 4 days post inoculation. Lowercase letters above columns indicate 
significant differences at the <0.01 level using Tukey statistic and ANOVA analysis. Bars 
indicate 1 SD. (D). Gene induction of xa27 in IR24. RNA from leaves treated with water, 
PXO99 and dTALE-xa27-containing PXO99 was used for quantitative RT-PCR with gene-
specific primers and rice TFIIA gamma subunit gene in chromosome 5 used as an internal 
control.     
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Figure 5.3. Four dTALEs targeted four Xa2-like genes in Nipponbare for gene activation and 
disease reaction. (A). Four dTALEs and their corresponding EBEs in the respective 
promoters of Xa27 homologs. (B). Disease reactions of Nipponbare leaves in response to 
PXO99 strains containing different dTALEs. (C), (D), (E), (F). Gene induction of individual 
Xa27 homologs in response to different Xoo strains as detected by RT-PCR with gene-
specific primers. The rice TFIIA gamma subunit gene was used as an internal control. 
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Figure 5.4. dTALE11 induced and overcame resistant gene xa13.  (A). Promoter sequences 
of the allelic Os8N3 and xa13 with TAL effector binding elements (EBEs). PthXo1 
recognizes Os8N3 (also named OsSWEET11, or Xa13) in susceptible rice IR24 but not xa13 
in the IR24-derived near isogenic resistant line IRBB13. dTALE11 was designed to activate 
both alleles by recognizing the identical promoter sequences (underlined  and overlapping 
with the TATA box) in IR24 and IRBB13. (B). dTALE11 with RVDs and their 
corresponding target nucleotides (EBE). (C), (D). Gene induction detected with RT-PCR. 
Leaf RNA of IR24 and IRBB13 from different treatments was subjected to quantitative RT-
PCR with gene specific primers. PCR for TFIIAγ5 was used as an internal control. ME2 is a 
pthXo1 knockout PXO99. (E). Disease severities (lesion lengths) caused by different Xoo 
strains in IR24 (grey bars) and IRBB13 (dark bars). Lesions were measured 10 days post 
inoculation. Error bars indicate ±SD. 
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Figure 5.5.  OsSWEET12 induction conferred disease susceptibility to Xoo. (A). Two 
dTALE binding elements (underlined) in the promoter of OsSWEET12. (B). Repeat units 
(RVDs) of two dTALEs and their EBEs. (C). OsSWEET12 induction as detected by RT-PCR. 
Leaf RNA of rice Nipponbare treated with different Xoo strains was subjected to RT-PCR 
with gene-specific primers. RT-PCR with TFIIAγ5 was used as an internal control. (D). 
Lesion lengths caused by Xoo in Nipponbare leaves. Lesions in 4-week old plants were 
measured 10 days post inoculation. Error bars indicate ±SD.  
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CHAPER 6 
CONCLUSION AND FUTURE WORK 
 
General Conclusions 
 The “one to one” TALE DNA recognition code enables the TALEs to become 
powerful technologies in synthetic biology and also in areas that TALEs can be used as site 
specific DNA binding proteins, such as nucleases, transcription factors and epigenetic 
modifiers. TALE-based technologies are applicable in a plethora of organisms. My work, in 
collaboration with others, on TALEs has largely focused on technology development and 
utilization, especially in the area of DNA-targeting using the TALE derived nucleases and 
transcription activators.  
 Basically, I have first demonstrated the TALE could function as DNA binding 
domain similar to zinc finger proteins. After fused with the FokI cleavage domain at the C-
termius, TALE nuclease proteins could generate DNA double-strand break at the expected 
sites. And the activities were comparabe to the activities of the well-characterized ZFNs (zinc 
finger nucleases).  
 After determining the activity of TALENs derived from the naturally TALEs, I 
conceived a method to synthesize novel TALE DNA binding domains for any preselected 
DNA sequence by assembling four types of modular TALE repeats (RVD NI, NG, NN and 
HD recognizing A, T, G, and C, respectively). Initially, I developed a restriction/ligation 
method with the PCR-amplified modular repeats. This method could assemble 8 repeats in an 
order of any combination. Later, I have improved the modular assembly method by 
combining the Golden Gate cloning strategy with a plasmid-borne repeat library. The 
improved method is simpler and more efficient to make active designer TALENs.  
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 With the proof of concept demonstration of generating functional TALENs in vitro 
and in vivo, I went on to modify the genes of interest with custom-engineered TALENs in 
rice coupled with rice tissue culture and transformation. The first target is the EBE of 
Os11N3 (or OsSWEET14) for the native TALEs AvrXa7 and PthXo3. The modified rice 
lines with EBE changes showed bacterial disease resistance because of the prevention of 
AvrXa7 and PthXo3 from binding and further transcriptional activation of the rice 
susceptibility gene OsSWEET14. The TALEN-induced genetic changes were also capable of 
transmitting into the progeny plants. Importanly, the TALEN transgenes could be genetically 
segregated out in some of progeny plants, resulting in lines with desired modification but 
lacking any “foreign” DNA left over in the genome. The study is the first case of using 
TALEN technology to create stable and heritable trait of agromonically significance. 
 Additionally, my work has demonstrated the feasibility in using designer TALEs to 
probe the gene function in rice. TALEs function as transcription activator by binding to the 
EBEs in the promoters of target genes after the bacterial pathogen injects them into host cells 
through a type III secretion system. By using the Xoo bacterium to produce and deliver 
designer TALEs, I was able to show one member of SWEET gene family (OsSWEET12) was 
a potential disease susceptibility gene for bacterial blight of rice provided it would be 
induced by an as yet unknown TALE.  
 
Future Prospects 
Other TALE fusion proteins  
TALEs bind to double-stranded DNA of specific sequences, while it has been shown 
that TALE is also capable of binding to DNA-RNA hybrid strand with the specificity 
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determined by the interaction between the TALE repeats and the sequence of DNA strand. 
The physical binding is able to block the accessibility of other macromolecules to the RNA 
strand, pointing to a prospect of potential use of designer TALEs to interfere with the DNA 
replication and retroviral infections (Yin et al. 2012).  
TALEs fused with different domains can function differently for various avenues of 
DNA-targeting. For example, TALE-derived recombinases can be used to recombine DNA 
sequences in bacterial and mammalian cells (Mercer et al. 2012); TALEs fused with 
fluorescent proteins to specifically target telomeres or satellite repeats located at centromeres 
are used for chromosome study and in vitro detection in fixed cells (Ma et al. 2013, Thanisch 
et al. 2013); TALEs fused with transposase are capable of selectively integrating single copy 
of transposon into a safe harbor (Owens et al. 2013).  
In addition to genome editing, TALEs have also been applied in epigenome 
modification at specific genomic loci. For instance, TALEs fused with the catalytic domain 
of chromotin-modifying enzyme ten-eleven translocation 1 (TET1) are utilized for specific 
CpG demethylation and analysis of gene regulation (Maeder et al. 2013). In a similar case, 
Mendenhall et al. fused TALEs with lysine-specific demethylase 1 (LSD1) to  selectively 
inactivate enhancer-associated chromatin state through demethylation of H3K4 mono- and 
di-methylation in a sequence specific manner (Mendenhall et al. 2013). Most recently, two 
components (SUVH2 and SUVH9) of RNA-directed DNA methylation complex in 
Arabidopsis thaliana were shown to bind to methylated DNA and recruit Pol V to reinforce 
RNA directed DNA methylation. When fused with a zinc finger protein, SUVH2 is capable 
of recruit Pol V to the ZF target site and establish DNA methylation and gene silencing 
(Johnson et al. 2014). Likewise, SUVH2, when fused with the rogrammable TALEs, is 
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capable of inducing site directed DNA methylation for gene silencing and functional analysis. 
Therefore, TALE-directed site specific DNA methylation, demethylation and histone 
modification may signicantly facilitate the epigenetic and chromatin state study.  
Opportunity for Improvement 
Progress in TALE-based technology development has occurred at an astounding pace, 
which speaks volumes about the positive change that a diverse group of research scientists 
can bring to a new technology when they have a common goal; in this case, creating a 
universally powerful tool for Genome Editing.  On the other hand, there are still many areas 
that could be improved, including toxicity tests, alternatives for the T0 recognition domain, 
evaluation of alternative RVDs, and an improved nuclease domain. 
Toxicity Test 
Toxicity was identified as an issue early in the development of nuclease based 
Genome Editing, and it still is an apparent issue with TALENs.  While progress has been 
made in testing the relative functionality of nuclease designs using methods such as the 
yeast-based nuclease assay, a simple, general test for nuclease toxicity has yet to be 
developed.  This is complicated by the fact that toxicity is not a universal issue, but may be 
more of a species-dependent or cell-specific problem.  Various solutions for toxicity have 
been suggested, but most do not address the central issue, and often it is simpler to simply 
test several engineered nucleases, then use the one that works best.  This screening for 
toxicity can be performed by evaluating relative survival based on co-transformation with a 
marker gene.  While this approach works, it is not always applicable or convenient, 
especially in plant cells that are not amenable to protoplast isolation or in animal cells in 
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which nucleases are delivered to individual cells one at a time.  Some out-of-the box thinking 
will be required to solve this problem. 
T0 Domain 
Another area for improvement is the repeat 0 region of the TALE DNA binding 
domain.  Repeat 0 binds to the first base in an EBE, which is generally a T.  Expanding the 
spectrum of this specificity would further increase the flexibility for identification of 
effective TALEN target sequences.  Structural data show that repeat 0 has a helix-loop-helix 
motif and that T specificity is based on its interactions with W232 in the KQWSG sequence 
of the loop.  When mutations are generated in this region, the specificity for a T is relaxed; 
however, these gains appear to be context specific.  That is to say, moving the mutation to a 
related TALE or using the mutation in a TALEN, TALE activator or a TALE recombinase 
changes the recognition pattern (Lamb et al. 2013, Tsuji et al. 2013, Doyle et al. 2013).  
Additionally, it has been demonstrated that repeat 0 from R. solanacearum preferentially 
activates promoters containing EBEs with a 5’ G.  However, when tested in a PthXo1 
construct, although the R. solanacearum repeat 0 changed specificity to G, it did so at the 
expense of activity (de Lange et al. 2013, Doyle et al. 2013).  Interestingly, an optimized 
TALE scaffold using the N terminal 207 a.a. plus the C terminal 63 a.a. from AvrXa10 
reportedly exhibited similar activity whether a target DNA sequence contained a 5’ C, A, T 
or G (Sun et al. 2012).  These reports suggest that the specificity of repeat 0 for a T is not 
immutable, but they also suggest that a larger scale effort will be needed to effectively 
accommodate A, C and G at position 0 in many contexts. 
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Alternative RVDs 
The most commonly used RVDs are HD, NI, NG, and NN for the recognition of C, 
A, T and G respectively.  While these RVDs work well, they each have strengths and 
weaknesses.  For example, NN recognizes A about as well as G, HD interacts strongly with 
C, but is sensitive to 5-methylcytosine (5mC), NI has a relatively weak interaction with A, 
and NG interacts strongly with T, but also recognizes 5mC (Streubel et al. 2012, Meckler et 
al. 2013, Lin et al. 2014, Deng et al. 2012b).   
Many other RVDs exist, but most have not been stringently tested.  Of the few 
examined, it has been found that NK has a higher specificity for G over NN, but also lower 
affinity, which results in less TALEN activity in yeast and human cell based recombination 
assays (Huang et al. 2011, Mahfouz et al. 2011, Cong et al. 2012).  In contrast, RVD NH has 
been shown to have higher specificity for G over NN without sacrificing affinity (Christian et 
al. 2012, Streubel et al. 2012, Mechler et al. 2013, Cong et al. 2012).  Also, N* (missing the 
13th aa) was shown to bind 5mC as well as C, A, T and G; making it a generic RVD (Valton 
et al. 2012). 
In addition to differences in binding affinity and specificity among the various RVDs, 
there exits polarity in the TALE DNA binding domain, with binding being strongest in the N-
terminal region and weakest in the C-terminal end.  This polarity makes a TALE much more 
sensitive to 5’ target site mismatches than 3’ mismatches, and at least one study has shown 
that RVD HD has a stronger affinity for C when located nearer to the N-terminus (Streubel et 
al. 2012, Meckler et al. 2013, Lin et al. 2014). 
The ability to specifically recognize modified and unmodified DNA has important 
implications in epigenetic and cancer research, but also has consequences for general 
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targeting efficiency.  Until the alternative RVDs are systematically tested for binding affinity, 
specificity and position effect, it will remain an open question as to which RVDs are best for 
any specific application. 
 
Improved TALE Nuclease Design 
TALENs and ZFNs could benefit from an improved nuclease design.  Both 
commonly use FokI, but FokI functions as a homodimer and engages in trans cleavage. Each 
of these characteristics contributes to cell toxicity, and improved heterodimeric forms of FokI 
have reduced much of the toxicity.  However, there is still much room for improvement.  
There are several reported examples of alternative structures, such a nickases, alternative 
dimeric nucleases and attempts to create monomeric TALENs that have the potential to 
improve application of TALENs under some conditions. 
 
Nickases 
A FokI nickase was produced by mutating the catalytic site (D450A) of one partner in 
a FokI heterodimer to induce a single strand break rather than a DSB (Ramirez et al. 2012, 
Wang et al. 2012, Kim et al. 2012).  The idea was to suppress the NHEJ rate in favor of HR, 
which worked. However, the HR rate was also greatly reduced (Metzger et al. 2011, Davis 
and Maizels. 2011, van Nierop et al. 2009).  A different approach to engineering a nickase 
reportedly fused the monomeric nickase MutH to a TALE DNA binding domain.  MutH is a 
DNA mismatch repair endonuclease that recognizes the sequence GATC.  This fusion 
protein was tested in a plasmid cleavage assay in vitro and shown to function as a nickase 
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(Gabsalilow et al. 2013).  Further exploration of these and other TALE-based nickases may 
eventually lead to higher HR efficiencies. 
 
Alternative Nucleases 
Because FokI trans activity causes some toxicity, the development of alternative 
nuclease partners may improve the general application of TALENs in Genome Editing.  The 
Type IIP restriction endonuclease PvuII was fused with a TALE, a catalytically inactive I-
SceI and a zinc finger array.  These new homodimeric nucleases were shown to have high 
specificity, but retained the PvuII recognition sequence as part of their overall target site 
(Fonfara et al. 2012, Schierling et al. 2012, Yanik et al. 2013).  This work demonstrates that 
other nucleases can be paired with various DNA binding domains to create greater 
specificity.  One wonders if a restriction enzyme with a four base specificity may be more 
versatile or if base specificity could be eliminated in an alternative nuclease. 
 
Monomeric TAL effector nucleases 
Because FokI nuclease requires dimerization and thus the use of paired TALENs, the 
development of monomeric forms may improve the general application of TALENs in 
Genome Editing.  A real breakthrough may come from the fusion of a nonspecific 
monomeric nuclease or cleavage domain and a TALE.  Such a nuclease would streamline 
TALEN production by halving the development work load and simultaneously produce a 
more compact enzyme.  Some attempts have been made to design a FokI monomer and to 
make TALE fusions to known monomeric nucleases. 
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A monomeric engineered nuclease has been reportedly isolated using a high 
throughput screen.  The nuclease included a TALE DNA binding domain fused to tandem 
FokI cleavage domains separated by a 95 aa linker. Yeast and human assays indicated that, 
compared with a standard TALEN heterodimer, this nuclease only had 9% to 36% activity 
and exhibited significantly higher cytotoxicity.  These characteristics may result from the 
shorter target leading to more off-target DSBs within the human genome, or they may be 
more related to the monomeric nature of this FokI design (Sun and Zhao, 2014). 
A “mega-TAL” fusion protein was described recently as another strategy for 
monomeric nuclease construction.  This nuclease is composed of a TALE DNA binding 
domain and the site specific LAGLIDADG monomeric meganuclease I-Anil.  In this fusion, 
I-Anil retains its native target site specificity, which is further enhanced by the TALE DNA 
binding domain.  This architecture, when combined with the Trex2 exonuclease, 
demonstrated high specificity and increased nuclease activity, which resulted in the 
modification of 70% of human cells compared to wild type I-Anil (Boissel et al. 2013). 
In another monomeric example, a TALE DNA binding domain was fused to the site 
specific GIY-YIG monomeric meganuclease I-TevI catalytic domain.  This domain was 
previously shown to be functionally separate from its native DNA binding domain, but it still 
retains partial site specific recognition, as the sequence CNNNG is required for nuclease 
action (Edgell et al. 2004).  Additionally, it was demonstrated that this I-TevI nuclease 
domain can be fused to other DNA binding domains to produce hybrid nucleases (Kleinstiver 
et al. 2012).  The I-TevI::TALE fusion proved to be a functional monomeric nuclease, and, 
as expected, retained the CNNNG sequence requirement as part of its overall target 
sequence.  This fusion was shown to have an activity of 8.9% compare to 6.9% for a standard 
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TALE::FokI fusion in plants and 4.3% versus 9.2% respectively in hamster CHO-K1 cells 
(Beurdeley et al. 2013).  
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